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ABSTRACT 
 
HARNESSING THE ANOPHELES MICROBIOME  
TO CONDITIONALLY EXPRESS ANTI-PLASMODIAL  
EFFECTORS DURING THE BLOOD MEAL 
 
By 
Jackie Lynn Shane 
December 2018 
 
Dissertation supervised by Dr. David Lampe 
 The control of vector-borne diseases such as malaria has been an extremely important 
research subject for hundreds of years. Because of the complex lifecycles of the pathogens that 
cause these diseases, finding a comprehensive treatment or preventative strategy has proven 
extremely difficult. Malaria alone is responsible for almost half a million deaths annually, most 
of them children under 5 years old. This disease is caused by parasitic protists in the genus 
Plasmodium that are transmitted to humans from Anopheles sp. mosquitoes. Most preventative 
strategies that are in use today revolve around controlling the vectors, including bed nets, 
insecticides, and larval habitat removal. Transgenic mosquito lines are also being produced that 
inhibit the mosquito from transmitting the pathogen; however, progress in this area is hindered 
by the number of species that vector Plasmodium as well as the ability of the transgenes to 
spread through wild populations. The way in which this study overcomes these hurdles is by 
using a technique called paratransgenesis.  
 v 
 Paratransgenesis is the process of genetically engineering symbionts to affect host 
phenotype; in this study, the natural midgut symbiont Asaia sp. SF2.1 was engineered to secrete 
antimalarial effectors causing the mosquito to be unable to transmit malaria. However, 
constitutive expression of these effectors causes a fitness disadvantage to the transgenic Asaia. 
Therefore, it is desirable to express these molecules only when Plasmodium is present in the 
mosquito midgut, namely when a mosquito takes an infected blood-meal. The first step in this 
process was to optimize this wild-type bacterium for use in the laboratory to find putative 
promoters that were induced under blood meal conditions. Three techniques were employed to 
find conditional promoters using the plasmid pGLR1: a promoter trap library, screening the 
promoter regions of conditional Asaia homologs, and RNA-seq analysis under the varying 
conditions. The latter two methods produced four blood meal induced (BMI) promoters that were 
then cloned into an antimalarial expression plasmid pCG18.  
 These conditional strains were evaluated for fitness against a constitutive control using 
maximum growth rate, ability to compete against wild-type Asaia, and the ability to colonize the 
mosquito midgut. Overall, the conditional strains outperformed the constitutive control and were 
tested for Plasmodium inhibition. All conditional constructs show significantly reduced infection 
rates of the mosquito from the wild-type Asaia, with three performing significantly better than 
the constitutive control. The ability of these conditional strains to not only reduce disease burden 
but compete effectively with wild-type bacteria demonstrates the effectiveness of using a 
paratransgenic approach to control vector-borne disease. These promoters will be used in further 
testing to insert antimalarial constructs into the Asaia genome and eventually be tested in the 
field. 
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 1 
1. Controlling Vector-borne disease: what was, what is, and what’s working 
1.1. What are VBDs? 
Infectious diseases account for over one quarter of all human morbidity and mortality1, and 
in the last 30 years the number of reported cases for many infectious diseases has increased 
significantly. These diseases are considered emerging and zoonoses, or diseases transmitted 
between animal and human, seem to be most prevalent2. When quantifying the abundance and 
characterization of emerging diseases it was also seen that vector-borne diseases (VBDs), 
diseases transmitted by an arthropod vector to a primary host, had disproportionately high rates 
of emergence compared to other types of infectious disease. For example, vector-borne diseases 
account for about 14% of all infectious diseases but make up almost 30% of all emerging 
diseases3. It is probable that this is due to VBDs having a lower host specificity since they must 
survive and persist through a variety of physiologically different organisms4.  This kind of 
adaptation has led to a plethora of organisms being used to vector disease. 
VBDs have plagued human civilization since the beginning of recorded medicine; most 
notably causing “The Plague” or “Black Death” in Europe in the 14th century. However, it was 
not until relatively recently, 1877, that the first transmission of disease from vector to human was 
demonstrated with an infection of filariasis, Wuchereria bancrofti,  from Culex mosquitoes5.  
Shortly after malaria, dengue, and yellow fever were similarly characterized6. Understanding 
how vectors transmit disease allowed progress in development of tropical regions, for example, 
in the construction of the Panama Canal7. Although understanding the vector-pathogen 
relationship helped to control these diseases, they remain a huge source of disease, making up 
over ¼ of all human illness8. It has been estimated that at least half of the world’s population has 
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been infected with at least one type of VBD8, causing roughly 1 billion infections and 1 million 
deaths per year9.  
1.1.1. Pathogens 
There are a wide variety of pathogens that can be transmitted by vectors to cause disease; 
most of which are zoonotic, infecting mainly non-human animals, and not strictly human 
parasites. Often humans end up as accidental hosts for these parasites; however, some disease-
causing pathogens do use humans as a primary host5.  These pathogens fall into four main 
categories: nematodes, protozoa, bacteria, and viruses. All of these, however, can be 
characterized as multi-host pathogens and as such have evolved systems that allow them to exist 
across various species. These pathogens are often ecological generalists allowing their infection 
of different distantly related species, overcoming the “species barrier”4. For example, West Nile 
Virus, in North America, is capable of colonizing 49 species of mosquito and ticks, and infecting 
over 229 species of animals including birds, alligators, and horses10. These parasites do this 
through a process called host adaptation, in which genetic changes or acquisition of genetic 
elements allow the pathogen to change its physiology to exist in the varying environments it will 
encounter between different hosts or even between different tissues within the host11. This 
process is mandatory for many of these pathogens because the microbes must both extract 
nutrients for survival and reproduction within the many different environments they encounter in 
their multi-host life cycle, as well as resist the hosts natural defenses to the parasitic invasion12. 
The life cycle of many parasites, especially those involving a blood-feeding arthropod, 
require similar steps in order to be transmitted and spread between host species. During 
mechanical transmission of the pathogen the parasite does not go through any change in its life 
cycle as a result of switching hosts5. This is seen usually for pathogens that are carried by 
 3 
arthropods from contaminated feces to their primary hosts- most commonly the vectors of human 
parasites are houseflies, Musca domestica13, as can be seen in Shigella14, Helicobacter pylori15, 
Vibrio cholera16, Toxoplasma, Giardia, as well as a great number of other diseases13.  More 
relevant to this research is the biological transmission of parasites, in which the pathogenic 
organism undergoes biological development within the vector before it can be passed on to its 
primary host. This can include simple propagative transmission, in which the parasite undergoes 
reproduction and cyclopropagative transmission, where there is development through the life 
cycle and reproduction within the vector. On the other hand, the parasite can undergo 
cyclodevelopemental transmission, which is development through the life cycle without 
reproduction; and finally vertical transmission, which requires the parasite to be passed down 
through generations of vector before being able to be passed on to the primary host5. In all types 
of biological transmission there is an extrinsic incubation period inside the arthropod vector that 
usually lasts between 7 and 14 days to allow for the parasite to undergo the developmental steps 
necessary in order to be transmitted17. 
1.1.2. Vectors 
Vectors of disease represent a substantial variety of organisms all across the globe; most 
commonly these vectors consist of arthropods. However, not all arthropods, and not even all 
blood feeding arthropods, become vectors for disease. The capacity of an organism to become a 
vector can be measured by their vectorial competence, or their ability to acquire, maintain, and 
transmit the pathogen18. As explained previously, the pathogen must undergo specific life cycle 
stages within the vector, and some arthropods simply to do not have the supportive environments 
in which this can occur. Things that affect vectorial competence include the ability of the vector 
species to take up the pathogen (having the correct mouthparts and being active when the 
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pathogen is available) and the ability of the pathogen to survive in the vector in a suitable area 
for growth and reproduction. Furthermore, a vector must possess membranes the pathogen can 
travel through to complete its life cycle and a complementary immune system. Lastly, the vector 
must be able to transmit the pathogen which can be done through biting, regurgitation, 
defecation, or even ingestion19. Vectorial capacity, on the other hand, is a measure of the 
efficiency of the vector to transmit the disease, which can be influenced by a host of other 
external factors, such as nutrient availability, seasonal fluctuation, and land use variability20.  
One of the most efficient group of arthropod vectors are mosquitoes8.  There are over 
3,500 species of mosquito, of which a relatively few actually vector disease6. Female mosquitoes 
require the nutrients in a blood meal to make essential proteins to produce eggs, and it is this 
obligatory blood-feeding is what allows female mosquitoes to transmit disease21. Notable 
examples of mosquito-bonre diseases include malaria, vectored by the Anopheles mosquitoes; 
West Nile virus, vectored by the Culex mosquito; and zika, chikungunya, yellow fever, and 
dengue, vectored by the Aedes mosquito. Two species, Aedes aegypti and Aedes albopictus, 
represent a substantial portion of vectors in this genus, most likely due to their abundant 
adaptation to human environments22. For example, Aedes aegypti has evolved to blood feed 
almost exclusively on humans and has adapted its habits to make use of the debris left in urban 
environments for larval breeding grounds. Furthermore, the range of this vector species puts at 
risk over half of the human population on earth6.   
1.1.3. What’s the problem? 
Considering the distribution and abundance of mosquito vector species across the globe, 
VBDs are quickly becoming an important area of research for scientists studying infectious 
diseases. Many of these diseases are considered emerging as discussed previously and are 
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neglected in terms funding for treatments and preventions. There are many reasons why these 
diseases are suddenly becoming more prevalent than was seen thirty or forty years ago, most of 
which directly involve the vectors of these pathogens and not the disease itself. First of all, the 
exponential human population increase creates many of the factors that contribute to the 
expanding ranges and numbers of infection. Urbanization itself creates an environment in which 
vector species can thrive and transmit these diseases quickly due to overcrowding and 
deterioration in living conditions8. Furthermore, inadequate water services, waste management, 
and sewage systems creates flourishing breeding grounds for vector mosquitoes7. Many 
pathogens have even begun to alter their life cycle to develop an urban epidemic cycle, in which 
they only transmit disease from person to person contradicting their normal zoonotic life cycle in 
which humans are primarily accidental hosts10. There are many reasons that human urbanization 
is growing, one of the main factors being people escaping violence in rural communities for the 
relative safety of city life23.  
 The movement of individuals has also caused a substantial change to the spread of VBDs. 
International trade and travel provide perfect mechanisms for these pathogens to spread to far 
away areas. Because species of mosquitoes that are able to vector diseases are already present 
globally, the transport of the pathogen can facilitate infection in areas that are otherwise 
unexposed7. For example, multiple strains of the dengue virus were only found in south east Asia 
in the early 1970’s and all other affected areas had only one strain of the virus8. However, due to 
increased travel and trade across the world, almost every tropical habitat is now hyperendemic 
with multiple strains of dengue viruses. The increase in West Nile Virus in the western 
hemisphere can also be attributed to the globalized movement of the human population8. 
Furthermore, changes in the way land is used in these endemic areas has contributed to the 
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spread of many vector-borne pathogens. Along with changes in water and sewage associated 
with urbanization, the deforestation caused by logging, agricultural development, or the 
construction of man-made facilities such as city expansion and roadways has caused the range of 
these pathogens to expand. For example, in South America, the logging of the Brazilian rain 
forest has caused the Plasmodium vector species Anopheles darlingi to expand its population as 
well as range. This is because of this mosquito prefers more sunlight than the forest canopy can 
naturally provide24. 
 In the past 50 years the global mean temperature has risen more than 0.6°C and the rate 
of temperature shift is larger than it has been in the last 1,000 years8. The warming of the 
environment can directly affect pathogens by shortening their extrinsic incubation period. This in 
effect makes the pathogen transmissible at earlier times and allows many more mosquitoes to 
transmit the parasite that would have otherwise died or not been available when the pathogen 
was infectious. Warmer temperatures also exacerbate most parasite’s replication inside the vector 
making the likelihood of infectious pathogens traveling to the salivary glands and being 
transmitted much greater25. Furthermore, increasing temperatures open up new territories for 
vectors that were previously uninhabitable because of low temperatures26. This has been seen 
most notably in the spread of malaria to the eastern African highlands where the increase in 
temperature showed a distinct correlation with an increase in vector species populations and 
incidence of disease27. In Europe it has also been seen that Aedes and Anopheles  vector species 
that have begun to establish in more temperate regions are beginning to spread to more northern 
regions of Europe and even into the United Kingdom28.  
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1.1.4. Malaria 
One of the most serious of these emerging diseases is malaria, which causes over 430,000 
deaths per year, most of which occur in children under 5 years old29. The economic burden of 
this disease is of great concern as well.  For example, in 2003, Uganda spent over 600 million 
U.S. dollars in direct and indirect costs due to the abundance of malarial cases. Only about two 
million of this money was spent on preventative strategies for controlling the disease30. The 
funding for disease research is burdensome as well, totaling almost 3 billion dollars in 201531.  
 Malaria is caused by parasitic protists belonging to the genus Plasmodium. These 
organisms have a complex life cycle involving an Anopheles mosquito vector and a human host 
(Figure 1.1). When a female mosquito takes a blood meal from a person infected with 
Plasmodium, the gametocytes are ingested and undergo sexual reproduction resulting in the 
invasion of motile zygotes (ookinetes) into the lining of the mosquito midgut. These will develop 
into oocysts that produce sporozoites through asexual reproduction32. These stages of the 
Plasmodium life cycle represent population limiting steps to the parasite’s survival; only about 
0.001% of the ingested gametocytes will survive to produce oocysts33. There are many reasons 
this bottleneck occurs, the most important of which is the mosquito’s immunity defense against 
foreign pathogens. The proteins TEP1 and LRIM1 are induced when a mosquito takes an 
infected blood meal and if genetically silenced in the mosquito, cause a dramatic increase in the 
number of oocysts that are formed34. Furthermore, the symbiotic microbiota that the mosquito 
possesses have been shown to help reduce Plasmodium loads inside the mosquito35, which will 
be discussed in depth below.  
  The few oocysts that are formed will then rupture to release the sporozoites that migrate 
to the mosquito salivary glands where they invade and reside in the salivary gland lumen. When 
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the vector mosquito then feeds on a human, the sporozoites are transferred to the human host22. 
These will infect liver cells and go through an asexual life cycle to become merozoites that infect 
and multiply in erythrocytes causing them to burst22. This process can take anywhere from 22-24 
hours36. A small portion will differentiate into gametocytes that will be able to infect the 
mosquitoes, thus completing the life-cycle22. The entire process from the initial introduction of 
the parasite to stages that are infectious to mosquitoes can take as little as 30 hours and at each 
life cycle stage transcriptional differences occur that can make creating control of the parasite 
difficult37. For this reason, much of the research involved in controlling the spread of malaria 
focuses on the mosquito vector itself. 
 
1.2. Vector control strategies 
One of the first global malaria control strategies was begun in Africa in 1993, however, due 
to insufficient emphasis on the vector, socio-political burdens of the disease, and lack of cost-
effective strategies not much progress was seen for disease reduction38. These early strategies 
were predominantly based on controlling the vector by controlling its environment, such as the 
use of bed nets, insecticides, and larval breeding habitat reduction. Bed nets were perhaps the 
first line of defense against mosquitoes and the diseases they transmit being used since the 18th 
century to prevent the biting of insects before the dangers of VBDs were realized39. Currently, 
bed nets being used are treated with insecticide to not only create a physical barrier to the vector 
but also repel the mosquitoes away from human dwellings. This has proven to be one of the 
simplest and cost-effective strategies for preventing transmission of the disease, affecting 
mosquito population densities, infection prevalence, and vectorial capacity40. However, these 
diseases, especially malaria, continue to spread and infect an unacceptable number of human 
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hosts. One of these reasons is simply the lack or improper use of these bed nets. For example, 
only between 60-70% of women in Uganda reported having at least one bednet per household 
and these numbers were even lower in rural communities41. Furthermore, even when bed nets are 
distributed for free, only 61% of pregnant woman were recorded as using them nightly42. Also, 
because these bed nets are distributed for free many people have been recorded as using them for 
unintended purposes such as fishing nets and clothing, however the validity of these claims are 
debatable43. Most interestingly however, is the adaptation by mosquitoes to overcome this 
physical barrier in malaria endemic regions. In rural Senegal, where bed nets are widely used, the 
malaria vector Anopheles funestus is six times more likely to display feeding behavior during 
daylight hours than at normal nighttime or crepuscular times when bed nets prevent them from 
biting44.  
Along with bednets, one of the most widely used vector control strategies is the spraying of 
insecticidal chemicals both in open air as well as indoor residual spraying. The widespread use of 
insecticides in the 1960’s helped to control almost all VBDs around the world. However, in 
subsequent years many control programs were disbanded and funding for research into VBDs 
dwindled as these diseases became less of a global health concern8. This unfortunately preceded 
the trends observed with newly emerging diseases across the globe discussed previously, of 
which VBDs make up a substantial percertage7. After the recognition that these diseases had 
been neglected and were subsequently reemerging, the first line of defense was to reinstate the 
insecticide control programs that had been disbanded along with creating new initiatives. This 
resulted in an even more robust use of chemicals to control disease vector arthropods45. The 
overuse of these chemicals, such as DDT, has caused a major insecticide resistance crisis in most 
endemic parts of the world, accounting for more than 100 species of mosquito acquiring 
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pesticide resistances. Many other chemicals have been and are currently being used and explored 
as vector control strategies; however, reports of resistance to almost all of these insecticides have 
been documented in at least one species of mosquito46. Interestingly, acquiring resistance by 
some vectors has actually helped to control these diseases due to a decreased vectorial capacity, 
caused by the insecticide resistance. For example Culex quinquefasciatus mosquitoes that have 
acquired insecticide resistances are less able to transmit Wuchereria bancrofti that causes 
filariasis19. However, in almost all other cases of resistance in vector species, their emergence 
calls for novel strategies to control the spread of vector-borne disease. 
1.2.1. Transgenesis 
Genetic approaches such as transgenesis, or the engineering of the mosquito genome, 
present new ways to fight malaria in the mosquito. Progress has been made in control strategies 
that involve population reduction (decreasing the number of potential vectors) and population 
alteration (changing the vectors phenotypically)32. Many studies involve the production and 
release of transgenically modified mosquitoes to accomplish these goals. The most productive of 
these studies involve the transgenic mosquito Aedes aegypti that vector dengue. One study in 
Brazil showed that by releasing about 4,000 transgenic males per hectactre they were able to 
suppress the mosquito population 47. However, these males showed a decrease in mating when 
compared to the wild type and the mosquito population was never fully exterminated even with 
multiple releases of the transgenic mosquitoes47. In a laboratory based study using Anopheles 
stephensi malaria vectors population reduction of mosquito populations was accomplished using 
a transgenic male determining factor to alter the sex-ratio of lab reared mosquitoes, in effect 
reducing the population size of subsequent generations48. These engineered mosquitoes cause 
sterility or death to achieve population reduction or are refractory to pathogen infection causing 
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population alteration49. However, like traditional sterile insect technique strategies, maintaining 
population reduction strategies in the field requires continual reintroductions of the transgenic 
mosquitoes3 until the local population become extinct.  
The implementation of population alteration strategies in the field is, in principle, very 
challenging due to the difficulty of spreading and sustaining the transgenes throughout large 
populations of mosquitoes5. For example, Aedes aegypti  mosquitoes were engineered to be 
resistant to the dengue virus; however, after 17 generations, all transgenes had been mutated or 
silenced50. This could be related to the fitness of the transgenic mosquitoes, which may be 
decreased due to factors such as extra energy costs to confer resistance, any mutations caused by 
the introduction of the exogenous gene, and inbreeding complications encountered when trying 
to establish the gene in the population51. To overcome these pitfalls, gene drive mechanisms are 
being investigated to drive these transgenes through populations to achieve high allele frequency. 
However, roadblocks remain, including the evolution of drive resistance in the vector52, 
problems associated with releasing large numbers of mosquitoes in endemic areas, and ethical 
impacts for the surrounding communities53. These barriers to implementation of transgenic 
vectors provide a compelling basis for the development of simpler and easier to manipulate 
transgenic control strategies. 
1.2.2. Paratransgenesis 
In this study, an alternative population modification technology, paratransgenesis, is 
employed. This involves the genetic modification of internal symbionts to affect their host’s 
phenotype32. This kind of strategy was inspired by the use of the bacterium Wolbachia in 
mosquito species for population reduction as well as alteration54. One of the first studies used 
Wolbachia to inhibit transmission of the dengue arbovirus by reducing the Aedes vector lifespan. 
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The ability of a mosquito to stay alive longer than the extrinsic incubation period of the arbovirus 
is a limiting factor in disease transmission. By using Wolbachia from Drosophila melanogaster 
researchers effectively reduced the vector lifespan enough to hinder the pathogen’s lifecycle54. In 
addition, this bacterium affects mosquito populations through infected males by creating 
cytoplasmic incompatibility with uninfected female mosquitoes and results in inviable eggs55. 
These population suppression studies have been moved to the field in areas such as Queensland, 
Australia, where they were shown to cause local extinction events in vector mosquito 
populations56.  However, further analysis into the effects of introducing this bacteria to the 
mosquito shows that essential mosquito population dynamics were compromised55,  and barriers 
to the transmission of the Wolbachia were erected by native bacterial symbionts57. Using the 
natural bacteria of the mosquito in a paratransgenic approach may overcome many burdens 
encountered during implementation of a transgenically modified insect species while avoiding 
the deleterious effects caused by using non-native microbes. 
By modifying genes of mosquito symbiotic gut bacteria it is possible to deliver 
antiplasmodial compounds directly in the compartment of the mosquito where the sexual stages 
of Plasmodium develop32. Wang et al. 2012, showed that by modifying the symbiotic bacterial 
species Pantoea agglomerans, engineered antiplasmodial effector molecules could be produced 
to inhibit Plasmodium development. Pantoea was found to be a dominant species in field caught 
Anopheles gambiae as well as in laboratory colonies of An. stephensi, An. gambiae and An. 
albimanus. This experiment used recombinant strains of Pantoea to secrete different anti-
malarial effector molecules58 using a hemolysin secretion system59. It was found that scorpine or 
(EPIP)4 when controlled by a neomycin phosphotransferase promoter from Tn5, had the greatest 
effect on Plasmodium oocyte reduction. When these two effector molecules were combined in a 
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dual-cassette the inhibition (reduction of oocysts) was close to 100%, decreasing the prevalence 
(percentage of mosquitoes with any oocysts) from >99% to <29%. One obstacle this did not 
tackle is how to introduce and spread the transgenic bacterial species in the wild population of 
mosquitoes58. 
Ideally, for prolonged control of malaria the paratransgenic bacterial species should be 
vertically transmitted between generations. This is a difficult task because in the first 12 hours of 
adulthood Anopheles mosquitoes evacuate the meconial peritrophic membrane of the midgut 
which reduces symbiotic bacteria by over 99.5%60. Recently, an easily transmitted symbiont, 
Serratia, was shown to be effective when engineered to produce anti-malarial effectors inside of 
mosquitoes61. However; it has been known for decades that strains of Serratia are opportunistic 
pathogens in humans62 and in recent years have developed multi-drug resistances causing more 
invasive and transmittable infections, especially in newborn babies63. Obviously, using a natural 
bacterium that is much less potentially pathogenic to humans would overcome the ethical 
implications of releasing this kind of genetically modified organism in the wild. The midgut 
symbiont Asaia, which is also easily transmitted between mosquito generations64, has rarely 
shown infection potential, and these events occur exclusively in extremely immunocompromised 
patients65,66.  
1.3. Vector microbiomes 
Mosquitoes are one of the most widespread and diverse insect groups. There is little doubt 
that their evolutionary success in some ways can be attributed to the symbiotic relationships they 
have established with microorganisms67. These intimately associated relationships allow for both 
the symbiont and mosquito host to undergo rapid evolutionary events that surpass normal rates of 
population change and permits the spread and fixation of these symbiotic relationships in 
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different host communities. For example, in a simliar arthropod system, the bacteria Rickettsia 
confers a fitness advantage to the sweet potato whitefly, increasing its survival by up to 30%. 
This resulted in the infection of Rickettsia going from near non-existance to fixation in less than 
six years68. This evolutionary interplay between symbiotic species has led to the hologenome 
theory which postulates that symbiotic organisms form a single unit with their host called a 
holobiont; this encompasses one entity for evolutionary selection in which all their genes (the 
hologenome) can be pooled as a global function of the entire holobiont69. 
1.3.1. Benefits of bacteria 
There are many insect species that have developed long-term symbiotic relationships 
with microorganisms and share a distinct evolutionary history with them. In mutualistic 
symbiotic relationships, the symbiont benefits from a protected environment and provides a 
benefit to their host organism. In most insects, this includes some sort of nutritional benefit to the 
host, such as vitamins, cofactors, or essential amino acids. However, some symbiotic microbiota 
provide much more distinct benefits to their specific host, such as providing a protective 
advantage. For example, Candidatus Regiella insecticola that have been incorporated into the 
aphid microbiome can protect them from damage from high temperatures or even provide 
resistance to the pathogenic fungus, Pandora neoaphidis70. 
Interestingly, bacterial density within the mosquito midgut is greatly increased when the 
mosquito takes a blood meal, seemingly due to the redox ability of enteric bacteria to cope with 
the stress of catabolizing a blood meal67. The number of symbiotic bacteria in the midgut during 
a blood meal is of great importance when trying to control VBDs such as malaria. For years it 
has been known that the microbiome of the mosquito midgut can inhibit malarial transmission. It 
was found that Anopheline species harboring diverse microorganisms in their midgut had 
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significantly less oocyst development than individuals raised in a sterile environment71. Another 
study showed that the rate of infection for Anopheles mosquitoes containing S. marcensces could 
be up to 200 times lower than control mosquitoes, although the bacteria also increased the 
mortality of the host72. Host death is a result of a significant overlap in immune response 
mechanisms for both bacterial and malarial infections73. Furthermore, Gram-negative bacteria 
found in the midgut have a much greater capacity to reduce Plasmodium oocyte formation than 
Gram-positive symbionts74.  
1.3.2. Microbiome Composition 
The ways in which these symbiotic relationships occur are varied but in mosquitoes the 
main source of acquisition of symbiotic bacteria is through the consumption of colonized nectar, 
larval water, or transmission from another infected mosquito. All mosquitoes feed on nectar for 
their everyday energy needs; a female mosquito only blood feeds in order to obtain the proper 
nutrition for egg development. For years it was believed that nectar should be free of 
microorganisms because plants would fight off the invading species to preserve the carbon 
reserve of nectar for pollinators. However it has been shown that not only are nectars inhabited 
by a range of microorganisms but that these symbionts can be transferred between different 
plants by pollinators75. When analyzed in both southern African and northern Israeli flowering 
plants the Gammaproteobacteria dominated this bacterial niche75,76. Both Pantoea and Asaia 
species were found to inhabit a variety of these species of flowering plants. It was also seen that 
most of the bacterial species sequenced from these communities were unidentified representing 
the lack of research into this new and interesting bacterial niche76. These habitats were originally 
only recognized for their fungal symbionts however it has been seen that many bacteria can 
dominate this environment and even coexist with yeast species, especially Gluconobacter.  The 
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variability seen with fungi vs bacterial dominance in these habitats has been correlated primarily 
to differences in temperature and not necessarily to differences in the microbiome77. This 
correlates heavily with the microbiome observed in the mosquito midgut, which shows a strong 
dominance of Gammaproteobacteria followed by Alphaproteobacteria and Betaproteobacteria69. 
In the last few years, experiments involving microbial screening of the mosquito midgut 
have increased due to emerging sequencing technologies and development of possible field 
applications78. Using mostly 16S ribosomal sequencing techniques, the basic microbial ecology 
of the mosquito midgut has been characterized although results differed between species and 
locations. It was found that in adult Anopheles gambiae, Proteobacteria and Bacteroidetes 
dominated the microbiome with the most abundant taxa belonging to Enterobacteraceae and 
Flavobacteriaceae79. Another study found that the majority of identified bacteria belong to the 
Gammaproteobacteria such as Pseudomonas and Aeromonas along with other species of 
Pantoea, Acinetobacter, Brevundimona, Bacillus, Sphingomonas, Lysinibacillus and Rahnella78. 
Importantly throughout many studies it was seen that bacteria in the genera Pantoea, 
Acenitobacter, and Asaia were found across multiple species of mosquito in significant 
quantities69.  
1.3.2.1. Asaia bogorensis 
Asaia sp. was first isolated in nectar from Indonesian flowers. It is a Gram-negative, rod 
shaped α-proteobacteria80. This bacterium colonizes a substantial range of arthropod disease 
vectors, including: Aedes aegypti and Aedes albopictus, vectors of a variety of human viruses 
such as dengue, chikungunya, zika, etc81 and Scaphoideus titanus, the leafhopper vector that 
transmits grapevine phytoplasma82. Potentially, pathogen inhibition engineered in this bacterium 
could be used to control a variety of VBDs. The first Asaia symbiont of mosquitoes was found in 
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the Asian malaria vector, Anopheles stephensi, in 200783. Since then, it has been discovered in 
An. gambiae, An. maculipennis, and Ae. aegypti as well67. It was shown to densely populate the 
female midgut, larval gut, and male reproductive tract. When mosquitoes were infected with a 
fluorescent expressing lab strain of Asaia sp.SF2.1, it persisted from the larval to adult stage, was 
passed to offspring from their mother during a process called “painting” and was transmitted 
during mating between male and female mosquitoes64,83,84. Furthermore, the ability of a 
paratransgenic Asaia strain has been tested for its ability to spread in semi-field like conditions 
by Favia et al. It was seen that the GFP fluorescent bacteria was able to spread to almost three 
fourths of the mosquito population in less than 20 days with only one introduction a couple 
dozen infected males; this also persisted across generations of mosquitoes as well85. 
Furthermore, Asaia is conserved in the mosquito microbiome, perhaps, due to the large benefit it 
generates for larval development86. It has also been shown to help inhibit Plasmodium 
transmission and be adapted to life inside mosquito midguts by resisting the immune response of 
the mosquito during pathogen infection87. Because of its native anti-malarial properties as a 
gram-negative symbiotic bacterium as well as its ability to spread throughout a population, Asaia 
may prove to be an excellent candidate for paratransgenic malarial control. 
In order to prevent malaria transmission, Asaia sp.SF2.1 was genetically modified to 
express antiplasmodial effector molecules that were secreted into the midgut88. However, 
producing these proteins in such large amounts causes stress to the organism and many of these 
anti-malarial effector molecules are also anti-bacterial in nature. Therefore, the fitness of the 
transgenic Asaia can be severely compromised. For example, in a similar paratransgenic study, 
the effector molecule PLA2 could not be expressed because it caused mortality of the transgenic 
bacteria89. Therefore, the overarching goal of this dissertation was to produce these effector 
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molecules only when Plasmodium is present inside the midgut or when the mosquito takes a 
blood meal. This was was accomplished by isolating conditional promoters that are activated by 
the influx of the nutrients found in the blood meal and using those promoters to drive 
antiplasmodial effectors that would effectively inhibit the transmission of malaria. 
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Figure 1.1) Life cycle of Plasmodium parasites in both the mosquito vector as well 
as the human host. The pathogen goes through mainly asexual life cycle in the 
human host infecting liver cells. These cells eventually burst and release parasites into 
the bloodstream where they undergo the erythrocytic cycle until a portion of the 
population will branch off to form gametocytes that will be infectious to the next 
mosquito that takes a blood meal. In the mosquito the parasite undergoes a sexual life 
cycle. Gametes fuse to form a zygote that developes into the free-swimming ookinete 
stage. This ookinete will invade the lining of the midgut to become an oocyst inside of 
which thousands of sporozoites will be made asexually. The oocyst will eventually 
burst releasing the sporozoites to infect the salivary glands allowing the parasite to 
infect the next human host.  
Labeled for free use from : https://www.cdc.gov/malaria/about/biology/index.html 
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2. Asaia sp. SF2.1 experimental techniques 
2.1. Background 
In the 19th century, scientists began the endeavor of trying to culture bacteria from the 
environment in the laboratory. This research began as an attempt to culture disease-germs and 
became a novel research topic in medicine90. Since then it has become apparent that some 
bacteria were much more easily cultured in the lab than other bacteria, even when they were 
obtained from the same source. It was observed first through microscopy that the number of 
bacterial cells observed from a sample far outweighed the number that could be cultured on a 
petri plate91. At first this phenomenon was explained by suggesting the excess of bacterial cells 
were simply dead and therefore would not grow. However, it was discovered that these cells 
were metabolically active and far exceeded the culturable bacteria by large orders of magnitude 
especially in freshwater, marine, and soil habitats92 where many species of bacteria coexist as a 
microbiome. In many bacterial communities it is observed that different species will provide 
resources utilized by other bacteria in the community and some species are unable to survive 
without these additional taxa and what they provide in the environment93. Because of this, the 
most culturable of the bacteria are usually the species that are able to adapt and change their 
physiology rapidly in accordance to their environment94. Also proposed is that only the bacterial 
species that require the lowest input of energy for their survival aside from the costs of 
reproduction, or energy of maintenance, will be able to be easily culturable. A great example of 
this is the bacteria Escherichia coli which has an maintenance energy of virtually zero and is one 
of the first and most widely used bacterium for scientific research95. 
To culture bacteria efficiently in the laboratory the energy of maintenance needs to be 
lowered to accommodate different physiologies of the bacteria of interest. One of the first key 
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factors that can prevent bacterial growth is the temperature at which it is grown. Different 
species of bacteria will only thrive if they are grown at optimal temperatures; variables such as 
protein denaturation and inactivation, RNA instability, and speed of cellular functions can all be 
limiting factors96.  These can also affect the distribution of energy within the bacterial cell and 
cause energy deficits in areas of DNA replication and bacterial growth, causing the bacteria to be 
unable to grow effectively. Most notably changes from the optimal temperature impact the lag 
phase of bacterial growth, which is reciprocally proportional to the growth rate97.  
Another of the most obvious components affecting bacterial growth in the laboratory is 
the nutrients supplemented in the growth media. Many bacteria are able to modify their 
physiological needs by inhibiting or enhancing the transcription of specific metabolic functions 
in order to grow in a variety of media. This was observed when bacteria from environmental 
samples were grown on media that did not replicate their environmental conditions and yet 
showed the ability to change and adapt to the differing growth medium92. However, in most of 
these cases the media used to grow the bacteria was highly supplemented with growth factors 
and amino acids that the bacteria could draw upon90. These nutrients can help the bacteria reach 
log phase faster and it was shown in E.coli  that the richness of the media used could be directly 
correlated to the rate of logarithmic growth98. It has also been observed that while bacterial 
growth may be hindered by a lack of nutrients many species of bacteria can go through what is 
called cryptic growth. In this state a small percentage of the bacterial population is selected to 
survive while others are programmed for death so that any remaining nutrients can be used by 
the surviving bacteria to stay viable as long as possible. Once these bacteria are supplied with the 
necessary nutrients they will then proceed through a normal growth cycle to recolonize the 
bacterial population92. 
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Along with the ability to adapt to different nutritional sources many species of 
environmental bacteria have the capability of resisting different kinds of antibiotics at variable 
doses. This is especially true for bacteria that live in a microbial community such as an 
organism’s microbiome. Many symbiotic microbes develop antibiotic resistance through 
rigorous selection of their populations from the overuse of antibiotics and antimicrobials by their 
host or in the environment99. Other more natural methods of acquiring resistance comes from the 
need to survive alongside microbes that may be producing antimicrobials as a mechanism of 
competition76. For the success of future experimental endeavors, such as genetic engineering and 
distinct species isolation from mixed culture and inside the mosquito midgut, it was very 
important for the ultimate success of our goal to explore the antibiotic resistances of our bacteria 
of interest.  
The bacteria used in this study is Asaia sp. is a Gram-negative, rod shaped, acetic acid, α-
proteobacteria. It was shown to grow well on mannitol and glutamate media with acidic pH at 
30°C100. All bacteria found within nectar and nectar-feeding insect microbiomes exhibit a strong 
sugar reliance and require a great deal of carbon for their physiological needs101. Acetic acid 
bacteria are also aerobic organisms but have the capacity to survive in low oxygen environments, 
such as inside certain host tissues. However, increases in aeration are known to reduce the lag 
phase and prolong the logarithmic growth phase of bacteria98. Therefore, optimizing this aspect 
of the bacterial growth can help to standardize data and make in-vitro experimentation more 
efficient.  
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2.2. Materials and Methods 
2.2.1. Basic Culture Techniques 
We first examined the temperature dependence of Asaia sp. SF2.1 to optimize the culture 
technique and establish at what temperatures the bacteria were able to grow. To do this, the 
freezer stock obtained from Italy of Asaia sp.SF2.183 was streaked to single colonies on mannitol 
agar. Three individual colonies were selected and grown for 2 days in mannitol broth at 30°C. 
Once these cultures displayed turbidity, they were diluted in mannitol to an OD600 of 0.1. Each of 
the 3 cultures were used to test growth at 6 different temperatures between 4°C and 37°C on both 
solid and liquid media. Each culture was streaked to single colonies on mannitol agar and 50µl of 
each culture was inoculated into 5mL of mannitol broth, thus making 3 plates and 3 broth 
cultures at each temperature. Over the course of two weeks the cultures were observed for any 
visible growth at which time number of days growing was recorded (Table 2.1).  
To optimize growth of the bacteria on varying media sources, several types of media and 
carbon sources were evaluated similarly. Just as was done to test the Asaia temperature 
parameters, the bacterium was streaked to single colonies and 3 cultures inoculated. From these 
cultures both solid and liquid cultures were made of each media: LB, mannitol, nutrient, TSA, 
YPD, sheep’s blood, and Davis and M9 minimal media with 1%(w/v) glucose102. Davis minimal 
media is made with 7g K2HPO4, 2g KH2PO4, 0.5g sodium citrate, 0.1g magnesium sulfate, and 1 
gram ammonium sulfate brought to 1 L of distilled water. These were all grown at 30°C for 5 
days to observe growth. After 5 days, any media not promoting Asaia growth was considered as 
no growth (Table 2.2).  
Another aspect of the growth medium tested was the ability of the Asaia to grow at 
varying concentrations of carbon. To do this, a 100%(w/v) solution of nectar was created using 
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1:2:1 ratio of glucose, sucrose, and fructose respectively. In Davis minimal broth the appropriate 
volumes of nectar were added to create 0.1%, 1%, 2%, 5%, 10%, 15%, 25%, 35%, and 50% 
nectar containing media. Cultures were reinoculated at 0.01 OD600 from broths made in the same 
way as previously described, so that each nectar concentration contained 3 cultures. They were 
observed for 5 days and growth recorded for each concentration. Considering the results from 
this data, the experiments performed on the varying medias was repeated with the addition of 
2%(w/v) nectar (Table 2.4) 
It was also noticed that the bacterium grew better in the larger Erlenmeyer flasks than in 
culture tubes which led us to evaluate its growth rate in different volumes of media and 
subsequently different amounts of aeration. Again, the original wild-type Asaia was used to 
inoculate 3 separate cultures. In the same manner as described previously, each culture was used 
to inoculate varying volumes of Davis minimal media with 5% nectar in culture tubes, from 1mL 
to 10mL. For the first 48 hours the time in which it took the cultures to reach an OD600 of 1.0 
was recorded after which the day that turbidity was seen was recorded. The cultures were grown 
in a shaking incubator at 30°C. 
It was imperative in our research to know the antibiotics that were effective on Asaia and 
the concentration at which they needed to be applied. Again, 3 colonies were selected from a 
mannitol streak plate of the original Asaia sp.SF2.1 stock; however, this time they were all 
inoculated into the same broth culture to account for any individual variation between isolates. 
Fifty microliters of this culture was used to inoculate 2 mL of Davis minimal media 
supplemented with 2% nectar with varying concentrations of the antibiotics kanamycin, 
chloramphenicol, gentamycin, tetracyclin, and apramycin. The concentration used to kill E. coli 
for each antibiotic is shown in Table 2.5 and 16 cultures were made for each antibiotic from 0-15 
 25 
times this concentration. The cultures were allowed to grow for 4 days at which time the lowest 
concentration culture that prevented bacterial growth was recorded (Table 2.5). 
Another aspect of this bacterium that was investigated was how many colony forming 
units (CFUs) were contained in a specific optical density. To evaluate this 3 Asaia colonies were 
used to inoculate 2mL of Davis minimal media supplemented with 5% nectar and grown 
overnight. The following day these cultures were diluted to an OD600 of 1.0 and 10 serial ten-fold 
dilutions were made for each. One hundred microliters of each dilution was plated on mannitol 
media and allowed to grow for 2 days. after which, colonies were counted and averaged across 
the three samples for any plates that had distinguishable colonies. From this, the number of 
CFUs contained in 100µL of an OD600 of 1.0 culture of Asaia were calculated. 
In order to culture the bacterium efficiently, a growth curve was constructed for the Asaia 
sp.SF2.1. The first successful curve constructed was performed by inoculating 2mL mannitol 
broth with a single colony from a new Asaia plate. This was allowed to grow overnight to about 
an OD600 of 1.0 and 100µL of the culture was used to reinoculated 100mL of Davis minimal 
media supplemented with 5% nectar in an Erlenmeyer flask. The culture was allowed to grow 
overnight, and optical density was recorded from 18-29.5 hours after inoculation until the culture 
reached stationary phase. These data were used to create a growth curve in excel (Figure 2.1A). 
Different inoculation ratios were also tested including 1/10, 1/50, and 1/100 of the final volume. 
The optical densities of these cultures were recorded from the initial inoculation for 16.5 hours 
(Figure 2.1B). 
2.2.2. Isolating Asaia from Mosquitoes 
To isolate wild-type Asaia from the midgut of the mosquito different media and 
antibiotics that were previously tested were used to preferentially select for the species. First, 
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mosquitoes were fed on a sugar meal containing an OD600 of 0.1 of a fresh Asaia sp.SF2.1.  
These were allowed to colonize the midgut for 24 hours to ensure that the bacteria had 
effectively colonized the midgut. Ten mosquitoes were dissected, and their midguts were 
homogenized in 100µl/midgut of PBS using a Kimble 1.5 mL pestle tissue grinder. These 
solutions underwent six 10-fold serial dilutions and 100µl of each solution was plated on a both 
mannitol and minimal media containing multiple different combinations of 68 mg/L 
chloramphenicol, 60 mg/L gentamycin, and 200 mg/L ampicillin since it was shown to be 
resistant to these antibiotics. Kanamycin was avoided as it is the major antibiotic resistance used 
to select for plasmid containing bacteria in our lab.  
The most prominent bacteria other than Asaia in the midgut microbiome were small 
round white colonies. Four of these colonies were used to inoculate mannitol media and grown 
overnight at 30°C. Two microliters of these cultures were used as DNA template to run a 
OneTaq PCR103 of the 16S ribosomal subunit coding region of the chromosome. The bands for 
each culture were extracted and a sequencing reaction was performed in both the forward and 
reverse direction with the same primers as used in the PCR. These products were run on an ABI 
300 single capillary sequencer and chromatograms were obtained for 3 of the four samples. 
These sequences were analyzed using BLAST and aligned with the bacterial genus of 
Elizabethkingia. The next step was to try using minimal media with a carbon source that the 
Elizabethkingia could not grow on. For this 2% (w/v) arabinose was used in Davis minimal 
media with the varying antibiotics used in the previous experiment. Administration of bacteria 
and mosquito dissections were performed as explained previously and Asaia sp. SF2.1 were 
singularly cultured on the plates. 
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Another important factor in isolating Asaia from the midgut was to ensure that our 
transgenically altered bacteria behaved in the same way and that it could be isolated 
independently from the wild type. This was accomplished by performing the same mosquito 
culturization as described previously to ensure that the mosquitoes were colonized with wild-
type Asaia. After 24 hours however, the mosquitoes were then fed sugar meal containing 0.1 
OD600 of the GFP fluorescent strain ANB50
104. This was again cultured for 24 hours before 
mosquitoes were dissected and midguts homogenized. They were plated in the same way as 
described previously on minimal media supplemented with arabinose, 120 mg/L kanamycin and 
either 136mg/L chloramphenicol or 60mg/L gentamycin. The colonies were analyzed for 
fluorescence and PCR was performed on 4 colonies for each antibiotic to ensure that the 
transgenically altered bacteria was indeed ANB50. 
2.2.3. Cloning techniques for Asaia sp. SF2.1 
Another hurdle that needed to be overcome was the difficulty encountered when trying to 
clone and transform DNA into Asaia sp.SF2.1. It was very common to have difficulty ligating 
Asaia chromosomal DNA in to vector plasmids while less difficulty was experienced using E. 
coli or other plasmid DNA. To do this, the vector pGLR1 (Figure 2.2) and the HmuT promoter 
sequence from the Asaia genome discussed in the following chapter was used in the ligation with 
a vector to insert ratio of 1:1, 1:2, 1:3, 1:4, 1:5, and 1:6.  These ligations were assembled using a 
temperature cycling ligation protocol105 and 2µl of each ligation was introduced through 
electroporation into E.coli top10 F’ freezer competent cells. These transformed cultures were 
grown for 1 hour in LB media without antibiotic then plated on LB agar containing 30 mg/L 
kanamycin. 
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The next step in optimizing the cloning of Asaia was to ensure that efficient 
transformations of vector DNA was possible. This was accomplished in two ways, through 
electroporation and mating of vector plasmids into the bacteria. To optimize the electroporation 
protocol, three Asaia colonies were picked from a fresh mannitol plate and inoculated into 
mannitol agar. These cultures were allowed to grow to log phase and then used to reinoculated 
both mannitol and minimal broth supplemented with 5% nectar. The optical densities of these 
cultures were recorded until the bacteria reached log phase. Four sets of competent cells from 
these cultures were made when the cultures reached 0.5, 1, 1.5, and 2 OD600 using a sucrose 
transformation protocol106. Directly after making each set of competent cells 100, 200, 300, and 
500, and 1000 ng of the plasmid pNB50 as well as a negative control of no plasmid were 
transformed using an electroporator with a 2mm cuvette and 2.5 kV. These were allowed to grow 
for 1, 2, and 4 hours without antibiotic selection before being plated on mannitol agar containing 
120mg/L of kanamycin to select for the plasmid. They were incubated for 72 hours at 30°C and 
colonies were counted for each.  
Another method to introducing plasmid DNA into Asaia is bi and tri-parental mating. For 
this technique, the plasmid pNB50 containing a constituitively expressed GFP was transformed 
into E. coli top10 F’ and E.coli S17 competent cells and named ENB50 and E17NB50 
respectively. The ENB50 was used in a tri-parental mating system with E. coli strain 
HB101+RK600107 and the E17NB50 already contained the mating genes needed for a bi-parental 
system. Asaia sp.SF2.1 as well as all of the E. coli strains were grown overnight and verified to 
be in log phase. Different ratios of donor, recipient and helper, in the tri-parental mating, strains 
were washed of antibiotic in warm mannitol media and resuspended in a total of 100 µl of warm 
mannitol. These solutions were plated on a nitrocellulose filter and let to grow overnight at 30°C. 
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The filter was then washed in warm mannitol and the solution was plated on mannitol containing 
120 mg/L kanamycin and 136 mg/L chloramphenicol. These were grown for 2 days at 30°C and 
any transformed colonies were counted and confirmed through Onetaq PCR103.   
2.3. Results 
2.3.1. Basic Culture Techniques 
The first idiosyncrasy noticed in the Asaia growth habits was its inability to grow at 
37°C, used for many other lab-cultured bacterial species. In previous years, Asaia was always 
grown at 30°C and the range in which the Asaia could possibly grow had not been investigated. 
New experimental techniques the lab required evaluation at different temperatures and the full 
range of temperatures in which this bacterium could grow was investigated. To do this, wild-type 
Asaia sp.SF2.1 was streaked to single colonies on mannitol agar. Three colonies were picked 
from the streak plate and grown overnight in mannitol broth. Each of the three cultures were 
used to streak plates and used to reinoculate broth at 6 temperatures: 4º, 19º, 25º, 30º, 35º, and 
37°C. Over the course of 2 weeks the growth of the cultures was observed. Once colonies were 
formed on the agar or turbidity was seen in the broth the cultures were removed and recorded 
(Table 2.1). It was seen that Asaia has a rather large temperature range especially in liquid 
culture, growing even at 4°C.  
 In order to accomplish gene induction for the specific aims of this thesis Asaia would 
need to grow media other than mannitol, however, it was known that not all media was 
supportive of bacterial growth. For example, Asaia did not grow in LB broth or agar. First a test 
of each media available in the lab was conducted. Growth was recorded in days as soon as 
colonies were seen on agar and/or turbidity observed in liquid media (Table 2.2). Fresh Asaia 
was able to culture both solid and liquid sheeps blood media as well as liquid Davis minimal 
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media just as quickly as the mannitol media. The bacteria was also able to grow on YPD, 
minimal M9 media, and TSB if let to culture for additional time. Davis minimal media is used 
throughout much of the remainder of these experiments.  
The ability of the bacteria to grow on varying concentrations of carbon were then 
evaluated because of its tendency to grow faster on media containing higher sugar 
concentrations. Since it was known that the bacterium was isolated from flower nectar a solution 
of sucrose, fructose, and glucose was made to mimic this carbon source. Using Davis minimal 
media the time it took the bacteria to grow in liquid broth was recorded just as in the previous 
experiment (Table 2.3). Surprisingly, bacterial growth was seen in all but the lowest 
concentration, even at 50% nectar. The best conditions for growth in minimal media occurred 
between 5 and 15% nectar concentrations. With this new information, the previous experiment 
with varying types of media was performed again with the addition of 2% nectar in each media. 
This addition allowed the bacteria to grow in all the media supplied and decreased the time it 
took Asaia to colonize each (Table 2.4). 
The fact that Asaia still took a very long time to grow despite optimizing the media and 
temperature conditions was concerning and further investigation was needed. When the bacteria 
were grown in an Erlenmeyer flask the time it took the bacteria to reach turbidity was greatly 
reduced compared to cultures inoculated in 5mL of media in a standard 15 mL test tube. The 
ability of Asaia to grow in 1-10 mL of minimal media in a test tube was evaluated over the 
course of 4 days. It was seen that the cultures containing more volume took a great deal longer to 
grow and the cultures that were over 7 mL failed to reach an OD600 of 1.0in four days of growth.  
Both one and two milliliter cultures performed similarly needing less than 24 hours to grow 
while 3-5 milliliter cultures took over a full day to reach a similar OD600. 
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It has been known that Asaia sp.SF2.1 was resistant to the antibiotic kanamycin, and it 
took a relatively high dose of 120 mg/L to completely kill the bacteria as compared to only 30 
mg/L to kill E. coli. Therefore, it was imperative to any future research with this bacterium to 
test for other antibiotic resistances the bacteria may contain. Varying concentrations of 5 other 
antibiotics as well as kanamycin were tested in liquid culture to find the concentration at which 
bacterial growth was inhibited (Table 2.5). Asaia was found to be highly resistant to 
chloramphenicol, ampicillin, and gentamycin compared to E.coli and also shows a higher 
resistance to apramycin but not to tetracycline. 
To quantify the CFUs of Asaia in liquid media, cultures were evaluated for optical 
density then diluted and plated on mannitol media. The number of CFUs on each plate were used 
to calculate the total number contained in each culture. By doing this it was observed that a 
culture of Asaia grown to an OD600 of 1.0contains 6x10
8CFUs/mL.  
A growth curve was first constructed using an inoculation ratio of 1:1000 and then 
followed up by inoculations of 1:100, 1:50, and 1:10.  A growth curve was constructed from the 
readings of optical density and minutes the culture was grown (Figure 2.1). It can be seen that 
the lowest 2 starting ratios provide the most logarythmic growth curve. Showing a clear lag 
phase, log phase, and stationary phase. It can also be observed that the lag phase of each culture 
gets exponentially larger as the inoculation ratio decreases.  
2.3.2. Isolating Asaia from Mosquitoes 
When performing in vivo experiments with Asaia it is extremely important to be able to 
isolate that bacterium from the rest of the bacterial species that make up the mosquito 
microbiome. The various media that Asaia can culture and antibiotic resistances that had been 
previously established were used to select for this bacterium from dissected midguts. The first 
 32 
hurdle that was encountered was that small round white colonies were persistent despite different 
antibiotic combinations on both mannitol and minimal media supplemented with nectar. When 
this bacterium was cultured and sequenced it was found to be a member of the genus 
Elizabethkingia. By varying culture conditions, it was discovered that these bacteria cannot 
survive on a sole carbon source of arabinose. It was then established that our Asaia sp.SF2.1 was 
able to utilize arabinose by streaking out a fresh culture on Davis minimal agar with 2% 
arabinose as a carbon source. The Elizabethikingia sp. was also streaked on this media to ensure 
that no growth occurred. The midgut isolation experiment was then repeated using only Davis 
minimal media supplemented with arabinose and the various antibiotics. It was found that Asaia 
could be individually isolated using this media and either 60 mg/L gentamycin or 68 mg/L 
chloramphenicol. 
To be sure that our engineered bacteria could also be isolated in this same fashion these 
experimented were repeated using the GFP fluorescent Asaia species ANB50. Midguts dissected 
from mosquitoes that had been cultured with this bacterium were plated on Davis minimal media 
with 2% arabinose, 120 mg/L kanamycin, and either 60 mg/L gentamycin or 68 mg/L 
chloramphenicol. These plates were viewed under fluorescence and it was seen that the plates 
containing gentamycin contained both glowing and non-glowing colonies. The plates containing 
chloramphenicol contained only glowing colonies and when validated through PCR these 
colonies were confirmed as containing the pNB50 plasmid. Both glowing and non-glowing 
colonies from the gentamycin plates were sequenced for the plasmid and all colonies were 
positive for containing the pNB50 plasmid. 
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2.3.3. Cloning techniques for Asaia sp. SF2.1 
For many years in the lab it had proven difficult to clone and transform plasmid DNA 
into Asaia especially when the plasmid DNA contained sequences from the Asaia chromosome. 
To rectify this, the the ligation protocol used when inserting Asaia DNA into a plasmid was 
optimized. Using a temperature cycling ligation protocol,105 6 different ratios of insert and vector 
were evaluated after transformation into E.coli top 10 F’ freezer competent cells. It was seen that 
the 1:1 and 1:2 ratio produced fewer than 10 colonies when plating the entire transformation. The 
1:3 and 1:4 ratio produced 20 and 26 colonies respectively from their entire transformations. The 
1:5 ratio produced over 100 colonies from the entire transformation and the 1:6 ratio produced 
over 500 colonies when the entire transformation was plated. 
Now that the optimal ligation ratio was established the transformation protocol for Asaia 
needed to be evaluated to ensure that when doing library screening enough colonies could be 
collected from single transformations. It had been shown that even when transforming whole 
plasmid into freezer competent Asaia the number of transformed colonies obtained were far too 
few to carry out a large scale library screening experiment with ease, commonly producing less 
than 15 colonies per whole transformation. Therefore, the first aspect of the transformation 
protocol invoked was to use a different method for making competent cells106. Using this new 
sucrose washing method transformation efficiency increased commonly producing over 100 
transformed colonies from each electroporation.  
However, it was important to increase this efficiency further by looking into the phase of 
growth of the Asaia being used to prepare competent cells, different concentrations of plasmid 
and growth times of the transformation without antibiotic selection. It was found that using 
cultures grown to around an OD600 of 1.0with 300-500ng of plasmid DNA produced the most 
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transformed colonies when grown at least 2 hours without antibiotic selection. The competent 
cells from the cultures at an OD600 of 1.0produced over 550 and 1.5 OD600 produced just shy of 
500 colonies for each plate of 100µL from the electroporation.  
Another transformation protocol that was optimized to enable subsequent experiments, 
was the conjugation using both bi-parental and tri-parental mating systems. The GFP fluorescent 
ENB50 and E17NB50 were used as the donor and the donor and helper in the tri and bi-parental 
matings respectively. The strain RK600 was used as the helper strain in the tri-parental mating. 
In all six ratios tested of E17NB50: Asaia sp. SF2.1 (1:1-1:6) in the bi-parental experiments, all 
failed to produce any transformed Asaia colonies. However, the ratios of 1:1:3-1:1:6 
(ENB50:RK600:SF2.1) of the triparental mating experiment all produced over 50 colonies for 
each mating. However, through repetition it was observed that this number fluctuated wildly and 
could not be standardized to produce consistent results. 
2.4. Discussion 
2.4.1. Basic Culture Techniques 
For experimental purposes, it was very exciting to see that Asaia could be grown at 
temperatures above 30°C. This is especially useful when performing any temperature regulated 
gene expression experiments. It is noticeable that the bacteria was not at its maximal growth rate 
and the colonies and cultures were not as robust or pigmented indicating the bacteria may not be 
at its optimal fitness59. For this reason, all experiments involving newly transformed Asaia or any 
fitness assessment of the bacteria must never be performed over 30°C. Considering that this 
bacteria lives inside a cold blooded animal or within flower nectar its inability to grow above 
normal environmental temperatures for its habitat is predictable84. Also interesting and useful in 
future experiments is the fact that the bacteria is able to grow, albeit slowly, at very low 
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temperatures as well. This may be result of the bacteria needing to survive cold temperatures it 
may be exposed to in the wild and also allows easier control over the growth rate of the bacteria 
in the lab.  
In order to test for conditional expression, the engineered Asaia will need to be plated on 
a variety of media. To test which of these would be facultative in this approach various media 
that was accessible was used to attempt to grow bacteria from a reinoculum of a log phase 
culture. It was interesting to note that the bacteria were able to grow on both minimal medias as 
well as blood media. The ability of the bacteria to grow on both of these types of media was 
imperative for testing induction from of promoters to only blood. Both minimal media were 
supplemented with 1% (w/v) glucose which is significantly more carbon than available in many 
commonly used media and the other media that Asaia grew on well were carbon abundant. This 
was indicative that the limiting factor in Asaia growth was the availability of carbon in the 
media. When increasing the sugar concentrations in all the previous media tested it was seen that 
the bacteria in fact was not limited by any other nutrient these media may have lacked. 
Furthermore, as the concentration of nectar increased in the media the time it took cultures to 
grow was decreased until the culture reached a 15% (w/v) concentration. Increasing the sugar 
concentration further did slow down the growth of the bacteria however did not seem to hinder 
the bacterial survival and it was even able to grow in the highest solution tested, 50% (w/v). 
Considering this bacterium was originally isolated from floral nectar, which can range between 
10-60% (w/v) sugar77, the ability of the bacteria to withstand the osmotic pressure that it would 
encounter in these environments76 is logical.  
The most efficient and replicated growth seen was with 5% nectar and Davis minimal 
media in a culture that was no more than 2mL total. This allowed the bacteria sufficient aeration 
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to reduce lag phase and increase the maximal growth rate of the bacteria and was therefore used 
for all culture conditions in future experiments. It was also necessary to find out the number of 
cells in liquid culture at a specific optical density in order to plate dilutions of culture effectively. 
From multiple serial dilutions it was calculated that an OD600 of 1.0 contains 6x10
8 million 
CFUs/mL. Therefore, experiments that involved plating Asaia from culture used 100 µL of an 
OD600 of 1.0x10
-6 on each plate to obtain about 600 CFU on each. 
In order to carry out various genetic engineering experiments with the Asaia sp.SF2.1 and 
be able to isolate it from mixed bacterial cultures, the antibiotic resistance profile of the bacteria 
needed to be evaluated. It was previously shown to be resistant to kanamycin up to 120 mg/L and 
other resistances were suspected to be present due to the factors it would encounter in the natural 
floral and mosquito microbiome. As seen in Table 2.5, Asaia has higher resistance to 
chloramphenicol, gentamycin, apramycin, and ampicillin when compared to laboratory strains of 
E. coli. Asaia did not possess resistance to tetracycline. and it could therefore be used at the 
standard dosage; apramycin and kanamycin are also candidates for antibiotic selection when 
used in the higher concentrations shown.   
2.4.2. Isolating Asaia from Mosquitoes 
Another important aspect to the success of this thesis work is the ability to isolate both 
wild type and engineered Asaia from the mosquito microbiome. Using the antibiotics that Asaia 
was found to have resistance to, midgut homogenates were plated and all except one species of 
bacteria along with the Asaia was able to be selected against. This persistent bacteria was 
Elizabethkingia and was found to make up a large percentage of the mosquito microbiome69. 
This genus was formed from the reclassification of specific Chryseobacterium species108 and is 
shown to have resistance to many antibiotics especially when analyzed from infection of 
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mammalian hosts109. It was found that this bacterium was unable to use arabinose as its sole 
carbon source108 so the midgut experiment was repeated with only arabinose added to the 
minimal media. By doing this Asaia could be isolated from these cultures using either 
gentamycin or chloramphenicol. Kanamycin was not used to select for wild-type Asaia because 
in order to maintain Asaia’s susceptibility to the antibiotic at higher doses. 
By not including kanamycin in our original isolation experiments it allowed us to easily 
select for Asaia that had been transformed to have a higher resistance to the antibiotic. This was 
necessary for recovering our engineered bacteria once it had been fed to mosquitoes for 
experimental purposes. Using the Asaia strain ANB50, which constitutively expresses GFP, the 
midgut isolation experiment was repeated and homogenized midguts were plated on the same 
media with the addition of kanamycin. It was seen that only on the gentamycin containing plate, 
the colonies did not display uniform fluorescence. These colonies as well as colonies from the 
chloramphenicol plates were validated as containing the plasmid; however, it seemed that the 
gentamycin was inhibiting the expression of GFP. This phenomena has also been seen in S. 
aureus, indicating that the gentamicin interferes with protein synthesis and may cause mis-
reading of mRNA110. 
2.4.3. Cloning techniques for Asaia sp. SF2.1 
Being able to efficiently engineer Asaia sp.SF2.1 was a major concern when developing 
my experimental protocol because of the difficulty in past experiments using Asaia DNA when 
cloning and transforming the bacterium with plasmids. Through testing of different DNA ratios 
and the adoption of a temperature cycle ligation protocol105, it was found that the technique to 
allow for the most transformants was using a 1:6 ratio of vector to insert. Further optimization 
was performed for the transformation of whole plasmid into Asaia in order to increase the 
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number of engineered bacteria seen with each transformation. It was found that using Asaia in its 
log phase of growth to create competent cells111, transforming those competent cells with at least 
300ng of plasmid DNA, and allowing the cultures to grow for 2 hours without antibiotic 
selection produced the most transformed colonies from each electroporation. When using over 
500 ng of DNA an increased rate of arcing occurred and would not be recommend for 
experimental use. Creating a mating protocol for the Asaia used in lab was another task that 
would make working with this wild bacterium more efficient. Unfortunately, no positive results 
were obtained from a bi-parental mating system but a protocol was established for tri-parental 
mating using E. coli strains Top 10 F’ and HB101+RK600107 at the same concentration with at 
least 3 times the concentration of Asaia. The number of colonies obtained from these matings 
varied greatly, however, and could not be used for large scale transformations of the bacteria, 
such as library screening.  
By optimizing the experimental techniques for culturing Asaia sp.SF2., large scale 
investigation into this bacterium can be performed with ease. The ability to grow the Asaia faster 
and healthier than was previously performed not only reduces the bench time needed for each 
experiment but will allow for more sufficient measurements of fitness once blood meal induced 
antiplasmodial strains of the bacteria have been engineered. While cumbersome and time 
consuming, the advantages of optimizing the use of this bacteria were immeasurable to me and 
hopefully will be useful for all future experimentation on this and other related wild-type species.  
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Table 2.1) Growth in days(d) of Asaia sp. SF2.1 at different 
temperatures in mannitol media at 30°C 
  4˚C 19˚C 25˚C 30˚C 35˚C 37˚C 
Solid NG 5d 3d 2d 3d NG 
Liquid 12d 4d 3d 2d 3d NG 
*NG denotes no growth seen after 14 days 
  
Table 2.2) Growth in days(d) of Asaia sp.SF2.1 on varying media 
  LB Mannitol Nutrient TSA/B YPD Blood Davis M9 
Solid NG 2d NG NG 3d 2d 3d 3d 
Liquid NG 2d NG 4d 3d 2d 2d 3d 
*NG denotes no growth seen after 5 days 
 
Table 2.3) Asaia sp. SF2.1 growth in days(d) on varying 
concentrations of carbon 
 0.10% 1% 2% 5% 10% 15% 25% 35% 50% 
Liquid NG 2d 1d 1d 1d 1d 2d 3d 3d 
*NG denotes no growth seen after 5 days 
 
Table 2.4) Growth in days(d) of Asaia sp.SF2.1 on varying media with 
2% nectar 
  LB Mannitol Nutrient TSA/B YPD Blood Davis M9 
Solid 2d 2d 2d 2d 2d 2d 2d 2d 
Liquid 2d 1d 2d 2d 2d 1d 2d 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.5) Antibiotic dosage to prevent Asaia growth 
Antibiotic E. coli dosage (mg/L) Asaia dosage (mg/L)  
Kanamycin 30 120 
Chloramphenicol 34 408 
Gentamycin 30 300 
Tetracycline 15 15 
Apramycin 100 200 
Ampicillin 100 >1200 
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Figure 2.1) Growth Curve of Asaia sp. SF2.1 using differing ratios 
of inoculum. A log phase culture of Asaia was used to inoculate fresh 
media in an Erlenmeyer flask.  A.) Only 100µL of Asaia culture was 
used to inoculate 100 ml of media and optical density was recorded 
after 18 hours. These readings were taken by hand every 15 minutes 
B.) three different volumes of the same inoculum were used in 100 ml 
of media and growth was recorded by a Spectramax i3x. 
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Figure 2.2) Vector pGLR1 used to find conditional promoters. The plasmid 
contains GFP-lux dual reporter genes, lacking promoters, and a kanamycin 
resistance marker. Located before the dual cassette is a multiple cloning site used 
to insert Asaia sp. SF2.1 genomic fragments.  
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3. Bloodmeal-induced promoters isolated from the Asaia genome 
3.1. Introduction 
The expression of gene products by bacteria has been a fundamental aspect of scientific 
exploration for over 70 years. In the 1960’s many new studies revolving around when and why 
these genes are expressed were conducted. Throughout the early studies into gene regulation it 
was hypothesized that the amount of product being made was directly correlated to the 
transcriptional activity of the genes112. The first gene regulation mechanism proposed was by 
Jacob and Monod in 1961 and accounts mainly for negative regulation of transcription113. During 
the subsequent years the regulation of amino acid metabolism was summarized through two 
main avenues: endproduct inhibition or metabolite activation114. Endproduct inhibition is the 
ability of the gene product to turn off transcription of the precursor gene and is extremely 
common in many biological systems such as the tryptophan opereron which has been very well 
characterized in E. coli.  When the tryptophan operon is turned on it produces the proteins 
necessary to construct tryptophan as well as the repressor gene trpR. When the newly formed 
tryptophan and TrpR polypeptide combine they form a repression complex that will turn off the 
transcription of the tryptophan operon115,116. Conversely, metabolite activation was described as 
one gene product turning on transcription of a different gene either in the same regulatory chain 
or one that is related. This idea has been elaborated and expanded on greatly with many 
examples such as steroid receptor family proteins that are responsible for not only their own 
transcription regulation but can be transported throughout the entire biological system of an 
organism, especially in higher eukaryotes, to affect multitudes of different genes that affect a 
variety of biological functions117. With more study into the regulators of these genes it was 
discovered that more than just polypeptides could be used to turn genes off and on. It was seen 
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that the lactose operon could be repressed in merozygote bacteria even when translation was 
chemically inhibited112. This opened up the possibility that many different biological and 
synthetic molecules could be used by a cell as an inducers or repressors of transcriptional 
activity. Whether the specific transcription factor being studied was composed of amino acids or 
nucleotides, the ability of environmental effectors to bind these molecules and structurally 
change them to fit across gene operators became apparent through research in this area. 
Noteworthy systems such as the arabinose operon118, alkaline phosphatase and histidine 
synthesis systems in E. coli112, and bacteriophage development118 were some of the first well 
characterized transcription induction systems.  
It quickly became apparent that many bacteria had adapted gene regulation systems to deal 
with their environment and how it may change over time. One reason for the shifting 
environment that bacteria encounter are the symbiotic relationships they cultivate with 
eukaryotic organisms. Most multicellular organisms have very elaborate defense mechanisms 
against pathogens which usually result in many antimicrobial properties as well. However, 
through coevolution, many bacterial species have evolved resistances to the eukayotic defense 
systems that can be regulated when they are most needed119. Such is the case inside the mosquito 
midgut. Most bacteria that inhabit arthropod midguts are obtained from the environment in 
which the host lives. This causes the bacteria to adapt to two very different environments 
depending on whether or not it is inhabiting the mosquito host or existing in the environment, 
such as within flower nectar which is the case for Asaia bogorensis. Furthermore, the 
environment inside an arthropod vector can be an ever-changing ecosystem for the symbiotic 
bacteria to adapt to. Factors such as feeding behavior, microbiome composition, and temperature 
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fluctuation are all aspects of this new environment that the bacteria must adapt to through 
regulation of genes made for these specific inducers.  
In this study we aimed to uncover genes and their promoters that are specifically regulated 
during the bloodmeal of an Anopheles mosquito in the Asaia genome. Blood from any organism 
is a highly elaborate and variable mixture that has many different biologically significant 
components that could be used as inducers or repressors of gene expression. To uncover these 
regions of the Asaia genome, a technique was used in which putative promoters were cloned into 
a reporter plasmid to analyze induction on media representative of the blood meal environment 
encountered within an Anopheles midgut. This technology was first used by Osbourne et al. to 
find plant induced genes in pathogenic bacteria, and is termed in vivo expression technology, or 
IVET120. There are many genes that can be used for reporters such as lacZ and antibiotic 
resistance genes; however, in this study the reporter used was the green fluorescent protein 
(GFP). This specific methodology is termed differential fluorescence induction (DFI) and was 
first used to identify pathogenic genes of Salmonella when it comes in contact with host cells121. 
DFI was used in this study to test putative promoters discovered through library screening, 
homologous alignment to commonly induced genes, and RNA sequencing. 
Before whole genome sequencing of organisms was possible many researchers used genomic 
library screening methods to discover the physicality and functionality of DNA sequences for 
specific species pertinent to their research. Libraries are formed from thousands of individual 
bacteria that have been genetically altered, either by mutagenesis or plasmid insertion, randomly 
in order to test entire genomes for a specific functionality120. The library constructed in this study 
uses plasmids containing random chromosomal DNA sequences from the Asaia genome to create 
the transgenic bacteria. Specifically, a promoter-trap library was used to demonstrate the ability 
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of the inserted genomic sequences to induce the expression of a downstream reporter in the 
plasmid. This allows the entire genome to be searched for putative promoters regardless of how 
it is annotated or its similarity to other bacterial species. 
Despite the wide genetic divergence of bacteria, even distantly related species share 
homologous genes. However, due to the specific ecological niche these organisms inhabit their 
physiological characteristics become distinct122. One such niche belongs to symbiotic bacteria 
that reside within an animal host. One of the most important functions these bacteria must 
possess is the ability to attain and metabolize sources of iron123. It is essential for all organisms to 
obtain iron for their physiological needs. However, because iron can become toxic in high doses 
and is poorly soluble, bacteria have developed specialized systems for controlling its 
regulation124. These include specialized iron uptake molecules like siderophores and 
hemophores, as well as direct uptake of the molecules through cellular contact125. They also 
possess iron storage proteins and reserves as well as proteins involved in iron detoxification and 
metabolism124. The regulation of these proteins depends on the environment inhabited by the 
organism and the available iron sources that can be utilized by the bacteria. Because of the 
importance of iron in bacterial metabolism the proteins involved in its regulation are highly 
conserved across bacterial species126. Whether under iron-rich or iron-limiting conditions the 
transcriptional machinery will react in both positive and negative ways to produce the necessary 
proteins for the specific needs of the organism127. 
A genome sequence can only provide limited information; to fully understand its physiology 
and functionality an organism’s transcriptome must ideally be studied. A transcriptome is 
defined as all the transcripts in the cell and the quantity of such at a specific life cycle stage or 
physiological condition128.  Due to emerging new technologies in massively-parallel DNA 
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sequencing, RNA-Seq has become the standard method for studying transcriptional activity in a 
system. RNA-Seq relies on Next-Gen sequencing technologies which produces a vast amount of 
data from single RNA samples129. Once the RNA is extracted from a sample and the rRNA is 
depleted, next gen sequencing technologies are used to sequence the sample. The RNA is usually 
fragmented with various methods including restriction enzymes, sonication, or physical 
shredding. The 3' end of the transcript is then polyadenylated or oxidated to retain the 
directionality of the transcript. PCR adapters are ligated to both ends of the fragmented 
transcripts and cDNA is created by reverse transcription. The cDNA is then amplified using PCR 
and the amplified fragments are sequenced using next gen sequencing technologies such as 
Illumina or 454 pyrosequencing130. By comparing the number of transcripts produced in different 
environments it is possible to find conditional genes and the promoters that drive them. 
Through these last two methods, conditional bloodmeal-induced (BMI) promoters from the 
Asaia genome were found and tested using DFI and IVET in culture. The library screen 
unfortunately failed to produce usable data and is discussed in the Appendix of this work.  
However, to truly be certain that these bacteria would function similarly inside the midgut of the 
mosquitoes the induction potential of the promoter needed to be tested with an actual blood meal 
inside the mosquito midgut. It is common knowledge that not all environments can be replicated 
in the laboratory. This is especially true for a complex environment involving eukaryotic tissues 
as well as inducing effectors as would be found in the blood meal131. So, the last step performed 
with all of these strains was to make sure their conditionality was retained when a mosquito was 
fed on blood in comparison with sugar. Fortunately, the cultivation of Anopheles mosquitoes has 
been developed for many years and is optimized for many different experimental designs. Once 
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putative promoters pass all in-vitro and in vivo induction experiments it will be possible to use 
them in antiplasmodial inhibition cassettes discussed in the following chapter. 
3.2. Materials and Methods 
3.2.1. Library Construction 
All strains, plasmids and primers used throughout this work are available in the appendix 
under supplementary tables 1 and 2. A positive control for the library was made using the 
constitutive promoter region from the pNB50 plasmid. Primers were made to add an EcoRI site 
on the 5’ end and BamHI site on the 3’ end and a PCR was performed using Phusion polymerase 
from ThermoFisher Scientific. The PCR products were electrophoresed on a 1% agarose gel and 
the correct size band was observed and then extracted using Zymoclean gel DNA recovery kit 
from ZymoResearch. At the same time the plasmid pGLR1 was extracted from a culture of 
EGLR1 using the QIAprep Spin Miniprep Kit from Qiagen.  The plasmid as well as the promoter 
PCR product were digested using the restriction enzymes EcoRI and BamHI from NEB. One 
microliter of calf intestinal phosphatase (CIP) was added to the pGLR1 digestion and both 
products verified through electrophoresis and extracted in the same way as before.  A ligation 
was performed using 1,3, and 6 times the plasmid concentration as insert. These ligations were 
placed in the thermocycler and run with temperature-cycling from 10°C to 30°C for 30 seconds 
each  overnight105. Twenty microliters of nanopure water was added to the ligations before 0, 
0.5, 1, and 2 microliters were electroporated into E. coli Top10 F’ competent cells. These 
cultures were allowed to grow for 1 hour before being plated on LB agar with 30 mg/L 
kanamycin. The following day the colonies were observed for fluorescence and 8 colonies were 
selected to be grown in LB broth supplemented with kanamycin. Plasmids from these cultures 
were extracted and verified via PCR for the promoter insert (Figure 3.3). Using Asaia freezer 
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competent cells, 200, 300 and 500 ng of plasmid DNA was transformed and allowed to grow for 
2 hours before being plated on mannitol media supplemented with 120 mg/L kanamycin. These 
colonies were allowed to grow for 3 days before being analyzed for fluorescence and inoculated 
into mannitol broth. Each broth culture was analyzed for fluorescence and the correct insert was 
confirmed via PCR and sequencing. 
To create a library of Asaia genomic DNA in the pGLR1 vector, E. coli top10 F’ 
competent cells were transformed by pGLR1 through electroporation creating the new strain 
named EGLR1. In four Erlenmeyer flasks, 20 ml of LB broth with 30 mg/L kanamycin was 
inoculated with a verified culture of EGLR1 and grown overnight at 30°C in a shaking incubator. 
Three plasmid preps were performed for each flask and combined to make one solution for each 
flask. One at a time, the plasmid preps were first verified via PCR and sequencing then digested 
with restriction enzyme SphI. Genomic DNA was also extracted from wild-type Asaia sp.SF2.1 
using the Master Pure complete RNA and DNA Purification kit from Epicentre biotechnologies 
from 4 cultures made from different colonies of an Asaia plate. These DNA extractions were 
combined and shown to contain 4 µg/µL genomic DNA. One fourth of this solution was used in 
a digestion with the 4-cutter restriction enzyme NlaII. This digestion was halted using 5µL of 
50mM EDTA at 1, 2, 3, 5 and 10 minutes and incubating it at 65°C for 5 minutes to denature the 
enzymes. These digestions as well as the vector digestion was run with electrophoresis on a 1% 
agarose gel. The band for the vector and the region of genomic digestions laying between 500 
and 1,500 base pairs were extracted.  These were then ligated overnight using 1, 3, 6, and 10 
times the insert to vector ratio. Ligations were transformed into both E. coli strains, top10 F’ and 
S17, competent cells as described previously and plated on LB agar with 30 mg/L kanamycin. 
The following day colonies from each plate were analyzed for fluorescence and counted. Over 
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the course of a week this process was repeated until over three times the length of the Asaia 
genome was represented in each library, then colonies were collected in a solution of 5mL LB 
broth with 30mg/L kanamycin and 5mL glycerol for each and stored at -80°C for later use. 
To ensure that the library was created properly, the percentage of the strains that 
contained inserts had to be quantified, and the insert contained in each strain had to be aligned 
against the Asaia genome. To do this, 50µL of the library was diluted in a series of 5 ten-fold 
dilutions, which were then plated on LB media with 30 mg/L kanamycin. This allowed us to 
count the total number of CFUs in the library and using the plate made from the third dilution of 
the library, 26 colonies were inoculated into broth culture. These cultures were used to perform a 
OneTaq PCR along with a pGLR1 negative control. These reactions were run through 
electrophoresis and 8 of the positive bands were sequenced. These sequences were then 
compared to the Asaia sp.SF2.1 genome using BLAST. 
This library was made in E. coli strains because of the difficulty that had been 
encountered when transforming large numbers of Asaia strains previously in the lab. To transfer 
these library plasmids into Asaia two methods were employed, mating and electroporation, thus 
the two separate libraries were made. The first method tested was a biparental mating system 
used with the S17 library. The mating was performed in the same way as described in the 
previous chapter and as seen before no transformed colonies were collected using bi-parental 
mating. When using both the S17 and top10 F’ libraries in a tri-parental mating, the same way as 
described previously, similar inconsistent results were seen. Therefore, it was decided that the 
best way in which to introduce these plasmids for repeatable, adequate results was to use 
electroporation. First, at least 200µL of library was collected and plasmid extracted and 
quantified. A new way to make Asaia  competent cells from fresh culture was employed111 using 
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the same protocol detailed in the previous chapter along with the same optimized transformation 
protocol.  The transformed cultures were then plated on the 30mg/L kanamycin, Davis minimal 
media supplemented with 5% nectar, as well as 100µM FeCl3 and Hemin to induce expression. 
This was later replaced with the minimal media with the addition of lysed blood to create what 
will be referred to as “chocolate agar”. These cultures were allowed to grow for at least 60 hours 
before being inspected for fluorescence on a stereoscope. 
Once the library was successfully transformed into Asaia the colonies needed to be 
screened for fluorescence on blood meal-like conditions. Any colonies showing fluorescence 
from the initial transformation plates were grown in a 96 well plate with 200µL per well of Davis 
minimal media containing 5% nectar and 120mg/L kanamycin, referred to hence forth as simply 
minimal media, as well as a minimal agar containing 100µM FeCl3 and Hemin to induce 
expression.  The 96 well plates were grown overnight until turbidity was seen, then a 48-pin 
replicator was used to plate each strain on varying media, minimal agar and minimal agar 
supplemented with either iron or hemin. In latter experiments 2-2’ dipyridyl was added to the 
minimal media to act as an iron chelator and chocolate agar was also used to look for inductions 
in expression. These dotted plates were allowed grow for 2 days before differences in 
fluorescence between the two media were analyzed under the stereoscope (Figure 3.4). Any 
strain showing induction on the iron and hemin supplemented plates (or chocolate agar) but not 
on the minimal media with or without the iron chelator, were streaked to single colonies on the 
same medias to ensure that the conditionality was retained in single cell isolates. These were 
verified on the stereoscope and documented using the imager. (Figure 3.5)  
 
 
 51 
3.2.2. Homologous genes 
  Another method used to isolate blood meal-induced (BMI) promoters from the Asaia 
chromosome was to analyze the genomes of other bacterial species for genes shown to be 
induced when the bacteria encountered blood-meal like conditions. These BMI genes were 
aligned to the Asaia sp.SF2.1 genome in BLAST to find Asaia homologs (Table 3.1). The 
promoter regions of these genes were estimated to be contained within 500 base pairs upstream 
of the translational start site or up to the next open reading frame if that was encountered first. If 
the gene was contained in an operon, the promoter region of the entire operon was used. The 
promoter region of the operon that contained the HlyA gene was analyzed using Bprom132 due to 
its complicated annotation in NCBI.  
Once these plasmids were transferred to Asaia the transformants were assessed for 
conditional fluorescence using the same media as used in the library screening section. First, the 
putative BMI strains were streaked to single colonies on inducing and minimal agar to assess 
qualitative fluorescence. Any strains that showed an increase in fluorescence on the inducing 
media were analyzed in liquid culture. Strains were grown to log phase in minimal broth and 
separated into different cultures with or without the addition of iron, hemin, or in later 
experiments 5% human blood. They were allowed to grow in these conditions for one hour and 
optical density and fluorescence were measured using a Spectramax i3x platereader from 
Molecular Devices with SoftMax Pro 7 software. The data were normalized to the fluorescence 
of a premeasured culture of the constitutively fluorescent Asaia strain ANB50 that had been 
separated into the varying media directly before analysis, to account for any signal quenching 
that may have resulted from the addition of the blood. Data was visualized in RStudio using 
barplot2. 
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3.2.3. RNA sequencing 
Since the whole genome of Asaia had been sequenced previously, RNA sequencing was 
used to discover BMI promoters as well. A fresh culture of Asaia sp.SF2.1 was made in 20 mL 
of minimal media from 3 separate colonies. This culture was diluted ten-fold when it reached log 
phase and was allowed to grow until it reach the beginning of log phase again at 0.4 OD600 when 
it was split into 4 separate cultures.  RNA was extracted, using the Qiagen RNeasy Protect 
Bacterial mini kit minimal media cultures of Asaia sp.SF2.1 as a control or containing different 
treatments: 2-2’ dipyridyl:100µM; FeCl3:100µM; hemin:100µM. This RNA was quantified and 
evaluated using a nanodrop spectrophotometer and shipped for sequencing to GENEWIZ 
(NJ,USA). Conditionally active genes are detailed in Table 3.2. The cloning of these fragments 
into pGLR1 and transformation was done in the same way as the homologous genes. Using the 
Topo 2.1 vector as an intermediate.  
These strains were verified through sequencing and screened in much the same way as in 
the previous experiments. They were first plated on section plates containing the varying 
experimental components to analyze the conditionality of the promoters (Figure 3.9). One 
promising strain, AGLR1.Hem, contained the promoter from the HmuT gene of the Asaia 
genome. To try to both increase the signal being produced and the efficiency of this promoter, 
the chromosomal sequence was reanalyzed. Upon further inspection it was found that the 
genomic region in Asaia contained a dual promotor working in both directions (Figure 3.10). G-
blocks, synthesized sequences of nucleotides ordered through NEB, of this region were inserted 
directly into pGLR1 in both directions using the EcoRI restriction site.  The plasmid with 
promoter insert running from the hemin ABC transport to the hypothetical protein was named 
pGLR1.HF and the insert running towards the Hemin ABC transporter gene was labeled 
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pGLR1.FH. These were then cloned into E. coli Top 10 F’ competent cells, grown and isolated 
through plasmid prep and transformed into Asaia sp.SF2.1. These clones were assessed for 
conditionality on solid media along with the positive and negative control and the AGLR1.Hem 
strain (Figure 3.11). The strength of these promoters in liquid culture was also assessed using a 
SPECTROMAX i3x in the same manner as previously explained (Figure 3.12).  
In another effort to quantify promoter strength an array of RT-qPCR experiments were 
designed. To begin the RT-qPCR experiment endogenous control primers were designed along 
with primers for not only the HmuT gene but 5 other genes that showed conditional expression 
on iron and hemin as well. The endogenous control genes used were the 16S and 23S ribosomal 
genes of Asaia as well as a set of primers that would anneal to pol1. Using the Qiagen RNeasy 
bacterial mini kit, RNA was extracted in the same manner as performed for the RNA seq 
experiment. This RNA was quantified using the nano-drop and equal amounts of RNA from the 
control, iron and hemin supplemented, and iron depleted media was used in reverse transcription. 
The High Capacity reverse transcription kit from ThermoFisher was used to create the cDNA 
from each sample. This cDNA was diluted into 5 ten-fold dilutions to be used in the qPCR 
reaction for efficiency curves. These primers along with the experimental primers for 
Bacterioferritin 1 and HmuT were first tested for efficiency. Each primer was tested with the 5 
dilutions of control cDNA using the Bullseye Sybr Green master mix from Midsci in triplicate. 
No template controls (NTC’s) were also added for each primer. To ensure that the endogenous 
controls did not vary between media, the 16S primers were used in a qPCR reaction with one and 
two tenfold dilutions of cDNA from each sample: control, iron, hemin, and dipyridyl.  
The first two tenfold dilutions of each cDNA sample were used in a Sybr qPCR reaction 
with the HmuT and bacterioferritin 2 primers with 16S as the endogenous control. These were 
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assessed on a Step-One Plus Real-Time PCR system from Applied Biosystems. Primers were 
then made to evaluate the amount of GFP being produced from the conditional isolates. To 
assess actual induction of the conditional strains on blood AGLR1.Hem was streaked on 
chocolate and minimal media along with a positive and negative control. Cells from these plates 
were collected using a 1:2 ratio of mannitol broth and RNA protect to stabilize the RNA and 
wash the colonies off of the plates. The RNA collected from these plates was used to create 
efficiency curves for the new primers as described previously. Two dilutions of the cDNA were 
then used to evaluate the amount of GFP transcript being produced from each sample.  
3.2.4.  In vivo expression 
In vivo activity of the promoters was assessed by observing the difference in fluorescence 
between blood and sugar-fed mosquitoes that had been cultured with the BMI and control Asaia 
strains. This was repeated at multiple stages of each putatitive promoter isolation experiment and 
is reflected in Figures 3.17-3.20. Figure 3.20 shows the cumulation of the most promising 
putative promoters used in the subsequent areas of this thesis work. The bloodmeal-induced 
(BMI) isolates, AGLR1 negative control, and constitutive positive control were fed to 
mosquitoes at an OD600 of 0.1 in a sugar meal. Bacteria were allowed to colonize the mosquito 
for 36 h; then half were fed blood and half fed sugar. The mosquitoes that fed on blood did so for 
10 minutes each on an anesthetized mouse and any mosquitoes that had not fed were removed. 
All experiments involving mice were approved by Duquesne University IACUC and followed 
approved ethical practices. All mosquitoes were kept for 2d at 30ºC and fed on sugar to allow 
time for the blood bolus to partially digest, after which the midguts of all mosquitos were 
dissected and analyzed through fluorescent microscopy.  
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To quantify the bacteria inside the midguts of these dissected mosquitoes, they were added to 
100µL/midgut PBS. These midguts were then homogenized using a tissue grinder and serially 
diluted 4-fold. 100µL of each dilution was plated on the selective agar outlined in the previous 
chapter under the section isolating Asaia from midguts. These plates were allowed to grow for 3 
days before CFUs were analyzed and recorded for each strain for each experimental condition. 
3.3. Results 
3.3.1. Library construction 
When analyzing the Asaia transformants made from the insertion of the labelled, 
constitutive nptII promoter into pGLR1 under the stereoscope, it was seen that all colonies 
showed uniform fluorescence. When single cells were observed under 400x fluorescent 
microscopy all the bacterial cells also showed constitutive fluorescence (Figure 3.1). These 
cultures were analyzed through PCR and sequenced using a DNA oligomer that primes in the 
GFP and verified that the nptII promoter region from pNB50 was present. Through multiple 
rounds of testing it was observed that the positive control did not retain its constitutive 
expression if the cultures were not fresh or if the iron chelator, 2-2’ dipyridyl, was added. More 
extensive sequencing was performed to cover a majority of the plasmid and it was found that 
many of the primers designed for pGLR1 did not bind to the vector. However, primers located in 
the GFP encoding DNA successfully produced clean sequences that showed no lux operon 
downstream of GFP in the plasmid. It was discovered that the transformed plasmid was one that 
had been made in a previous experiment labelled pJS30 (Figure 3.2). This plasmid was created 
by removing the labelled nptII promoter from pNB50 which had also contaminated the culture 
providing the positive PnptII sequences found prior. A new positive control needed to be created; 
however, many transformations proved extremely difficult when attempting to express 
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fluorescence and luminescence constitutively and no constitutive promoters were found that 
showed constitutive expression across all media and phases of growth. Of specific interest was 
one clone that used the promoter region of the 30S ribosomal subunit protein S12, rpsL. 
However, even this transformant lost induction when the bacteria were grown past log phase or 
under any environmental stress. Therefore, all further experiments were performed with the 
constitutively expressing pNB50. 
When creating both the S17 and top10F’ promoter trap libraries, 4 separate 
transformation experiments were performed. Three of these successfully produced enough CFUs 
to represent three times the entire length of the Asaia genome. The fourth transformation was not 
added to these libraries because there was an unusually high ratio of glowing colonies. Normally 
between 5-10% of transformed E. coli colonies showed fluorescence, however in the fourth 
experiment almost half of the transformed colonies were expressing GFP.  Before screening in 
Asaia, the validity of the library was tested through PCR and sequencing analysis. Only the 
top10 F’ library was used due to the difficulty optimizing a biparental mating system in Asaia. 
Through PCR it was seen that 88% of the transformed colonies contained inserted DNA (Figure 
3.3), and once sequenced, was positively aligned to the Asaia genome. Through titer testing of 
the library it was also found to contain 17,620 CFUs/µL.   
After verification the top 10F’ library plasmids were transformed into fresh Asaia 
sp.SF2.1 competent cells and grown on inducing media. Colonies that were found to be 
fluorescent on the inducing media were then screened on minimal media with and without the 
iron chelator as well as inducing media do determine if any strains were conditional to the replete 
media conditions (Figure 3.4). If a putative BMI strain was discovered, it was streaked to single 
colonies on similar media and liquid cultures were analyzed under fluorescent microscopy to 
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ensure that the conditionality was retained throughout individual cells in the culture. Two 
putative BMI strains verified in this method were AGLR1.16G9 and AGLR1.1F7 (Figure 3.5).  
However, identifying the Asaia genomic DNA that they came from proved extremely difficult. 
Eventually a sequence obtained from primers annealing in the GFP showed that these strains 
were again a contaminant of the pJS30 plasmid as was seen with our positive control. No other 
putative BMI strains were discovered using this method due to the inability to eradicate this 
contaminant and the success of other strains identified through different means. 
3.3.2. Homologous genes 
To uncover BMI promoters from Asaia sp.SF2.1, the genome was searched for sequences 
homologous to genes known to be induced by bloodmeal-like conditions in other bacterial 
species. Many of these genes are important in the pathogenesis of infectious bacteria or used for 
iron homeostasis (Table 3.1). Promoter regions of the homologues in Asaia were cloned into the 
pGLR1 plasmid and used to induce expression of the dual GFP-lux operon.  Five promoters 
exhibited conditional expression when the bacteria were exposed to blood meal-like conditions 
AGLR1.SodB, AGLR1.HlyA, AGLR1.HlyC, and AGLR1.Ferr. AGLR1.SodB and AGLR1.bfr 
were the first BMI strains discovered and were tested on minimal agar with the iron chelator, 
iron, or hemin (Figure 3.6). SodB showed induction on hemin and bfr did not show expression 
on any of the media. The strains discovered later, as well as SodB, were tested on minimal and 
chocolate agar (Figure 3.7). This was due to iron and hemin induction not translating inside the 
mosquito midgut as discussed in the following section on in vivo expression.  
The strains that produced fluorescence only on blood supplemented plates were then 
evaluated for induction in liquid media, and GFP production was quantified using a fluorescent 
spectrophotometer. AGLR1.SodB and AGLR1.Ferr showed induction on chocolate agar but did 
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not produce significant additional fluorescence in minimal broth supplemented with blood. 
AGLR1.HlyA, and AGLR1.HlyC were significantly induced in all blood supplemented media 
(Figure 3.8).    
3.3.3. RNA sequencing 
To fully understand the transcriptional activity under blood meal conditions, an RNA 
sequencing analysis was performed for Asaia under different culture conditions.  RNA was 
extracted from bacteria grown in minimal media, iron and hemin supplemented or iron-depleted 
conditions. This was analyzed by the company Genewiz and the genes of interest are shown in 
Table 3.2. It can be seen that many of the genes shown were induced when dipyridyl was added 
to the media meaning that the media was extremely iron depleted. These were of interest because 
of the potential for using them to induce a repressor while the blood meal is not present. In 
effect, turning on our gene of interest in blood meal conditions.  
The first two promoters tested were for the hemin abc transporter, HmuT and 
bacterioferritin 2. It can be seen that in our construct the HmuT promoter induced GFP 
expression on both hemin and iron supplemented media but not in the dipyridyl supplemented 
media while the bacterioferritin promoter induced expression when the bacteria were exposed to 
iron as expected (Figure 3.9). When the promoter region was reanalyzed for the hemin ABC 
transporter gene it was seen that an iron induced gene ran on the opposite strand about 170 bp 
upstream (Figure 3.10). The hypothetical protein that was also induced by this promoter had an 
iron transport motif and was also found to be upregulated in the same experimental grouping 
from the RNA seq analysis as the hemin ABC transport protein. To try to increase the effectivity 
of this promoter, the sequence only lying between the two opposing genes was created and 
cloned into the pGLR1 expression system in both directions. These were tested in a similar 
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manner as described previously and it can be seen that the Hem and HF strains behave similarly 
and are induced on the hemin supplemented media while the promoter running in the reverse 
direction induced expression on all media exluding hemin (Figure 3.11). These were further 
tested in the spectrophotometer and similar results seen for the first two strains however the FH 
strain showed induction on hemin and not on the iron supplimented media (Figure 3.12).  
Because of the inconsistencies seen for the HmuT promoters, it was important to study 
the induction using q-RT-pcr. Primers were made for the hemin abc transporter as well as the 
bacterioferritin 2. Endogenous controls were also constructed for the 16S and 23S rRNA genes 
and primer efficiencies were calculated for each. Both the 16S and Bact.2 primers passed the 
efficiency curve standards with 5 dilutions (Table 3.3). Hemin and 23S primers would only be 
effective with the first 3 dilutions. Furthermore, 16S had an even higher efficiency (94%) when 
the last dilution was excluded from calculation. Using this information, the amount of variation 
of the 16S endogenous control CDNA had to be evaluated between samples.  The variation 
between Ct values should be insignificant and only result from slight variation in pipetting. It 
was found that any variation seen across samples using the 16S gene was insignificant (Figure 
3.13); the 16S ribosomal gene could be used conclusively as an endogenous control in the 
experiment. When analyzing the difference in expression of the HmuT and Bacterioferritin genes 
in different media it was seen that the bacterioferritin behaved as expected but the HmuT gene 
was actually transcribed over 8 times more in the 2-2’ dipyridyl treated media and only 1.5 fold 
in the hemin supplemented media (Figure 3.14).  
  Due to the inconsistency of the quantitative data collected in liquid media both with the 
Spectramax and through qPCR, it was decided to collect RNA from our engineered Asaia strains 
on solid media.  It was also important that the environment inside the mosquito gut was 
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represented correctly, therefore colonies were plated on minimal media and chocolate agar 
(Figure 3.15). The difference in opacity between the two media was highlighted using the imager 
is the reason for the background fluorescence seen on the minimal media plates. Furthermore, the 
excess fluorescence seen in the corners of the plates is from the permanent marker used to label 
the dishes. RNA was extracted from the AGLR1.Hem plate and used for the remainder of the 
experiment. 
The efficiency of the new GFP primers used with 4 dilutions of the cDNA made through 
reverse transcription was 102.58% and could be used, however the kanamycin primers failed the 
efficiency test and were not used. When the Ct of each sample amplified with the GFP primers 
was evaluated it was seen that there was in increase in GFP transcript between the two media 
(Figure 3.16).  To determine the fold change the ΔΔCt method was used in which the Ct of the 
endogenous control on each experimental condition is subtracted from the Ct of the experimental 
gene, GFP, on the same condition. These are then subtracted from one another for the ΔΔCt 
value. The fold change can then be calculated by raising 2 to – ΔΔCt133f. Using this formula, it 
was found that in two experiments the GFP transcript being produced on the chocolate agar was 
2.5-fold higher than that produced on minimal media. 
3.3.4. In vivo expression 
The putative BMI promoters were screened for conditionality inside the mosquito 
midgut, where the bacteria were fed to mosquitoes which were then fed on either sugar or blood. 
After dissection the midguts were analyzed under fluorescence. The first promoters to be tested 
were from the library screen of the Asaia genome, AGLR1.1F7 and AGLR1.16G9. Both of these 
strains produced increased fluorescence in blood fed mosquitoes compared to mosquitoes only 
fed on sugar (Figure 3.17). However, upon repeated experimentation it was found that this was 
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not always consistant. Furthermore, it was extremely difficult to obtain sequences from these 
strains using primers that bound onto the pGLR1 vector sequence. To fully understand what was 
occurring a primer was used that bound to many different forms of GFP and sequenced upstream 
of the GFP start site. Using this method, it was found that both strains were actually a 
contaminant plasmid pJS30 (Figure 3.2). Also, when the quantity of transgenic bacteria was 
enumerated from the midguts assessed under fluorescence it was found that the midguts that 
showed the most fluorescence also had the highest number of transgenic bacteria. So much so 
that the lowest diluted plate still did not contain single colonies and was therefore unable to be 
counted. The midguts that did not show fluorescence contained very little transgenic bacteria if 
any when enumerated from the dilution plates. 
When testing for conditionality inside the midgut using putative promoters discovered 
through the RNA sequencing analysis first the AGLR1.Hem and AGLR1.B2 were used. It was 
seen that the HmuT promoter did induce expression in the blood fed mosquitoes without 
induction when the mosquitoes were only fed on sugar (Figure 3.18). The AGLR1.B2 strain did 
not produce fluorescence in the midgut regardless of the meal contents. After discovering the 
bidirectional nature of the HmuT promoter, the short construct promoters were generated and 
tested in vivo alongside the original AGLR1.Hem (Figure 3.19). It can be seen that both the Hem 
and HF constructs induced expression only when the mosquitoes were fed a blood meal while 
the FH promoter running in the opposite direction induced expression in both blood fed and 
sugar fed midguts.  
The last promoters tested for conditionality in vivo were the strains discovered by 
searching the Asaia genome for homology to genes from related bacteria that are induced in 
blood meal like conditions. Using the strains AGLR1.Sodb, HlyA, HlyC, and Ferr along with the 
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Hem and HF promoters already used another midgut fluorescent experiment was performed 
(Figure 3.20). Again, it was shown that the Hem and H-F produced fluorescence in the blood fed 
midguts only. Both AGLR1.HlyA and HlyC also induced expression of the GFP in the presence 
of a blood meal but not when the mosquitoes were only fed on sugar. Both SodB and Ferr strains 
induced expression in both conditions.  
To be sure any increase in fluorescent was solely caused by the induction of GFP the 
transgenic bacteria inside 10 of the mosquito midguts that had been were quantified (Table 3.4). 
It can be seen that there are actually fewer colony forming units in all the blood fed midguts than 
what was seen in the sugar fed mosquitoes.  
 
3.4. Discussion 
3.4.1. Library Construction 
Controlling gene expression using wild bacteria can be extremely challenging due to the 
many survival mechanisms used by these bacteria in order to optimize their fitness in their 
natural habitat. Through this search we developed the hypothesis that Asaia was capable of 
changing its expression of the transgenic elements that were engineered in some way in order to 
reduce the energy costs to the bacteria. The first instance this was observed was when the 
positive control was being constructed. The first attempt at creating a constitutive positive 
control using the pGLR1 plasmid was unsuccessful because of a contaminant plasmid pJS30. 
The pJS30 plasmid is much smaller than pGLR1, lacking the lux operon. Even if the correct 
plasmid was constructed with the nptII promoter for pGLR1 the Asaia may have preferentially 
selected any transformants containing the smaller plasmid with the same antibiotic resistance 
genes to reduce its energy costs in making the pGLR1.  This was further supported when 
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analyzing BMI strains later that contained pGLR1 with a functional promoter and dual operon 
cassette but only expressed the GFP and no visible light. One possible explanation for this is that 
the energy costs to the bacteria when expressing the Lux operon was too great and the natural 
gene regulation machinery of the bacteria, which has evolved for survival in the wild, was used 
to turn off the transcription or translation of this large protein system.  
The fact that pJS30 was acting constitutively in most cases was also surprising 
considering that this plasmid had the labelled nptII promoter removed upstream of the GFP. 
Upon further inspection of this plasmid and pNB50, from which it was derived, it was seen that 
no terminator existed between the kanamycin open reading frame and the GFP. Both of these 
genes run in the same direction on the plasmid so it seems likely that the promoter driving the 
constitutive expression of kanamycin was also driving the expression of GFP like an operon. The 
removal of the labelled promoter did hinder the stability of this constitutive expression so it may 
be that this region of DNA was beneficial in the expression of the protein but not required. When 
analyzing this labelled promoter it was also identified as a simple backbone used in many 
plasmids and did not contain the functional regions of the nptII promoter as it was described. 
Because of these issues along with the failure to find a constitutively expressing promoter that 
worked in the pGLR1 plasmid, the pNB50 plasmid was used as the positive control in all 
conditionality experiments.  
Contamination problems continued to exist when creating and analyzing the promoter-
trap libraries. The first instance of this was when creating the libraries the fourth transformation 
attempt resulting in an extremely high number of fluorescent colonies. This occurred multiple 
times when transferring the plasmids from E. coli to Asaia for testing. When sequenced it was 
found that again these plasmids contained the pJS30 or pNB50 plasmid. Even when finding 
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promoters that seemed to show conditionality in culture as well as the mosquito midgut, these 
two plasmids became difficult to remove contaminants that provided many false positives. Such 
was the case with the two library strains that passed all of the conditionality assessments but 
when sequences were finally found were shown to match pJS30. Again, this is most likely due to 
all of these plasmids containing kanamycin resistance and the expression systems on these 
plasmids being a lower energy cost to the bacteria so they are preferentially selected over the 
GFP-lux dual reporter system. Because it was seemingly impossible to remove these 
contaminants from our top 10 F’ library and standardization of mating systems in Asaia had 
failed, the use of the promoter trap library system was abandoned for more promising techniques 
to discover BMI promoters.  
3.4.2. Homologous genes 
The most fruitful of these techniques proved to be the search for BMI promoters from 
genes that were homologous to conditionally expressed genes from related bacteria. When first 
exploring these genes, iron and hemin were used as inducers and many homologous genes in 
Asaia were found. However, after many failed in vivo experiments it became obvious that the 
induction seen with just these two chemicals were not the inducers that were active in the blood 
meal. This could be due to iron sequestration in most mammalian blood where any free iron in 
the plasma would be purged using transferrins and other iron storage proteins. Therefore, the 
available iron for the bacteria is limited134. Moving forward genes induced in pathogenic bacteria 
were explored because of their induction when exposed to actual eukaryotic blood. Through this 
method two inducible promoters were found from the hemolysin A and C genes in Asaia. These 
genes are located in two different operons as can be seen with the alpha hemolysin genes in 
many pathogenic E. coli135. Being that hemolysin genes are found in many bacteria, either 
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symbiotic or pathogenic125, that encounter mammalian blood, such as those in the midguts of 
blood-feeding vectors, they have great potential for use in different paratransgenic systems 
studying vector-borne disease. 
3.4.3. RNA Sequencing 
With the advent of new technologies, large scale nucleotide sequencing has become a 
much more cost effective and efficient way to characterize bacterial genomics. Using RNA 
sequencing it is possible to identify all the genes being transcribed in an organism at a particular 
life cycle stage or physiological condition. For our purposes, the Asaia transcriptome was 
characterized under what we thought would be blood-meal inducing conditions, using inducers 
such as iron and hemin. Surprisingly, the promoter region of a gene expressed under iron limited 
conditions, the hemin abc transporter, HmuT, actually showed the most potential for conditional 
expression in the blood meal. Again, it seemed that using single chemicals such as iron and 
hemin as inducers did not replicate blood meal conditions in which the bacteria were exposed.   
To fully understand the induction of this HmuT promoter RT-qPCR was performed to 
quantify the transcription of these genes under varying conditions.  When performing this 
technique, it is extremely important to have proper controls and primers for each gene being 
tested. For optimized efficiency a primer should allow for a 2-fold amplification, or 
amplification factor, for each round of qPCR. This results in an increase in Ct (crossing 
threshold) of around 3.35 with 10-fold increasing concentration136. The Ct of a sample is 
recorded by analyzing the amount of fluorescence produced in each cycle. As the PCR 
experiment is run the amount of signal being produced becomes logarithmic which is the point in 
which the threshold value will be placed. This is usually around 1 on the y-axis, which is a 
measure as the log of the Rn, or normalized fluorescence. A melt curve was also established to 
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ensure that the primers were annealing to DNA and not simply forming primer dimer pairs137. 
When analyzing the data, it became obvious that only the 16S and Bacterioferritin 1 primers 
would be able to pass the test with all 5 dilutions. The 23S and Hemin ABC transporter primers 
would only use the first 3 dilutions. This is because the values of the NTC’s for these two genes 
overlapped with the Ct values in the last 2 dilutions. The way in which an efficiency curve is 
made is by ploting the Ct value against the log of the dilution. The slope of this line is assessed 
and used to calculate an amplification factor for each primer which corresponds to the percent 
efficiency of each primer. These data are shown in Table 3.3. 
The HmuT gene was transcribed significantly more on iron limited conditions and only 
slightly more in the heme supplemented broth. This is different than what was observed when 
analyzing the induction of this promoter with GFP on agar and broth with the same conditions. 
This may be due to a difference in the amount of transcript versus protein product being 
produced or, it may be due to the putative HmuT promoter behaving differently in the plasmid 
than how the construct works in the chromosome. If the latter is true then to integrate any 
expression system into the chromosome, the entire expression cassette would need inserted into 
the chromosome instead of using the native location of the promoter to drive the inserted gene. 
To quantify the induction seen in our AGLR1.Hem strain the amount of GFP transcript being 
made on minimal media versus blood enriched media was analyzed. Although the induction of 
the gene was just over twice what was seen on minimal media, we felt comfortable moving 
forward with this gene construct because of its replicable results both in culture as well as inside 
the mosquito midgut.  
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3.4.4. In vivo expression 
When testing the plasmid constructs for induction to the blood meal inside the mosquito 
midgut different strains were found and tests performed on many different occasions. This is the 
reason that some strains such as AGLR1.Hem have an increased number of mosquitoes 
observed. It was one of the first strains used and was therefore tested the most frequently. 
Through all tests both putative HmuT promoters retained their conditionality inside the midgut. 
The more recent strains developed from homologous pathogenic genes were tested in at least 3 
separate experiments and both putative hemolysin promoters retained induction only to the blood 
meal. Furthermore, to ensure the difference in fluorescence was due to a change in gene 
expression and not because of additional bacteria in the blood fed mosquitoes, the transgenic 
bacteria were quantified. When doing this it was observed that the number of transgenic bacteria 
actually decreased in blood fed mosquitoes. This may be due to the extreme bacterial growth 
seen in the natural microbiome during a blood meal. The GFP fluorescent Asaia may not have 
been able to compete as effectively when the number of native bacteria increased significantly. 
This could be problematic when these promoters would be used to express antiplasmodial 
molecules, but the fact that the fluorescence was still observable may mean that the 
antiplasmodial expression will also be enough to cause inhibition. Furthermore, it has been seen 
that producing fluorescence and luminescence in Asaia is strongly selected against. The 
observation that the bacteria that are expressing the GFP were not as fit as the natural microbiota 
fall in line with the excessive energy costs for these expression systems seen through other 
experiments. 
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Figure 3.1) Positive control GLR1.PnptII.  Asaia sp. SF2.1 were 
transformed with a recombinant pGLR1 plasmid containing the labelled 
nptII promoter from pNB50 upstream of the GFP-LUX dual reporter. 
This control was the standard for screening promoter activity. 
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Figure 3.2) Plasmid pJS30 constructed from the removal 
of the nptII promoter from pNB50. This allowed the 
promoter region to be used for insertion of Asaia genomic 
DNA to form a library. This plasmid was abandoned in favor 
of pGLR1 to be used in this promoter screen experiment. 
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Figure 3.3) Verification of genomic inserts into pGLR1 reporter to form the 
promoter trap library. Asaia sp. SF2.1 genomic digestions between 500 and 1500 
base pairs were inserted into pGLR1 and transformed into E. coli top 10 F’ to form 
the library. Individual colonies were evaluated for the presence of a genomic 
insertion. The insertions were checked via PCR and show that over 85% of 
transformants contain genomic insertions. 
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Figure 3.4) Blot screen from 96 well plates of glowing colonies from 
Asaia sp. SF2.1 library made with 48 pin replicator tool. The cultures 
were blotted onto Davis minimal media with 1% glucose either alone or 
with 100µM FeCl3, 100µM hemin, or 50µM 2-2’ dipyridyl. The circled 
strains on the dipyridyl plates were considered conditional possibilities and 
streaked to single colonies on 100 µM 2-2’ dipyridyl to ensure that no 
fluorescence is seen. 
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Figure 3.5) Strain AGLR1.1F7 and AGLR1.16G9 show 
conditional expression on blood-like conditions. These 
strains were from the library screen of Asaia sp. Sf2.1 and 
streaked to single colonies on iron supplemented (FeCl3) or 
iron depleted (Dip) conditions. The bacteria only produce GFP 
when supplemented with iron and the amount of GFP is 
reduced greatly when the iron chelator 2-2’ dipyridyl is added 
to the media. 
   AGLR1.1F7                  AGLR1.16G9 
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Table 3.1) Homologous BMI promoters in related bacterial species used to make putative blood-meal induced 
GFP strains of Asaia 
Asaia 
strain 
Homolog-
ous Gene 
Original 
Species 
Primary 
gene 
function 
Asaia 
Homolog 
gene ID  
Amino 
acid 
similarity 
Contig 
Promoter 
region 
cloned 
(bp) 
Source 
AGLR1.
HlyA 
HlyA 
Helicobacter 
pylori 
Hemolysin 
P792_091
25 
51% 22 
4286-
4556 
138  
AGLR1.
HlyC 
HlyC 
Vibrio 
cholera 
Hemolysin 
transferase 
P792_096
55 
55% 24 
25967-
25425 
139 
AGLR1.
Ferr 
TrxR 
Helicobacter 
pylori 
Oxidative 
stress 
protection 
P792_120
65 
43% 33 
9024-
8748 
140 
AGLR1.
SodB 
SodB 
Escherichia 
coli 
Oxidative 
stress 
protection 
P792_082
20 
62% 2 
251914-
252466 
141 
AGLR1.
Bfr 
Bfr 
Escherichia 
coli 
Iron storage 
P792_128
70 
74% 4 
105339-
105838 
142 
AGLR1.
AcnA 
AcnA 
Escherichia 
coli 
TCA cycle 
enzyme 
P792_140
35 
76% 5 
130897-
131396 
143 
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   AGLR1.SodB                        AGLR1. Bfr
         AGLR1.Bfr 
Figure 3.6) Strain AGLR1.SodB and AGLR1.Bfr show 
conditional expression on blood-like conditions. These 
strains were isolated from homologous promoter clones of 
pGLR1 in Asaia sp. Sf2.1 streaked to single colonies on 
iron supplemented (Fe and Hemin), or iron depleted (Dip) 
conditions.  
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AGLR1 AGLR1.SodB 
AGLR1.HlyA 
Minimal 
Media 
Choc. 
Agar 
Figure 3.7) Qualitative fluorescence of conditional promoter strains of 
Asaia sp. SF2.1 plated on minimal media and media supplemented with 
blood. The conditional strains found through homologous promoter screening 
were plated on minimal media and chocolate agar half plates and fluorescence 
was photographed using a fluorescent imager 
AGLR1.Ferr AGLR1.HlyC 
Minimal 
Media 
Choc. 
Agar 
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Figure 3.8) Putative BMI promoters quantitatively increase fluorescence of 
four Asaia conditional strains when exposed to blood in liquid media. There 
was a significant difference in fluorescence for four BMI strains in minimal 
media or media supplemented with blood. No significant difference between 
media was seen for both the positive, ANB50, and negative, AGLR1, controls, 
as well as the SodB and Ferr isolates. Fluorescence readings were taken during 
log phase and normalized to the OD600 of each culture. Significance was 
assessed using Welch’s t-test and error bars are representative of standard error. 
p-values <0.05= *  <0.001=*** 
  
AGLR1    SodB     HlyA      HlyC      Ferr     ANB50 
              
     Blood                  Minimal media 
* 
*** 
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Table 3.2) RNA-seq evaluated differential expression of genes from Asaia sp. SF2.1 induced when 
Iron(top) or 2-2’ dipyridyl(bottom) were added to minimal media compared to a minimal media 
control 
Feature ID 
Asaia 
sp.SF2.1 
contig 
Contig 
region 
start 
 Contig 
region 
end 
Experiment
al Difference  
 Fold 
Change  
P792_12875 Bacterioferritin 2 contig 4 106248 106740 52223 3.48 
P792_16855 Monooxygenase contig 9 35314 36856 1100 2.385 
P792_04020 contig 12 63637 63769 1435 2.23 
P792_11090 contig 13 157795 158008 856 2.009 
P792_06450 contig18 40536 40773 21545 36.612 
P792_11975 Hemin ABC Transporter contig 32 175 1096 6915 21.043 
P792_11980 contig 32 1265 3113 9977 11.856 
P792_16700 contig 9 1984 2680 4592 15.217 
P792_07890 contig 2 190565 191006 3093 16.543 
P792_12870 Bacterioferritin 1 contig 4 105838 106069 13033 10.343 
P792_08855 contig 21 3011 3335 381092 8.999 
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Figure 3.9) Strains AGLR1.B2 and AGLR1.Hem 
show conditional expression on blood-like conditions. 
These strains were isolated from RNA-seq proposed 
promoter clones of pGLR1 in Asaia sp. Sf2.1 streaked to 
single colonies on iron supplemented (Fe and Hemin), 
or iron depleted (Dip) conditions.  
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Figure 3.10) Dual promoter intergenic region used to create AGLR1.HF and 
AGLR1.FH. This region lies between the hemin ABC transporter substrate binding 
gene (ETC97988.1) and a hypothetical protein containing an iron transport motif 
(ETC97996.1). This promoter region is used to induce both genes in opposite 
directions on the complimentary strands. 
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Figure 3.11) Strains AGLR1.HF (A), AGLR1.pnptII (B), AGLR1.Hem(C), 
AGLR1.FH (D) and AGLR1(E) streaked to single colonies. These are plated on control 
media, iron supplemented (Fe and Hemin), or iron depleted (Dip) conditions. The media is 
arranged in the same orientation on every plate as seen in A. 
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AGLR1    Hem       HF       ANB50 
Blood           Minimal media 
A 
B 
AGLR1.Hem       AGLR1.HF       AGLR1.FH 
Control        Iron         Hemin       Dipyridyl 
Figure 3.12) Quantification of fluorescence of Asaia conditional strains 
under varying media conditions. Measurements taken from log phase cultures 
taken at 30 second intervals in a Spectramax 3.1 spectrophotometer. A) There 
was a significant difference in average fluorescence for strains when hemin was 
added to the culture compared to the control. B.) Both hemin and HF strains also 
show a significant increase in fluorescence when blood was added to the media. 
Both AGLR1 negative control and ANB50 positive control show no significant 
difference in fluorescence. P<0.001=*** 
 
*** 
*** 
*** 
*** 
*** 
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Table 3.3) Efficiency evaluation of 16S and 23S 
endogenous control primers and experimental Hemin and 
Bact.2 primers used for qPCR quantification of promoter 
strength through transcriptional activity. 
  Slope 
Amplification 
Factor Efficiency 
16S -3.5622 1.91 90.86% 
23S* -3.2165 2.05 104.34% 
Hemin* -3.2003 2.05 105.34% 
Bact. 2 -3.341 1.99 99.21% 
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Figure 3.13) Endogenous 
control of 16S shows no 
variation in expression 
between media. The 16S 
control primers from Asaia 
sp. SF2.1  were used to 
evaluate if differential 
expression was seen in the 
four different media tested. 
Since no difference in 
amount of transcript was 
detected these primers can 
be used in further qPCR 
experiments.  
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Figure 3.14) Transcription of conditionally expressed genes varies when iron, 
hemin, or dipyridyl is added to the media. The Hemin ABC transporter gene 
showed an 8 fold increase in expression when 2-2’ dipyridyl was added to the media 
and only a 1.5 fold increase when iron or hemin were added to the media. Bact 2 
showed a ten fold increase in expression when iron was added to the media and a 
drastic decrease in expression when the iron chelator was added.  
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Figure 3.15) Positive control AGLR1.pnptII, negative control 
AGLR1 and conditional strain AGLR1.Hem streaked to 
single colonies on minimal media and chocolate agar. It is seen 
that the constitutive control is fluorescent on both media and the 
negative control shows slight conditionality on the chocolate agar. 
The AGLR1.Hem is conditional to the chocolate agar.  
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Figure 3.16) HmuT transcription is 
increased on media supplemented with 
blood. In two separate experiments with 
two tenfold dilutions, the HmuT gene was 
shown as transcribed over 2.5 more times 
when blood was supplemented to the 
minimal media.  
500 µm 
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Figure 3.17) Compound microscope images of sugar fed and blood fed mosquito 
midguts under bright field or florescence microscopy. The upper panel is a negative 
control of a mosquito’s midgut fed only on sugar without the addition of any bacteria. 
AGLR1.nptII is a positive promoter expressing GFP in the presence (blood fed) and 
absence (sugar fed) of iron. AGLR1.1F7 and AGLR1.16G9 are conditional promoter 
strains found through library screening that express a great amount of GFP when 
mosquitos have blood fed, but notably less when they were sugar fed only.  
 
   100 µm    100 µm 
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Figure 3.18) Sugar fed and blood fed mosquito midguts under bright field or 
florescence microscopy cultured with Asaia containing differing plasmids. 
AGLR1, the empty vector in Asaia, is the negative control and AGLR1.pnptII is a 
constitutive promoter expressing GFP in the presence and absence of blood. The 
first column is the merged image of the bright field and fluorescence images that 
follow it accordingly. AGLR1.B2 shows very little induction under either 
condition. AGLR1.Hem, outlined in red, shows conditional fluorescence when 
exposed to a blood meal vs sugar meal and represents a putative conditional to be 
analyzed further. After visualization the recombinant bacteria were counted 
through dilution and plating and showed no significant difference between the 
sugar fed and blood fed mosquitoes 
500 µm 
500 µm 
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Figure 3.19 Sugar fed and blood fed mosquito midguts under bright 
field or florescence microscopy cultured with Asaia containing 
differing plasmids. Wild-type Asaia sp. SF2.1 is the negative control 
and AGLR1.pnptII is a constitutive promoter expressing GFP in the 
presence and absence of blood. AGLR1.Hem shows conditional 
fluorescence when exposed to a blood meal vs sugar meal. Both 
AGLR1.H-F and AGLR1.F-H show fluorescence under both blood fed 
and sugar fed conditions and are considered constitutive isolates. After 
visualization the recombinant bacteria were counted through dilution 
and plating and showed no significant difference between the sugar fed 
and blood fed mosquitoes 
   100 µm    100 µm 
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AGLR1 
N=127 
 
 
Figure 3.20.) BMI Asaia isolates retain induction in vivo in response to a mosquito 
blood meal. Bacterial cultures of each strain were fed to mosquitoes and differences in 
fluorescence were analyzed between the blood fed and sugar fed individuals of each 
strain. AGLR1, which contains no promoter, serves as the negative control and ANB50 
is a constitutively fluorescent positive control. The strains outlined in grey, 
AGLR1.Hem, HF, HlyA and HlyC, show conditional fluorescence when exposed to a 
bloodmeal vs sugar meal indicating these promoters are induced by the bloodmeal in 
the mosquito.  
AGLR1.Hem 
N=105 
AGLR1.HF 
N=76 
 
AGLR1.SodB 
N=61 
 
AGLR1.HlyA 
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AGLR1.HlyC 
N=67 
 
AGLR1.Ferr 
N=62 
 
ANB50 
N=115 
 
       Strain     Sugar Fed   Blood Fed 
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Table 3.4) Colony counts of transgenic Asaia obtained from 10 
dissected midguts per strain show lower abundance in blood fed 
midguts than in sugar fed midguts.   
AGLR1 Hem HF SodB HlyA HlyC Ferr 
Blood Fed 230 20 10 120 100 2370 70 
Sugar Fed 9400 930 2120 2240 8000 5640 15520 
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4. Antiplasmodial Asaia Strains 
4.1. Introduction 
Malaria is one of the most serious human diseases, which causes over 430,000 deaths per 
year29. Malaria is caused by parasites in the genus Plasmodium, which have a complex life cycle 
involving an mosquito vector and a human host32. The part of the life cycle that is investigated in 
this research centers around the midgut of the Anopheles mosquito. During this time a severe 
population bottleneck occurs at the oocyst stage of the Plasmodium life cycle, reducing the 
number of organisms to much less than 1% of the original amount ingested144. This is due to a 
variety of immune responses generated by both the mosquito as well as the bacterial symbionts 
making up the midgut microbiome. These anti-plasmodial effects occur during the invasive stage 
of the life cycle preventing the ookinete from invading the midgut lumen to create oocysts. Most 
studies have shown this happens through an increased immune response of the mosquito due to 
the native bacterial stimulus35. Other studies have also seen that these symbiotic bacteria can 
create anti-plasmodial effectors such as reactive oxygen species that act on these invasive stages 
of the pathogen145. 
 The microbial communities that live inside different Anopheles species vary depending 
on geographical location and feeding behavior; however, most species tend to retain a core 
microbiome dominated by Proteobacteria. The most abundant of these bacteria able to cross-
colonize across different species of mosquito are the Pantoea, Acinetobacter, and Asaia69.  The 
species Asaia sp.SF2.1  has also been shown to be easily transmitted both horizontally and 
vertically in mosquito populations64 and was chosen as the strain to be used in this 
paratransgenic approach. By modifying genes in the wild-type strain of Asaia sp.SF2.1, it is 
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possible to deliver antiplasmodial compounds directly to the compartment in the mosquito where 
the population bottleneck occurs in the invasive stages of the pathogen32. 
Previously, Asaia sp.SF2.1 was engineered to express antiplasmodial effector molecules 
that were secreted into the midgut88. The antiplasmodial used in this study is the anti-microbial 
scorpine and was selected due to its proven ability to decrease prevalence of the parasites in the 
mosquito midgut88. Scorpine is a peptide that was isolated from scorpion venom and inhibits 
both zygote and ookinete formation146.  Most scorpion venom disrupts ion channels in a 
microbes cell wall to interfere with membrane permeability147. Scorpine is unique from many 
anti-microbial peptides in that it contains both a defensin-like C-terminal segment, and a 
crecropin-like N-terminal region146. Both of these types of peptides have shown anti-microbial 
effects on their own either by interfering with ion channels in the cell membrane147, or hindering 
DNA replication or transcription148, respectively. The exact antimicrobial mode of action that 
scorpine employs has yet to be characterized.  
 We hypothesize that constitutive production of antimicrobial proteins is deleterious to 
the fitness of the transgenic bacterial strains. Therefore, promoters that are activated by the influx 
of the nutrients found in the bloodmeal, hereafter referred to as bloodmeal induced (BMI) 
promoters, were used to drive the expression of scorpine. These promoters were identified in the 
previous chapter. To ensure that the anti-plasmodial is in contact with the pathogen it must also 
be secreted out into the midgut where the Plasmodium develops. To do this a TonB secretion 
signal was added to the C-terminus end of the protein. This secretion signal works with TonB 
dependent transporters to move them across both the inner and outer membranes of gram-
negative bacteria. Primarily this system is used to transport iron but is also shown to transport 
carbohydrates and other chemicals in some systems149. 
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4.2. Materials and Methods 
4.2.1.  Creating the antiplasmodial strains 
Antiplasmodial plasmids were constructed using the vector pCG18, which has a 
constitutive neomycin phosphotransferase promoter driving the expression of the antiplasmodial 
peptide scorpine which is fused to an alkaline phosphatase reporter gene and the 150 base pair 
TonB dependent secretion signal. The upstream region of GFP in the pGLR1 plasmid, including 
the terminator and multiple cloning site, was inserted into pCG18 at the promoter region, 
replacing the constitutive promoter. This new promoterless vector was named pCG18.glr1. The 
BMI promoters discovered in chapter 3 were cloned into this construct at the multiple cloning 
site using standard PCR ligation or Gibson assembly upstream of scorpine.  
To ensure that the effector scorpine was also conditionally expressed in the 
antiplasmodial system the amount of protein for each construct on blood and minimal media was 
analyzed through western blotting. Each construct was grown to log phase and verified through 
PCR before being streak on both minimal media and chocolate agar plates. Control plates 
without bacteria were used to evaluate the amount of protein collected from the media itself. 
These plates were allowed to grow for 2 days at 30°C before colonies were collected with 1.5 
mL of minimal media. One milliliter of each suspension was collected and spun down at 12,000 
rpm for 5 minutes. The supernatant from these cultures was collected and placed on ice while the 
pellet was resuspended in 20% B-per in TBS. The total protein for each of these samples was 
analyzed through a Bradford assay after accounting for the excess protein collected from the 
blood media. Each supernatant sample was then diluted to the same total protein concentration 
and 75 µL of each was added to 25 µL of 3x Laemmli buffer and boiled for 10 minutes. 15 µL of 
these samples were loaded into a 10% Mini-PROTEAN® TGX™ precast gel with a Precision 
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Plus Protein™ Kaleidoscope™ molecular mass ladder both from BioRad. These were run at 
200v for 30 minutes after which they were transferred to a PVDF membrane in a BioRad transfer 
apparatus using Tris-Glycine transfer buffer (25mM Tris, 150mM glycine, 10% methanol) at 100 
V for 60 minutes. The membrane was blocked using 4% BSA TBS-T solution (50 mM Tris-CL, 
150 mM NaCl, 0.1% Tween20, 4% w/v fraction V BSA, pH 7.5) overnight at 4°C. The 
following day the blot was incubated with the bacterial alkaline phosphatase antibody (HRP) 
from GeneTex at a 1:5,000 dilution suspended in blocking buffer and again incubated overnight 
at 4°C. The membrane was then washed in cold TBS-T for 15 minutes four times. Advansta 
WesternBright Sirius chemiluminescent HRP substrate was applied to the membrane for 2 
minutes in the dark before being visualized on an Odyssey Fc dual mode imaging system from 
LI-COR. 
4.2.2. Fitness assessment 
Fitness was first tested by measuring the maximum growth rate of each strain. To do this, 
each Asaia strain was inoculated at an OD600 of 0.1 in 200µl of a 96 well plate. The OD600 was 
analyzed over 24h at 15-minute intervals using a SPECTRAMAX i3x spectrophotometer 
(Molecular Devices). The SoftMax Pro 7 software was used to create growth curves of collated 
replicates of each strain until they reached stationary phase. Growth curves were further analyzed 
using the package growthrates150 in RStudio to find the maximum growth rate of each strain of 
Asaia.  Data was visualized in RStudio using barplot2151 
The ability of the transgenic strains to survive when competed in a culture with wild-type 
Asaia was tested in a competition experiment. First a plasmid retention experiment was 
performed in triplicate. Each antiplasmodial strain of Asaia was grown to log phase in minimal 
media with 120mg/L kanamycin. The cultures were then pelleted at 8,000 rpm and washed three 
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times with minimal media without any antibiotic. The pellets were then resuspended in minimal 
media and grown for an additional 6 hours at which time they were diluted into 6 ten-fold 
dilutions. One hundred microliters of the last two dilutions were plated on minimal agar with and 
without kanamycin. After two days the amount of CFUs on each plate were analyzed and 
compared. Once plasmid retention was verified, the antiplasmodial strains were competed with 
the wild type, at least ten replicates of each were grown to log phase (ACG18:10, 
ACG18.Hem:11, ACG18.HF:12, ACG18.HlyA:10, ACG18.HlyC:12) and mixed with wild-type 
Asaia in a 50/50 ratio of a 0.5 OD600 culture. These mixed cultures were allowed to grow for 6h, 
then diluted to 1.0 x10-5 OD600 of which 100µl was plated on minimal media with or without 120 
mg/ml kanamycin. The ratio of transgenic bacteria was calculated by comparing the CFUs on the 
selective media to the CFUs on the nonselective media. Data was visualized in RStudio using 
boxplot151. 
The final fitness assessment performed was a mosquito colonization experiment that was 
repeated in triplicate. Each strain was fed to Anopheles stevensi mosquitoes at a an OD600 of 0.1 
dilution in the sugar meal. After 36h, mosquito midguts were dissected and homogenized using a 
tissue grinder. Ten midguts for each strain were pooled and diluted to 100µl PBS/midgut. These 
samples were again diluted 100-fold in PBS and 100µl of each dilution was plated on kanamycin 
supplemented minimal media. CFUs for each strain were counted and compared to the total 
number of CFUs collected across test groups. Data was visualized in RStudio using barplot2151 
 
4.2.3. Plasmodium Inhibition 
To evaluate the inhibitory effect of the Asaia strains containing the antiplasmodial 
plasmid constructs, adult female ND4 Swiss Webster mice were infected with Plasmodium 
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berghei ANKA 2.34. Parasites were allowed to develop in the mice until parasitemia level 
reached 4-10%. At this point the mice were sacrificed and blood was collected via cardiac 
puncture. The infected blood was diluted with RPMI media to 2% parasitemia, then 200µl 
(5x107 parasites) was injected intraperitoneally into an uninfected mouse. At the time of this 
transfer, each Asaia strain to be tested was fed to Anopheles stephensi mosquitoes at a an OD600 
of 0.1 dilution in the sugar meal.  
The parasites were cultured in the mosquito for 48 hours before testing for exflagellation 
which was repeated every two hours. To test for this, 2 µl of the blood from each mouse was 
mixed with 2 µl of 1 mg/ml heparin and 6 µl of exflagellation media. The exflagellation media 
(1L RPMI media supplemented with 2g sodium bicarbonate, 50mg hypoxanthine, 20.5mg 
xanthurenic acid) mixed with 2µl of 1 mg/ml of heparin in PBS and 2µl of blood collected from 
a tail prick of the mouse to replicate conditions inside the mosquito gut. These mixtures were 
incubated at 19 ̊C for ten minutes and exflagellation events were counted. Parasites were allowed 
to develop in the mosquito for 12d at 19ºC in order to form oocysts. After 12d, the mosquito 
midguts were dissected and stained with a 100-fold dilution of 2% mercurochrome stain for 2 
minutes. They were then left to destain for 5 minutes in PBS. The midguts were analyzed under 
100x microscopy and the number of oocysts per midgut were counted for each test group. All 
steps in this process were performed blindly and ordered randomly. Data was visualized in 
RStudio using Bee Swarm152. 
To optimize the number of oocysts formed in each midgut, an experiment was performed 
where the time the Plasmodium had to develop inside the mouse was limited. First, the initial 
infection and transfer of Plasmodium between mice was performed the same as discussed above. 
However, wild-type mosquitoes were fed on the second infected mouse at 7 different time points 
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for 6 minutes. Each test group was given 12 days to let the oocysts develop, then midguts were 
dissected and oocysts counted.  
To produce replicated and standardized antiplasmodial results, the beginning of each 
antiplasmodial experiment was performed as described above until 36 hours post P1 plasmodium 
infection of the second mouse, after which each test group of mosquitoes was blood-fed on this 
mouse for 6 minutes each. The order of the test groups was rotated randomly and blindly for 
each of the 3 trials conducted. The ability of the parasite to undergo exflagellation was also 
tested at this time after feeding the mosquitoes using 6µl exflagellation media mixed with 2µl of 
1 mg/ml of heparin in PBS and 2µl of blood collected from a tail prick of the mouse. At least 2 
exflagellation events occurred for each malarial trial. After the oocysts developed for 12 days, 
the midguts were dissected and analyzed and the oocysts counts for all three trials were 
combined and analyzed in RStudio. 
  
4.3. Results  
4.3.1. Creating the antiplasmodial strains 
The four validated BMI promoters were cloned from the reporter plasmid pGLR1 into the 
scorpine secretion plasmid pCG18. A transcriptional terminator (T1) was added upstream of the 
BMI Asaia promoters, creating pCG18.glr1 (Figure 4.1). The promoters drive a scorpine 
antiplasmodial effector fused to E. coli phoA. This antiplasmodial effector has been used 
previously with constitutive promoters and was shown to be one of the most refractory to P. 
berghei infection88. These new constructs were transformed into Asaia and validated for 
conditional expression through western blot analysis. All BMI strains conditionally expressed 
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scorpine only on blood supplemented media while ACG18, the positive control expressed the 
antiplasmodial constitutively (Figure 4.2). 
 
4.3.2. Fitness assessment 
Before testing for Plasmodium inhibition, the fitness of each of the strains was assessed 
to evaluate whether they survived better than the Asaia strain that constitutively expresses 
scorpine. To do this, the maximum growth rate (µmax) of each strain was measured (Figure 4.3). 
The strains ACG18.Hem and ACG18.HlyA showed a significant increase in µmax from the 
constitutive positive control ACG18. However, all transgenic strains had a significantly 
decreased maximum growth rate compared to the wild-type Asaia. 
A competition experiment was also performed in which each antiplasmodial strain was 
grown with wild-type Asaia. First, a plasmid retention experiment was conducted for all isolates. 
Over a period of six hours no significant loss of plasmid occurred while grown without antibiotic 
(Figure 4.4). For the competition, the scorpine secreting strains were grown in a 50/50 culture 
with wild-type Asaia inoculated at a 0.5 OD600, which is the beginning of log phase for the 
bacteria. These cultures were allowed to grow for 6h and then plated on minimal media with or 
without antibiotic. The ratio of surviving transgenic Asaia was calculated by comparing the 
number of colony forming units (CFUs) on the kanamycin supplemented plates, which only 
contained strains harboring the antiplasmodial plasmid, to the non-selective plates, containing all 
of the bacteria present in the culture (Figure 4.5). The constitutively expressing strain showed a 
drastic reduction in CFUs while the BMI strains all retained relatively high ratios of transgenic 
bacteria. This is especially true for the ACG18.Hem construct, which retained half of the 
bacterial population when grown with the wild Asaia strain.  
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Finally, the fitness of these strains was tested in vivo, within the mosquito midgut. The 
transgenic bacteria were fed to the mosquitoes in the same way as in the fluorescence 
experiments described in the previous chapter. After 2d, ten midguts from each strain were 
dissected and homogenized in PBS and CFUs were enumerated (Figure 4.6). ACG18.HlyA had 
the highest rate of colonization in the midgut followed by ACG18.Hem. A significant increase in 
colonization was also seen for ACG18.HF compared to ACG18. ACG18.HlyC did not show a 
significant increase in colonization over the constitutive control. 
4.3.3. Plasmodium Inhibition 
In the very first antimalarial experiment, mosquitoes were cultured with 1.0 OD ACG18, 
ACG18.Hem, ACG18.HlyC, Asaia sp SF2.1, and ANB97 though a sugar meal overnight. The 
wild-type bacteria acted as a negative control and the ANB97 was included because it had 
previously been tested in malaria inhibition experiments and was proven to be effective. Each 
test group of mosquito was blindly labeled to decrease any chance of biases and then fed for 6 
minutes each on a single mouse. The mosquitoes that had not blood fed were removed from each 
group and the rest were kept at 19 ̊C for ten days to allow oocysts to develop. Midguts were then 
dissected and stained for 15 minutes using a 0.02% mercurochrome solution and the number of 
oocysts for each were counted (Figure 4.7). A decrease in parasite prevalence was observed for 
all the constructs secreting scorpine especially significant for the ACG18 and ACG18.Hem. The 
significance of the data was assessed using quantile regression calculated using RStudio. These 
data show extremely high oocyst counts and were therefore optimized by limiting the time the 
Plasmodium had to develop inside the mouse (Figure 4.8). Before 36 hours the number of 
oocysts in the midgut is negligible and could not be used. Oocyst numbers steadily increase from 
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there and become more variable. Therefore, all further experimentation was performed with a 36 
hour incubation of the plasmodium in the second mouse.  
Each transgenic antimalarial Asaia strain and wild-type Asaia were fed to A. stephensi 
mosquitoes as was done previously. The mosquitoes were then fed on mice infected with 
Plasmodium berghei.  The pathogens were left to develop for 12d before the mosquitoes were 
dissected and oocyst numbers counted for each midgut (Figure 4.9). A significant decrease in 
median oocyst numbers occurred in all test groups secreting the antimalarial construct when 
compared to mosquitoes fed on the wild-type Asaia sp. SF2.1. All BMI strains reduced the 
oocyst median number to almost one tenth of the wild type control, indicating a strong 
antiplasmodial effect in these paratransgenic mosquitoes. Importantly, the prevalence, or 
incidence of infection, of the pathogen was significantly reduced in all antiplasmodial isolates, 
over 25% in the BMI strains. The constitutive positive control, ACG18, only decreased the 
prevalence of infection by 15% from the wild type and showed higher median oocyst numbers 
compared to the BMI isolates. This difference in prevalence was significant for ACG18.Hem, 
with the lowest pathogen prevalence approaching 50% inhibition, as well as ACG18.HlyA and 
ACG18.HlyC 
4.3.4. Discussion 
Mosquito-borne diseases remain a very real threat to over half of the world’s population, 
and their range has been spreading due to globalization, urbanization, and climate change153. 
Current preventative strategies center around controlling the vectors of these diseases; most 
often, this involves the use of bed nets and insecticides154. However, many mosquito species 
have evolved resistances to commonly used insecticides45 and some have even altered their 
biting behavior to gain access to humans at times of the day when bed nets are not being used44. 
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Other vector control strategies involve transgenically modifying the mosquito vector genome; 
however, mutation rates in transgenes, reproductively isolated populations, as well as the large 
number of species that vector pathogens may make implementing this technology challenging in 
the wild32. 
Paratransgenesis may bypass these roadblocks by employing bacteria that can be easily 
transferred between species and individuals and are easily distributed in the wild using feeding 
stations or inoculating the larval water155. This approach has been verified in semi-field 
experiments with the bacterial symbiont used in this study, Asaia sp.SF2.185. When employing a 
paratransgenic control strategy it is important to ensure that the transgenic bacteria are 
competitive enough to survive in the wild microbiome of mosquitoes. Producing anti-pathogen 
effectors can severely compromise their fitness. Therefore, conditional expression of these 
proteins when the pathogens are present is imperative in the field application of these bacteria. 
The introduction of blood into a mosquito midgut causes a huge environmental shift for the 
symbiotic bacteria in the midgut as well as a substantial increase in microbial flora156. This 
change in environment can induce a variety of conditionally expressed genes in the native 
microbiome, and some select promoters of these genes were utilized to express anti-pathogen 
effectors.  
The four BMI promoters that were developed in the conditional expression aim of this 
dissertation and the constitutive positive control promoter were used to drive the antiplasmodial 
effector gene scorpine. These constructs were verified for conditionality using western blot 
analysis and the BMI strains showed increased expression when grown on blood supplemented 
media. The ACG18 constitutive strain expressed the protein constitutively on both types of 
media. The ability of these strains to survive better in wild populations than a constitutively 
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expressing strain was verified both in culture and the mosquito midgut. Strains ACG18.HlyA 
and ACG18.Hem had significantly increased maximum growth rates (Figure 4.3) compared to 
the constitutive positive control which can be correlated to relative fitness of the bacteria59. It is 
important to note that these growth rates were still significantly decreased from the wild type; 
however, the p-value for these comparisons were very close to 0.5 and could be increased after 
these cassettes are optimized when inserted into the Asaia genome.  All BMI strains also 
survived significantly better than the constitutively expressing strain when competing in culture 
with wild-type Asaia (Figure 4.5). This is most likely due to the decreased fitness cost associated 
with not expressing the antiplasmodial construct constitutively89. This increase in fitness 
persisted in vivo, for all strains except ACG18.HlyC, and they colonized the mosquito midgut 
significantly better than the constitutively expressing ACG18 strain (Figure 4.6). Without the 
pressure of producing the antiplasmodial effector molecules and reporter proteins constitutively, 
these strains were able to flourish in the natural microbiome.  
BMI strains fed to mosquitoes prior to Plasmodium infection significantly reduced 
median oocyst numbers and prevalence of the parasite. Prevalence is the percent of individuals 
with at least one oocyst. This is the most important metric for malarial inhibition considering that 
even one oocyst can result in thousands of sporozoites making the mosquito infectious during 
subsequent blood feedings. 
To begin testing for malaria, a trial run of the malaria life cycle without the addition of 
transgenic bacteria was conducted to ensure that the results could be analyzed easily. Any steps 
that were misleading or dysfunctional were optimized before beginning the paratransgenic 
experiment. In both cases, the first step was to inoculate the mice from frozen P.berghei ANKA 
2.34. The parasites were obtained from blood stocks of mice that had been infected with 
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Plasmodium from mosquitoes and mixed RPMI media and frozen in the Dewar. This indicates 
the stock is P0 which means it has not been transferred from mouse to mouse. This is important 
because after too many transfers the Plasmodium loses its ability to undergo its sexual stages 
seen in the mosquito. To ensure that this had not happened the ability of the pathogen to undergo 
exflagellation was evaluated. Exflagellation is when the male gametes in the blood cells grow 
flagella out of the cell and can then move to locate a female gametocyte.  
The results seen from this first experiment were analyzed through quantile regression in 
RStudio. This was done because the median of each group is used instead of the mean. This is 
standard in this kind of experiment because it is common that mosquitoes will either not take up 
the bacteria or the parasite. In this experiment, there was only indication of the latter since almost 
all mosquitoes were infected. The lack of bacterial uptake can be seen easiest in the ACG18 
strain where there is nice grouping for all midguts excluding one extreme outlier. To reduce the 
number of outliers seen, the bacteria can be fed to the mosquitoes earlier to ensure sufficient 
uptake and colonization of the midgut.  
Furthermore, this data show extremely high oocyst counts. This is problematic for a 
variety of reasons, including the excess time spent repeating these experiments as well as 
difficulty distinguishing numbers of oocysts when they are crowded. To reduce this burden the 
optimal incubation time for the Plasmodium was assessed and 36 hours was chosen because it 
showed a great reduction in oocyst numbers and less variability than many of the other testing 
times.  Using this technique, the final culminative malaria inhibition experiments were 
performed. 
 Through this method, all BMI strains reduced the prevalence by over 25% from the 
control, with some strains approaching 50% inhibition. This is even more promising considering 
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that infections with P. berghei in the laboratory show dramatically increased oocyst numbers 
than natural infections would occur in the field34. Furthermore, it is quite possible that the few 
remaining oocysts in our test group mosquitoes may not produce many functional sporozoites. 
This was seen by Isaacs et al. when using transgenic mosquito strains to inhibit Plasmodium 
falciparum oocyst and sporozoite development in Anopheles stephensi157. This could result from 
the antiplasmodial effector protein inhibiting proper formation within the oocyst or the effector 
acting on any remaining sporozoites that may be released. 
All BMI isolates, except for ACG18.HF, also showed a significant prevalence reduction 
from the positive constitutive control. This is especially obvious when looking at the prevalence 
of the pathogen, which decreased by almost 30% in the ACG18.Hem strain compared to the 
positive control. This may be due to the increased fitness of these BMI strains and their ability to 
colonize the midgut more efficiently than the ACG18 constitutive strain. Since these BMI strains 
were able to survive and more robustly colonize the midguts of these mosquitoes, they are able 
to produce more of the antimalarial effector and cause this decrease in prevalence that is seen 
from the positive control32. 
The correlation of results for the midgut colonization and competition experiments, 
showing the most fit of the bacterial strains to be the ACG18.HlyA and Hem strains is of 
immense value considering ACG18.Hem also had the greatest reduction of Plasmodium 
infection. Most likely these attributes are caused by stricter control of gene expression, reducing 
any effects the gene has on the bacteria when turned off and greater, possibly more immediate, 
expression of the gene while the bloodmeal is present. These BMI strains are candidates for 
further testing and will be used to create antiplasmodial constructs incorporated into the 
chromosome of Asaia. This will remove the need for antibiotic resistance to maintain plasmids 
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and allow for longer retention of the antiplasmodial gene cassette. This may further increase the 
fitness of these transgenic strains and allow for field testing of these strains in Plasmodium 
infected regions.  
This paratransgenic control strategy can be expanded to many vector-borne diseases that 
plague countries across the world. The ability of the transgenic Asaia to colonize a variety of 
disease vector arthropods would allow this technique and even these constructs to be used in 
many different disease control programs. Furthermore, because these conditionally expressing 
strains compete efficiently with the wild-type bacteria, they will be able to be transmitted 
between and down generations of mosquitoes to create an enduring control strategy of disease 
vectors.  
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Figure 4.1) Vector pCG18.glr1 was constructed from cloning the 
terminator (T1) and multiple cloning site (MCS) of pGLR1 to the 
promoter region of pCG18. This allowed easy insertion of putative promoters 
from GLR1 constructs verified in the previous section as well as ensuring that 
the transcription of the antimalarial gene was only driven by these promoters. 
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Figure 4.2) Scorpine is conditionally expressed in all BMI isolates while 
retaining constitutive expression in the positive control ACG18. Expression of 
the antimalarial scorpine was evaluated from colonies collected from minimal(M) 
and chocolate agar(C) through western blot analysis. The top band that lies around 
61.1 kD correlates with the size of the secreted protein and the smaller band at 
55.4kD shows the protein construct without the secretion signal. The hemolysin 
promoters show a stronger band than the ACG18.Hem and HF, however all 
conditional constructs show increased protein production when blood is 
supplemented to the media. 
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Figure 4.3) Conditional BMI Asaia isolates have a significantly increased 
maximum growth rate in comparison to the constitutive ACG18. Growth 
curves and maximum growth rates were calculated from 10 individual 
isolates of each strain grown over log phase of the bacteria in RStudio and 
differences between the constitutive ACG18 and BMI isolates were assessed 
using a one-way ANOVA with Dunnett’s correction error bars are 
representative of standard error of the mean. 
p-values <0.001=             
SF2.1        ACG18      ACG18.Hem  ACG18.HF   ACG18.HlyA  ACG18.HlyC 
** **
**
 110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACG18        ACG18.Hem      ACG18.HF     ACG18.HlyA    ACG18.HlyC 
Figure 4.4) The antimalarial Asaia isolates retain their plasmids over the 
course of 6 hours without antibiotic. Three individual colonies were tested for 
each isolate. They were grown in minimal media with kanamycin to log phase, 
then washed twice and resuspended in minimal media to 0.5 OD600. These 
cultures were grown for 6 hours then plated with and without antibiotic. The 
number of CFUs on each media were compared and no significant difference was 
observed between media. Welch’s t-test was used to assess significance and error 
bars are representative of standard error of the mean. 
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Figure 4.5) BMI antimalarial Asaia isolates survive better than the 
constitutive control when competed with wild-type Asaia sp. SF2.1. Each 
strain was competed in minimal media with wild-type SF2.1 in an initial 50/50 
culture during log phase of the bacteria. Ratios of transgenic vs. whole culture 
CFUs are displayed above. P-values lower than 0.001 were achieved for the 
comparison of isolates ACG18.Hem, HF, and HlyC to the constitutive ACG18 
control while a p-value of 0.004 was seen for ACG18.HlyA. Statistical 
significance was determined using one way ANOVA with Dunnett’s 604 
correction and error bars are representative of standard error of the mean. 
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*** * *** 
Figure 4.6) BMI Asaia antimalarial isolates colonize the mosquito midgut more 
efficiently than the constitutive control.  Antimalarial Asaia strains were fed to 
mosquitoes and 10 midguts from each sample were pooled and plated on selective 
media. Transgenic CFUs were counted for each strain and taken as a ratio of the 
total across all strains. Data were pooled for three trials and significant differences 
from the constitutive ACG18 were assessed one way ANOVA with Dunnett’s 
correction in RStudio; error bars are representative of standard error of the mean.  
p-values <0.05=         <0.001=             
ACG18      ACG18.Hem     ACG18.HF ACG18.HlyA   ACG18.HlyC 
*** * 
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Figure 4.7) Plasmodium inhibition inside the mosquito midgut using 
the bloodmeal induced antimalarial effector molecule, scorpine.  It can 
be seen that the new CG18 and CG18.Hem constructs decrease the median 
number of oocysts significantly from the wild type SF2.1. Neither the 
originally designed constative strain NB97 nor CG18.HlyC showed a 
significant reduction. Significance was assessed using quantile regression 
in Rstudio. 
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Figure 4.8) Limiting the time Plasmodium develops inside the mouse before 
feeding to mosquitoes can control the infectivity of the pathogen inside the 
mosquito. The number of oocysts seen from 36 to 52 hours of incubation 
increases as time elapses. The lowest and most stable counts were obtained after 
36 hours. This timepoint will be used in the remainder of malaria experimentation. 
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Figure 4.9) Increased Plasmodium inhibition in mosquito midguts using 
blood meal induced promoters. In three separate trials, oocysts were 
counted in mosquitoes infected with Asaia strains that were fed on a P. 
berghei infected mouse. Each dot represents an individual midgut and the 
number of P. berghei oocysts it contained.  SF2.1 is the wild-type Asaia 
strain (negative control) and ACG18 is the constitutively-expressing positive 
control. All strains secreting scorpine significantly reduced the median 
number of oocysts (horizontal bars) compared to the wild-type strain 
(p<<0.001). The prevalence of infection was not significantly different 
between the wild-type and the positive constitutive control. All BMI strains 
show a significant decrease in prevalence compared to the constitutive 
positive control ACG18 (comparison bar at top of graph).  Prevalence is the 
fraction of midguts with at least one oocyst.   
p-values <0.01= **   <0.001= ***   
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5. Summary and Future Directions 
5.1. Summary 
The issue of vector-borne disease control has plagued the human population for centuries and 
only just recently have human interventions into the control of these diseases been focused on 
maintaining the vectors that transmit them. Malaria has proven to be one of the deadliest and 
most burdensome of these kinds of diseases and many investigative efforts are underway to 
prevent the spread of this disease by inhibiting the vector mosquitoes. Most of this research 
focuses on manipulating the mosquito genome directly through transgenesis; however, 
roadblocks remain to create a long-term solution that will be effective in wild mosquito 
populations. Because of these constraints, our lab has chosen to focus our research on a more 
microscopic level, to the microbiome that inhabits the mosquito. Using a method called 
paratransgenesis, the microbial symbiont, Asaia, inside the mosquito midgut has been engineered 
to produce anti-plasmodial effectors that inhibit the Plasmodium and prevents the mosquitoes 
from transmitting the disease. These bacteria were previously engineered to produce the effectors 
constitutively, and although they effectively reduced disease prevalence, the ability of the 
transgenic bacteria to survive let alone thrive was extremely restricted. Because of this, this work 
has focused on conditionally expressing the anti-plasmodials during the blood meal. The work 
presented here demonstrates the steps that were necessary in order to accomplish this goal: 1.) 
Optimization of the experimental techniques used while working with the wild-type Asaia sp. 
SF2.1 in order to efficiently carry out all further research regarding the bacterium. 2.) Isolating 
native conditional promoters from the Asaia genome using in-vitro expression technology to 
show differential fluorescent induction on blood-meal like conditions. 3.) Driving anti-
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plasmodial effectors using the native BMI promoters while retaining pathogen inhibition and 
increasing fitness in comparison to the constitutively expressing strain. 
5.1.1. Asaia sp.SF2.1 experimental techniques 
When this experiment was first begun, the ability of this bacteria to be manipulated in the 
laboratory was very constrained. Previously, it was seen that the Asaia took a very long time to 
grow and would only grow under very specific conditions. However, many of these culturing and 
experimental aspects had not been fully investigated to find the range of bacteria or the optimal 
techniques to use when working with Asaia in the laboratory. Because the experiments that had 
been planned to isolate BMI anti-plasmodial strains would be intensive the techniques used in 
the laboratory were first optimized to allow for effective work to be conducted.  
First, many of the basic culturing methods were investigated to simply produce more 
efficient protocols when handling the bacteria or to ensure that the bacteria were able to grow on 
the media necessary to screen for conditional expression on blood-meal like conditions. It was 
seen that the bacteria were able to grow on almost all media tested as long as an abundant 
amount of sugar was added to the media. Because this bacterium was first isolated in flower 
nectar, the need for added sugar is not surprising. This was very useful for this study because it 
allowed us to culture the bacteria on any media necessary to show the conditionality of the 
promoters that were isolated. It was also discovered that aeration of the culture was the main 
limiting factor in how long it took to replicate and grow to log phase. These conditions along 
with the temperature and antibiotic resistances tested, will allow all future research with this 
bacterium to be conducted in a much more efficient and productive manner.  
Furthermore, very few experiments had been performed inside mosquito guts using this 
bacterium in the lab so its isolation from that environment was optimized for both wild type and 
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engineered SF2.1. Using the antibiotic and growth media data generated from the previous 
experiments, these bacteria were solely isolated from the midgut despite persistent contamination 
of an extremely antibiotic resistant bacteria Elizabethkingia being present in the cultures. 
Although this contaminant has not shown up in our lab reared mosquitoes again, the selective 
media generated to prevent this bacterium from growing should effectively isolate Asaia from 
almost any environmental bacterial culture. Very importantly, it was also seen that the ability of 
Asaia to produce fluorescence could be compromised by chemicals in the media, in this case 
gentamycin. Knowing this information will be extremely useful for all bacterial reporter systems 
that utilize fluorescence in this bacterium. 
Finally, it was extremely important to optimize the genetic manipulation techniques of 
this bacterium due to the very poor results seen previously when engineering Asaia. Through 
multiple rounds of tests it was shown that using fresh culture in log phase to create sucrose 
competent cells that would be used immediately was much more effective than using pre-made 
frozen competent stocks. The ligation ratios and amount of DNA to be transformed were also 
optimized for electroporation to ensure that when manipulating this bacterium, especially in 
screening experiments, the amount of transformed colonies would be sufficient. It was also 
discovered that Asaia could be mated using a tri-parental mating system which can be used to 
increase the efficiency of plasmid transfer.  
By optimizing the experimental procedure used when working with Asaia the following 
experiments to find and use BMI promoters in a paratransgenic antiplasmodial system benefitted 
greatly. Not only could the bacteria grow faster and on more types of media but the general 
behavior of the bacteria became better understood. Furthermore, the ability to isolate the bacteria 
from the midgut was crucial for any in vivo experimentation to be performed and optimizing the 
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genetic engineering of the bacteria helped to produce much more abundant and reliable 
transformants. 
5.1.2. Blood meal-induced promoters isolated from the Asaia genome 
The ability of any genetically engineered bacterium to survive and spread in the wild is of 
considerable importance when creating strains used for a paratransgenic control strategy of 
disease.  Through experimentation it has been seen that producing antiplasmodial effectors from 
Asaia all the time has caused the bacteria to suffer in its ability to survive and grow. Because of 
this it was hypothesized that producing them only during the blood meal would be essential if 
these paratransgenic strains were to ever be used in the wild. Therefore, conditional promoters 
from the Asaia genome were investigated to find ones that could drive a fluorescent reporter only 
on blood-meal like conditions.  
Although library screening had been an effective technique in previous experiments, this 
experiment seemed to produce too many contaminants and false positives to rely on it for finding 
BMI promoters. Mainly, conditional promoters were found from searching the literature for 
homologous genes that are induced in pathogenic bacteria when they come in contact with host 
blood. First, only iron and heme responsive promoters were investigated and even though they 
produced conditional fluorescence in selective media these results did not carry over inside the 
mosquito midgut. Therefore, only blood was as an inducer of expression in all subsequent 
experiments. Furthermore, the ability of Asaia to produce both reporters in the dual expression 
cassette was not replicable. Although GFP was able to be produced conditionally, visible light 
from the LUX operon was only produced on rare occasions. This could possibly be due to the 
size and energy requirements of the operon being a stressor to the bacteria. Therefore, it is 
possible that Asaia employs transcriptional or translational repressors to turn these genes off or 
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selects for any mutations in the coding of the lux operon to decrease its energy requirements to 
survive in the system. 
 Using RNA-sequencing was effective at finding conditionally expressed genes; however, 
because this experiment was performed early in the thesis work, both iron and hemin were used 
as inducers instead of whole blood added to media. Therefore, most promoters found to be 
induced on iron and hemin were nonfunctional in the mosquito midgut. However, one gene, 
HmuT, was induced in iron replete conditions seemed to have a conditional promoter that was 
induced by the blood meal when used to drive GFP. Through these last two methods, four 
conditional promoters were verified; Hem, HF, HlyA, and HlyC, and used to drive 
antiplasmodial effectors in further experiments. 
 
5.1.3. Antiplasmodial Asaia Strains 
 The four conditional promoters discovered through differential fluorescence induction as 
well as a constitutive nptII promoter as a positive control, were cloned upstream of a scorpine 
secretion construct translationally phused to a phoA reporter gene.  These were verified for 
differential expression on blood supplemented media using western blot analysis and all BMI 
strains conditionally expressed the construct while the positive control maintained constitutive 
expression.  
 Because the goal of this work was to make more fit strains of the antiplasmodial Asaia, it 
was important to test the fitness of the strains against the constitutively active positive control. 
This was done through growth rate analysis, competitions with wild-type Asaia, and a 
colonization experiment. In the growth rate analysis the ACG18.Hem and ACG18.HlyA strains 
show a significant increase in the maximum growth rate from the constitutive ACG18. This 
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increase has been correlated to an increased fitness of the bacteria. However, all of the BMI 
strains still had a significantly decreased growth rate from the wild-type Asaia. This was not 
completely unexpected as the wild-type strain is grown without antibiotic while the plasmid 
containing strains are not. Furthermore, because these bacteria contain plasmids they are 
spending more of their energy on transcribing and translating the other genes that are 
constitutively expressed on the plasmid. The wild-type bacteria obviously do not have this 
pressure so they would inherently have an increased fitness. 
 A further measure of fitness was assessed by competing each antiplasmodial strain with 
the wild-type bacteria. Because wild-type Asaia must be grown without kanamycin a plasmid 
retention experiment was performed and showed that there was no significant loss of plasmid in 
our antiplasmodial strains after 6 hours of growth without antibiotic. Therefore each competition 
was carried out for 6 hours and the number of transgenic and wild-type bacteria were 
enumerated. Each BMI strain was shown to compete significantly better than the ACG18 in 
culture with Asaia SF2.1. Of note is the ACG18.Hem strain which retained a 50% ratio of 
transgenic vs total bacteria, meaning that it was able to compete just as well as the un-engineered 
bacterium. 
 The last measure of fitness tested was the ability of the bacteria to colonize the mosquito 
midgut. Each antiplasmodial bacteria was fed to mosquitoes in a sugar meal at the same dilution. 
These were let to colonize the mosquito before the midguts were dissected and homogenized. 
The homogenates were plated for each bacterium and the ratio of transgenic bacteria for each 
experiment was calculated from the total amount collected. All BMI strains showed increased 
colonization from the constitutive control except for AG18.HlyC. Again, the Hem and HlyA 
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strains had the highest degree of increase indicating that the ability to culture the gut may depend 
primarily on the maximum growth rate of the bacteria.  
 Considering all of the strains had a significantly increased fitness from the constitutive 
ACG18, they were all tested for plasmodium inhibition along with a negative control of wild-
type Asaia. The first experiment performed produced hundreds of oocysts per midgut and was 
not replicative of numbers even close to what would be found in nature. Therefore, the time in 
which the Plasmodium had to develop inside the mouse was optimized for the lowest and most 
standardized infection rate possible. This was seen to be 36 hours because around 20-30 oocysts 
were present on almost all midguts and no midguts were found without oocysts. Using these 
data, 3 separate experiments were performed and oocysts numbers merged to show that all of the 
antiplasmodial strains significantly reduced oocyst numbers from the wild type. The BMI strains 
also showed a significant decrease in pathogen prevalence as well whereas the constitutive 
ACG18 strain did not. This means that the BMI strains that were shown to be more fit were also 
better at inhibiting Plasmodium than the constitutive control as well. Most likely because these 
strains were able to colonize and thrive in the midgut much better than the ACG18 therefore 
having a stronger effect once the blood meal was introduced to the environment. 
 These finding are extremely important not only to the field of malaria research but for 
any vector borne disease involving a blood-feeding arthropod. Because Asaia is virtually a 
nonpathogenic bacterium that can colonize a range of arthropods it has the potential to be 
adapted to inhibit a variety of different pathogens while retaining fitness that would allow the 
systems to be used in wild populations. Before these strains of bacteria can be analyzed in wild 
populations however, they must first be optimized to a permanent antiplasmodial system unlike 
the plasmids used in this study. 
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5.2.  Future Directions 
The overarching goal of this work is to create antiplasmodial strains of Asaia that could 
actually be utilized in the wild to inhibit the spread of malaria. Although this works makes some 
necessary progression towards this goal there are still many hurdles to overcome before 
implementation of this paratransgenic strategy can be accomplished.  Due to the exploratory 
nature of the study the experiments performed thus far have been done in antibiotic sustained 
plasmids. Although this makes laboratory use of this strain relatively easy, this system could 
never be maintained in the wild. Furthermore, to test for the effects of these paratransgenic 
strains over multiple generations these effectors must be retained in the bacteria over a much 
longer time. These new stable strains must then be subjected to the same kinds of fitness and 
anti-plasmodial tests as described here to be viable candidates to move forward to field 
applications. 
5.2.1. Creating Stable Paratransgenic strains 
The ability of the Asaia strains made in this work to both inhibit Plasmodium and 
compete effectively with the wild-type bacteria found in the mosquito gut has enabled this 
research to begin readying these paratransgenic strains for use in the field. The antiplasmodial 
effectors used in this study were all contained on antibiotic resistant plasmids and maintained 
with antibiotic. All bacterial plasmids, whether native or engineered, are only stable within the 
bacterial host if they confer a fitness advantage of some sort to the bacteria158. In the laboratory, 
this fitness advantage is manipulated by controlling the environment that the bacteria are grown. 
However, when designing systems that could be utilized in an uncontrolled environment, 
different techniques for stabilizing transgenic DNA must be applied.  
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5.2.1.1. Chromosomal integration 
One way in which to make a transgenic strain more stable is to integrate the foreign DNA 
into the chromosome. Chromosomal integration of foreign DNA has been utilized since the early 
1970’s. It has applications across a broad range of scientific endevors from pharmaceutical 
manufacturing to basic science research tools159.  For this research, the transgenic DNA will be 
inserted into the Asaia genome downstream of the conditional promoters found in this study. 
This will potentially add to the gene operon that each promoter controls to allow the 
antiplasmodial effectors to be expressed in the same way as the native genes contained in the 
open reading frame.  
 
To add these antiplasmodial effectors to the chromosome many different techniques can 
be used. The experiments currently being performed are utilizing I-SceI gene replacement, in 
which a suicide plasmid is used to insert homologous DNA with the transgenic mutant allele into 
the chromosome along with an I-SceI recognition site. This plasmid will undergo homologous 
recombination to insert its entire length into the chromosome. After which, the I-SceI recognition 
site can be cleaved to create a double strand break and recombination of the DNA will result in 
either transgenic or wild type sequence (Figure 5.1)160. If this method fails to work other options 
are available as well, such as, the Crispr-Cas9 system. This technique uses the Cas9 nuclease of 
the bacterial immune system to target specific chromosomal sequences using an RNA guide. One 
caveat of this system is that the chromosomal sequence must immediately precede a protospacer 
adjacent motif (PAM) of 5’-NGG161. However, this type of tool still needs to be specifically 
optimized for use in Asaia.  
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Once these transgenic bacteria have been made they must also be tested for their ability 
to express and secrete the antiplasmodial effectors and their ability to inhibit malarial infection in 
the mosquito as was done previously using the plasmid comprised strains. In addition, these new 
strains will then be tested for their ability to pass through mosquito generation while maintaining 
their fitness in the natural microbiome and ability to inhibit Plasmodium.  
5.2.1.2. Effects to mosquito hosts 
In addition to ensuring that these stable transgenic strains inhibit malaria over multiple 
generations of mosquitoes and that they are retained in the mosquito microbiome they must also 
be tested for any effects they confer for the mosquito host. These strains must not drastically 
hinder the overall survival or fecundity of the mosquito. If these strains of bacteria cause the 
mosquito to die or inhibit their ability to reproduce they will not be able to be transmitted 
throughout mosquito population. On the other hand, if these bacteria conferred some sort of 
fitness or reproductive advantage to the mosquito it would be important to note as well. This 
could potentially allow the bacteria to spread very rapidly however could be a major ethical 
concern when considering field release. 
5.2.2. Field testing 
The last step of this multi-study research is to test these paratransgenic strains in the field. 
To do this, the first experiments to be performed could use a semi-field study as was done with 
plasmid based Asaia by Mancinni et al, 201685. In this way, different bacterial release strategies 
can be tested for their effectiveness. Once these methods are validated in a semi-field setting, 
experiments can be moved to field sites such as those in Burkina Faso.  
 There are a number of ways to introduce these bacterial strains to a natural environment. 
As has been done in the lab, these bacteria can be mixed with sugar in a feeding station that the 
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natural population of mosquitoes can feed off of. These strains may also be inoculated into larval 
water to colonize the larvae and subsequently the adults. This may be able to also be 
accomplished by Asaia colonized eggs being laid in the water. In a very small experiment 
performed during this study GFP fluorescent Asaia was passed from mosquitoes to their eggs 
and into the larval water. When all the larva had pupated, the larval water was saved and 
uninoculated eggs were placed into this water. The GFP Asaia was shown to colonize this fresh 
larva and persist in the emerged adult. More experiments involving this technique would need to 
be accomplished before this method of environmental release can be verified.  
 Lastly, these bacteria can be introduced into the environment through introduction of 
infected males. By infecting males with these bloodmeal-induced antimalarial strains the bacteria 
do not need to undergo the fitness pressures of a blood meal since only female mosquitoes feed 
on blood. It has been shown that Asaia infected male mosquitoes can spread the bacteria during 
copulation to the offspring64. This would bypass the induction of the bacteria in the female due to 
the blood meal needed to produce eggs. Therefore, the second generation of the mosquitoes 
would have had no appreciable fitness disadvantage until it is already established in the 
population.  
5.3. Closing remarks 
The data obtained through this work enhances the possibility to employ a paratransgenic 
technique to combat the spread of malaria in wild populations of mosquitoes. Once these 
transgenic Asaia strains have been made stable the implementation of them in the field can be of 
great use in the fight against this deadly disease. Furthermore, because this paratransgenic 
strategy uses symbiotic bacteria that are found throughout a range of arthropod vectors, it may be 
possible to use this method to inhibit the vectorial capacity of not only many different Anopheles 
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mosquitoes but a wide array of disease causing vectors. This in effect becomes an extremely 
valuable tool for vector-borne disease control. 
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7. Appendix 
7.1. Supplementary tables 
Supplementary Table 1.) Bacterial species and plasmids used in this study 
Species Relevent Characteristics Source 
E. coli Top 10 
F' 
Fˉ mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 
∆lacX74 recA1 araD139 ∆(ara-leu)7697 galU galK 
rpsL (Strz) endA1 nupG 162 
E. coli HB101 E. coli K-12/B hybrid, Smr recA thi pro leu hsdRM 107 
S17-1λpir  
E. coli K-12 Tpr Smr recA thi hsdRM1 RP4::2-
Tc::Mu::Km Tn7, λpir phage lysogen 163 
Asaia 
bogorensis 
Isolate from orchid tree flower, Indonesia (ATCC 
BAA-21) 100 
Asaia sp. 
SF2.1 Wild-type strain isolated from Anopheles mosquitoes 83 
Plasmids  Relevant Characteristics Source 
pRK600 
Cmr ColE1oriV RP4tra RP4oriT helper plasmid in 
triparental matings 163 
pGLR1 
Promoterless GFP-lux Dual reporter, Kanamycin 
resistance, pBBR origin. Creates Asaia strain 
AGLR1. 164 
pGLR1. 1F7 
pGLR1 with library screened promoter at MCS for 
GFP-lux dual reporter. Creates Asaia strain 
AGLR1.1F7. This has been confirmed as 
contaminated 
This 
study 
pGLR1. 16G9 
pGLR1 with library screened promoter at MCS for 
GFP-lux dual reporter. Creates Asaia strain 
AGLR1.16G9. This has been confirmed as 
contaminated 
This 
study 
pGLR1. pnptII 
pGLR1 with labelled pnptII promoter from ANB50 at 
MCS for GFP-lux dual reporter. Creates Asaia strain 
AGLR1.pnptII. This has been confirmed as 
contaminated 
This 
study 
pGLR1. Hem 
pGLR1 with 500 base pair HmuT homolog promoter 
at MCS for GFP-lux dual reporter. Creates Asaia 
strain AGLR1.Hem. 
This 
study 
pGLR1.B2 
pGLR1 with bacterioferritin homolog promoter at 
MCS for GFP-lux dual reporter. Creates Asaia strain 
AGLR1.B2. 
This 
study 
pGLR1.HF 
pGLR1 with shortened HmuT homolog promoter at 
MCS for GFP-lux dual reporter. Creates Asaia strain 
AGLR1.HF. 
This 
study 
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pGLR1.FH 
pGLR1 with Iron transport protein promoter ahred in 
the reverse direction with the HmuT homolog 
promoter at MCS for GFP-lux dual reporter. Creates 
Asaia strain AGLR1.FH. 
This 
study 
pGLR1.SodB 
pGLR1 with SodB homolog promoter at MCS for 
GFP-lux dual reporter. Creates Asaia strain 
AGLR1.SodB. 
This 
study 
pGLR1.AcnA 
pGLR1 with AcnA homolog promoter at MCS for 
GFP-lux dual reporter. Creates Asaia strain 
AGLR1.AcnA. 
This 
study 
pGLR1.FtnA 
pGLR1 with FtnA homolog promoter at MCS for 
GFP-lux dual reporter. Creates Asaia strain 
AGLR1.FtnA. 
This 
study 
pGLR1.Bfr 
pGLR1 with Bfr homolog promoter at MCS for GFP-
lux dual reporter. Creates Asaia strain AGLR1.Bfr. 
This 
study 
pGLR1.Ferr 
pGLR1 with ThxC homolog promoter at MCS for 
GFP-lux dual reporter. Creates Asaia strain 
AGLR1.Ferr. 
This 
study 
pGLR1.HlyA 
pGLR1 with HlyA homolog promoter at MCS for 
GFP-lux dual reporter. Creates Asaia strain 
AGLR1.HlyA. 
This 
study 
pGLR1.HlyC 
pGLR1 with HlyC homolog promoter at MCS for 
GFP-lux dual reporter. Creates Asaia strain 
AGLR1.HlyC. 
This 
study 
pBBR1MCS-2 Used for Plasmid construction 165 
pNB50 
Constitutive GFP plasmid driven by the nptII 
promoter. Creates Asaia strain ANB50. 166 
pNB97 
Antimalarial Scorpine driven by nptII promoter, 
siderophore secretion signal, PhoA reporter gene, 
Kanamycin resistance. Creates Asaia strain ANB97. 88 
pCG18 
Antimalarial Scorpine driven by nptII promoter, 
TonB secretion signal, PhoA reporter gene, 
Kanamycin resistance. Creates Asaia strain ACG18. 
This 
study 
pCG18.glr1 
pCG18 with pGLR1 terminator and MCS upstream 
of scorpine. Creates Asaia strain ACG18.glr1. 
This 
study 
pCG18.Hem 
pCG18.glr1 with 500 bp HmuT homolog promoter at 
MCS driving scorpine. Creates Asaia strain 
ACG18.Hem. 
This 
study 
pCG18.HF 
pCG18.glr1 with shortened HmuT homolog promoter 
at MCS driving scorpine. Creates Asaia strain 
ACG18.HF. 
This 
study 
pCG18.HlyA 
pCG18.glr1 with HlyA homolog promoter at MCS 
driving scorpine. Creates Asaia strain ACG18.HlyA. 
This 
study 
pCG18.HlyC 
pCG18.glr1 with HlyC homolog promoter at MCS 
driving scorpine. Creates Asaia strain ACG18.HlyC. 
This 
study 
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Supplementary Table 2.)  Primers used in this study 
Oligo Sequence 5' - 3' Purpose 
FAsodB.AVRII TACCTAGGGTCATCAACGGCAT
CATGGGC 
Cloning promoter region of sodB 
into pGLR1 
RAsodBSPHI TAGCATGCGGTCGCGTCTCCTG
GACT 
Cloning promoter region of sodB 
into pGLR1 
FpnptIIMboI TAGATCAACCGGAATTGCCAGC
TGGGG 
Cloning promoter pnptII from 
ANB50 into pGLR1 
RpnptIIMboI TAGATCTTTTTCCTCCTTATAAA
GTTAATC 
Cloning promoter pnptII from 
ANB50 into pGLR1 
FAacnaAVRII TACCTAGGATCCAGCGCTGCAC
CC 
Cloning promoter region of acnA 
into pGLR1 
RAacnaSPHI TAGCATGCGGCTTGTCCTCCTG
CCTTG 
Cloning promoter region of acnA 
into pGLR1 
FAbfrAVRII TACCTAGGCCAGCGTGATCGAG
AGTGG 
Cloning promoter region of bfr into 
pGLR1 
RAbfrSPHI TAGCATGCCAGCCATTCCACTT
CAGAACGG 
Cloning promoter region of bfr into 
pGLR1 
FAhemAVRII TACCTAGGGGTGAGGATCATGT
AGGGCT 
Cloning promoter region of hmuT 
into pGLR1 
RAhemSPHI TAGCATGCGGTTCCTGACCCTT
TTCTGC 
Cloning promoter region of  hmuT  
into pGLR1 
FAB2AVRII TACCTAGGACCAAGAGCGAGA
TCGGT 
Cloning promoter region of  
bacterioferritin 2  into pGLR1 
RAB2SPHI TAGCATGCGGTTGGCTCCTTTT
TCTGT 
Cloning promoter region of  
bacterioferritin 2  into pGLR1 
FAferrEcoRI GAATTCCTCTCCGGTTGCCC Cloning promoter region of  trxR 
homolog into pGLR1 
RAferrBamHI1 GGATCCCCATATCTGTCCGG Cloning promoter region of trxR 
homolog into pGLR1 
FAhlyaAvrII TACCTAGGCGCCCGATCTTGAA
AC 
Cloning promoter region of hlyA 
into pGLR1 
RAhlyaSphI TAGCATGCTGGGGCTTTTCCGC Cloning promoter region of hlyA 
into pGLR1 
FpGLR1term/m
csNsiI 
TACAGTATGCATGGCGCGCCCA
GCTG 
Cloning of terminator and MCS of 
pGLR1 into pCG18 at promoter 
region 
RpGLR1term/m
csNdeI 
TACAGTCATATGTTTTTCCTCCT
GCATGCC 
Cloning of terminator and MCS of 
pGLR1 into pCG18 at promoter 
region 
QPCR Hemin 
ABC F 
GCGGACATAGGTCGTCCATT Quantifying the amount of transcript 
being made of HmuT in wild-type 
Asaia SF2.1 
QPCR Hemin 
ABC R 
ACGCTTAAGGCGTGGAAAGA Quantifying the amount of transcript 
being made of HmuT in wild-type 
Asaia SF2.1 
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QPCR B2 F GCTTTCACCCACCAGGATCT Quantifying the amount of transcript 
being made of bacterioferritin 2 
protein in wild-type Asaia SF2.1 
QPCR B2 R CTGATCGAGCGCATCCTGTA Quantifying the amount of transcript 
being made of bacterioferritin 2 
protein in wild-type Asaia SF2.1 
qpcr 16S f CTCGGAATGACTGGGCGTAA Quantifying the amount of transcript 
being made of 16S rRNA in wild-
type Asaia SF2.1 
qpcr 16S r TATCAAATGCAGCCCCAAGGT Quantifying the amount of transcript 
being made of 16S rRNA in wild-
type Asaia SF2.1 
qpcr 23S f CCCAGCTCACGTACCACTTT Quantifying the amount of transcript 
being made of 23S rRNA in wild-
type Asaia SF2.1 
qpcr 23S r CTCGATGTCGGCTCATCACA Quantifying the amount of transcript 
being made of 23S rRNA in wild-
type Asaia SF2.1 
GFP QPCR 
FWD 
GATGGAAGCGTTCAACTAGCA Quantifying the amount of transcript 
being made of GFP from pGLR1 
transformed Asaia 
GFP QPCR 
REV 
GCAGATTGTGTGGACAGGTAAT Quantifying the amount of transcript 
being made of GFP from pGLR1 
transformed Asaia 
FpGLR1term/m
csGibs 
TTGTGATGGCTTCCATGTCGCA
GCTGTCTAGGGCGGCGG 
Gibson assembly of pGLR1 
construct promoter regions into 
pCG18  
F18promGibs GAAAAACATATGAAACTTCGC
AAG 
Gibson assembly of pGLR1 
construct promoter regions into 
pCG18 
R18promGibs CGACATGGAAGCCATCAC Gibson assembly of pGLR1 
construct promoter regions into 
pCG18 
RGLRhfGibs CTGCTTGCGAAGCTTCATATGT
TTTTCCCTAATGCTCATGGTTCC
TG 
Gibson assembly of pGLR1.HF 
promoter regions into pCG18 
RGLRhlyaGibs CGAAGCTTCATATGTTTTTCGC
ATGCCAAGCCCAAGGGTG 
Gibson assembly of pGLR1.HlyA 
promoter regions into pCG18 
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Abstract  
Asaia sp. are abundant members of the microbiota of Anopheles sp. mosquitoes, the principle 
vectors of malaria.  Here we report the draft genome sequence of Asaia sp. strain SF2.1. This 
strain is under development as a platform to deliver antimalarial peptides and proteins to adult 
female Anopheles mosquitoes.  
  
Asaia sp. SF2.1 is a Gram-negative member of the alpha-Proteobacteria, family 
Acetobacteraceae (12).  Asaia sp. were first isolated from the nectar of tropical flowers and 
subsequently from insect midguts (3, 7, 12, 13).  The taxonomy of the genus Asaia is in flux and 
we are hesitant to assign Asaia sp. SF2.1 to a specific species, although it seems to be most 
closely related to either Asaia bogorensis or Asaia platycodi (unpublished obervations).  Asaia 
sp. SF2.1 was isolated from a laboratory colony of Anopheles stephensi where it is extremely 
abundant in the gut, salivary glands, ovaries and testes of this insect (5).  Asaia sp. have also 
been uncovered in Anopheles mosquitoes in the field, especially An. gambiae, the most 
important vector of malaria in Africa (3, 4, 6).  Efforts to genetically engineer Asaia sp. SF2.1 
are underway in order to provide a platform to deliver antimalarial effector molecules to 
Anopheles mosquitoes in the field in an effort to block transmission of malaria, a strategy called 
paratransgenesis (1, 6, 11).  The sequence reported here is the first for the genus.  
  
Sequencing and annotation of the genome of Asaia sp. SF2.1 was performed by ACGT, Inc.  The 
standard protocol for the NexteraXT DNA sample preparation kit was used.   
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The purified fragmented DNA was used as a template for a limited cycle PCR using Nextera 
primers and index adaptors.  A second library was prepared using the Nextera Mate Pair Sample 
Preparation Kit.  
  
In order to generate clusters of DNA, both libraries were sequenced in a paired-end 2 x 150 bp 
protocol by MiSeq™.   The sequence reads passing the Illumina purity filter were demultiplexed.  
4,097,892 standard library reads were generated, giving an average coverage of 351X based on 
the 3.5Mb genome.  To generate additional mate pair reads, a second MiSeq run was done using 
the mate pair library.  This run generated 999,241 mate pair reads (86X coverage).  
  
De Novo Sequence Assembly  
A 93X coverage subset of the small-insert library and the mate-pair library were assembled de 
novo using ABySS (10), Velvet (14), and SOAPdenovo2 (8).   The best Velvet, ABySS, and 
SOAPdenovo2 contig sets were combined together using CISA (9) to produce an assembly with 
51 contigs. The largest contig is 506 kb, the N50 length is 162 kb, and the total assembly length 
is 3.5 Mb. The GC content is 59.6%.  
  
Genome Annotation  
Annotation of the genome was performed by the NCBI Prokaryotic Genome Annotation Pipeline 
version 2.0 (https://www.ncbi.nlm.nih.gov/genome/annotation_prok/).   A total of 3098 genes 
were predicted using this method, including 3005 protein-coding genes, 44 pseudogenes, 3 
rRNAs, and 45 tRNAs.  
  
Nucleotide sequence accession numbers.    
This Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the 
accession AYXS00000000. The version described in this paper is version AYXS01000000.  
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Abstract 
Vector-borne diseases are a substantial portion of the global disease burden; one of the deadliest 
of these is malaria. Vector control strategies have been hindered by mosquito and pathogen 
resistances, and population alteration approaches using transgenic mosquitos still have many 
hurdles to overcome before they can be implemented in the field. Here we report a paratransgenic 
control strategy in which the microbiota of Anopheles stephensi was engineered to produce an 
antiplasmodial effector causing the mosquito to become refractory to Plasmodium berghei. The 
midgut symbiont Asaia was used to conditionally express the antiplasmodial protein scorpine only 
when a blood meal was present. These blood meal inducible Asaia strains significantly inhibit 
pathogen infection, and display improved fitness compared to strains that constitutively express 
the antiplasmodial effector. This strategy may allow the antiplasmodial bacterial strains to survive 
and be transmitted through mosquito populations, creating an easily implemented and enduring 
vector control strategy. 
More than half of the world’s population is at risk of vector-borne diseases, which make up one-
sixth of all global illnesses1. Factors such as insecticide resistance, urbanization, globalization, 
and climate change have caused these diseases to expand and adapt to new environments. Many 
of the disease causing pathogens are transmitted through blood ingestion by arthropod vectors, the 
most prevalent of which are mosquitoes2. Current preventative measures for these diseases revolve 
around vector control strategies, most commonly through the use of insecticides. However, 
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increasing resistance to insecticides creates a need to combat vector-borne diseases with new 
approaches3–5. 
Progress has been made in novel control strategies that involve mosquito population reduction 
(i.e., decreasing the number of potential vectors), and population alteration (i.e., changing the 
ability of vectors to transmit pathogens)6. Many studies involve the production and release of 
transgenically modified mosquitoes to accomplish these goals. These engineered mosquitoes cause 
sterility or death to achieve population reduction or are refractory to pathogen infection causing 
population alteration7–9. However, like traditional sterile insect technique strategies, maintaining 
population reduction strategies in the field requires continual reintroductions of the transgenic 
mosquitoes3,9 until the local population becomes extinct. The implementation of population 
alteration strategies in the field is, in principle, very challenging due to the difficulty of spreading 
and sustaining the transgenes throughout large populations of mosquitoes5. For example, Aedes 
aegypti mosquitoes were engineered to be resistant to the dengue virus; however, after 17 
generations, all resistance genes had been mutated or silenced10. This could be related to the fitness 
of the transgenic mosquitoes, which may be decreased due to factors such as extra energy costs to 
confer resistance, any mutations caused by the introduction of the exogenous gene, and inbreeding 
complications encountered when trying to introduce the gene into the population11,12. To overcome 
this pitfall, gene drive mechanisms are being investigated to drive these transgenes through 
populations to achieve high allele frequency8,13. However, roadblocks remain, including the 
development of drive resistance in the vector14,15, problems associated with releasing large 
numbers of mosquitoes in endemic areas, and ethical impacts for the surrounding communities9. 
These barriers to implementation of transgenic vectors provide a compelling basis for the 
development of simpler and easier to manipulate transgenic control strategies. 
An alternative population alteration technology is paratransgenesis16. This strategy involves the 
genetic modification of the microbiota to affect their host’s phenotype6,16. A similar strategy has 
been effective using the bacterium Wolbachia in mosquito species for population reduction as well 
as alteration17. However, when it was introduced into the microbiome, mosquito population 
dynamics were compromised18 and barriers to the transmission of the Wolbachia were erected by 
native bacterial symbionts19. Using the natural bacteria of the mosquito in a paratransgenic 
approach may overcome some of the burdens encountered during implementation of a 
transgenically-modified insect species while avoiding the deleterious effects caused by using non-
native microbes. 
One of the most serious vector-borne diseases is malaria, which causes over 430,000 deaths per 
year20. Malaria is caused by parasites in the genus Plasmodium, which have a complex life cycle 
involving a mosquito vector and a human host6. Importantly, a severe population bottleneck occurs 
at the oocyst stage of the Plasmodium life cycle within the mosquito midgut, reducing the number 
of parasites to much <1% of the original number ingested21,22. Paratransgenesis to reduce the 
frequency of malaria transmission seeks to close this bottleneck. 
Several bacterial species have been proposed for antiplasmodial paratransgenesis that were 
recovered from the vectors themselves23–25. A particularly attractive species is Asaia bogorensis. 
Asaia is transmitted from mother to offspring26, persists into adulthood27, and densely populates 
the female midgut, larval gut, and reproductive organs of Anopheles mosquitoes19,25. Furthermore, 
Asaia seems to be conserved in the mosquito microbiome, perhaps due to the benefit it generates 
for larval development20. This bacterium colonizes a substantial range of arthropod disease vectors, 
including Aedes aegypti and Aedes albopictus, vectors of a variety of human viruses such as 
dengue, chikungunya, zika, etc19., and Scaphoideus titanus, a leafhopper vector that transmits 
grapevine phytoplasma28. Potentially, pathogen inhibition engineered in this bacterium could be 
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used to control a variety of vector-borne diseases. Asaia sp. SF2.1 was genetically modified 
previously to express antiplasmodial effector molecules that were secreted into the midgut29. 
However, constitutive production of these proteins is deleterious to the fitness of these bacterial 
strains. 
Strains of Asaia suitable for release in the field will have to compete with the microbiota already 
established in the midgut and thus should be as fit as possible if they are expected to persist and 
spread throughout the mosquito population, even over short time spans. We hypothesized that 
producing antiplasmodial effector molecules only when Plasmodium is present inside the midgut 
should lead to increased fitness when compared to strains that express effectors constitutively. This 
was accomplished in this study by isolating promoters that are activated by the influx of the 
nutrients found in the blood meal, hereafter referred to as blood meal induced (BMI) promoters. 
Here we show that conditionally induced antiplasmodial genes expressed by midgut symbiotic 
bacteria not only significantly reduce the prevalence of Plasmodium infection compared to strains 
that use constitutive promoters, but also allow the transgenic bacteria to compete more effectively 
with wild type Asaia and to improved colonization of the mosquito midgut. 
Results 
Isolation of native Asaia BMI promoters. To uncover BMI promoters from Asaia sp. SF2.1, the 
sequenced genome30 was searched for genes homologous to those known to be induced by blood 
meal-like conditions in other bacterial species. Many of these genes are important in the 
pathogenesis of infectious bacteria or are used for iron homeostasis (Table 1). Promoter regions of 
these genes were cloned into the pGLR1 plasmid and used to induce expression of a dual GFP-lux 
operon31. 
 
 
 
 
Table 1 Homologous BMI promoters in related bacterial species used to make putative blood-
meal induced GFP strains of Asaia 
BMI Asaia 
strain 
Homo
logou
s 
Gene 
Original 
Species 
Primary gene 
function 
Asaia 
Homolog 
gene ID  
Amino 
acid 
similarit
y 
Referen
ce 
AGLR1.He
m 
HmuT 
Yersinia 
pestis 
Hemin ABC 
transporter 
P792_1197
5 
55% 181  
AGLR1.HF1 HmuT 
Yersinia 
pestis 
Hemin ABC 
transporter 
P792_1197
5 
55%  181 
AGLR1.Hly
A 
HlyA 
Helicobacter 
pylori 
Hemolysin 
P792_0912
5 
51% 138  
AGLR1.Hly
C 
HlyC 
Vibrio 
cholera 
Hemolysin 
transferase 
P792_0965
5 
55% 139 
AGLR1.Ferr TrxR 
Helicobacter 
pylori 
Oxidative stress 
protection 
P792_1206
5 
43% 140 
AGLR1.Sod
B 
SodB 
Escherichia 
coli 
Oxidative stress 
protection 
P792_0822
0 
62% 141 
AGLR1.Bfr Bfr 
Escherichia 
coli 
Iron storage 
P792_1287
0 
74% 142 
AGLR1.Acn
A 
AcnA 
Escherichia 
coli 
TCA cycle enzyme 
P792_1403
5 
76% 143 
1
AGLR1.HF was constructed using the same but greatly shortened promoter region used in 
AGLR1.Hem 
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Six of eight putative BMI promoters exhibited conditional expression when the bacteria were 
exposed to blood in vitro: AGLR1.Hem, AGLR1.HF, AGLR1.SodB, AGLR1.HlyA, AGLR1. 
HlyC, and AGLR1.Ferr. Each strain was first qualitatively tested on minimal chocolate agar which 
contains lysed red blood cells. The strains that produced fluorescence only on blood supplemented 
plates were then evaluated for induction in liquid media, and GFP production was quantified using 
a fluorescent spectrophotometer. AGLR1.SodB and AGLR1.Ferr showed no significant difference 
in fluorescence between growth on minimal media versus growth in liquid media supplemented 
with blood. AGLR1. Hem, AGLR1.HF, AGLR1.HlyA, and AGLR1.HlyC were significantly 
induced in the blood supplemented cultures (Fig. 1). 
 
  
Fig. 1 Putative BMI promoters significantly increase fluorescence of four Asaia conditional strains when 
exposed to blood. There was a significant difference in mean fluorescence for four BMI isolates in minimal 
media compared to media supplemented with blood (Welch’s t-test, n = 10 for each strain and condition). 
No significant difference between the different media was seen for both the positive (ANB50) and negative 
(AGLR1) controls, as well as the SodB and Ferr strains. Fluorescence readings were taken during log phase 
and normalized to the OD600 of each culture. Height of bars are the mean value for that treatment. Error bars 
represent standard error of the mean (s.e.m.) (n = 10). Individual data points are superimposed on the bar 
charts. Statistical significance was determined using Welch’s two-tailed t-test where significance is 
represented by *P < 0.05, **P < 0.01, and ***P < 0.001. Only significant differences are labeled 
 
Once the conditionality of the promoters was validated in vitro, experiments were performed 
inside the mosquito midgut to ensure the conditional activity of the promoters was retained. Each 
bacterial strain was fed to female Anopheles stephensi mosquitoes in a 0.1 OD600 dilution sugar 
meal. The bacteria were allowed to colonize the mosquito for 24 h and the test groups were split 
for subsequent blood or sugar feeding. After 2 days all the mosquito midguts were dissected, and 
each strain was analyzed for differential fluorescence between blood-fed and sugar-fed conditions 
(Fig. 2). Asaia strains AGLR1.Hem, AGLR1. HF, AGLR1.HlyA, and AGLR1.HlyC retained their 
conditionality in mosquitoes. AGLR1.SodB and AGLR1.Ferr exhibited high background or 
constitutive expression inside the midgut, respectively, which was similar to their behavior in 
liquid media. 
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Construction and fitness measures of antiplasmodial strains. The four validated BMI promoters 
were cloned from the reporter plasmid pGLR1 into the scorpine secretion plasmid pCG18 
[https://www.ncbi.nlm.nih.gov/nuccore/?term = MG702576]. A transcriptional terminator was 
added upstream of the BMI Asaia promoters to ensure that there was no transcriptional interference 
from the kanamycin resistance gene, creating pCG18.glr1 
[https://www.ncbi.nlm.nih.gov/nuccore/?term = MG702577] (Fig. 3). The promoters drive a 
scorpine antiplasmodial effector gene fused to E. coli phoA which encodes an alkaline phosphatase 
reporter gene. This effector configuration was used previously with constitutive promoters and was 
shown to be highly refractory to P. berghei infection29. The BMI scorpine strains were tested for 
conditionality on blood and were found to produce the scorpine fusion protein only when blood 
was present (Fig. 4), reproducing the pattern found with GFP. 
 
Fig. 2 BMI Asaia strains retain GFP induction in vivo in response to a mosquito blood meal. Bacterial 
cultures of each strain were fed to mosquitoes and differences in fluorescence were analyzed by eye 
between the blood fed and sugar fed individuals of each strain. AGLR1, which contains no promoter, is 
the negative control and ANB50 is a constitutively fluorescent positive control. The strains outlined in 
gray, AGLR1.Hem, HF, HlyA and HlyC, show conditional fluorescence when exposed to a blood meal vs 
sugar meal indicating these promoters are induced by the blood meal in the mosquito. Images are 
representative of all observed midguts and all midguts were observed at the same magnification. The size 
bars are each 100 µM 
AGLR1 
N = 127 
AGLR1.Hem 
N = 105 
AGLR1.HF 
N = 76 
AGLR1.SodB 
N = 61 
AGLR1.HlyA 
N = 69 
AGLR1.HlyC 
N = 67 
AGLR1.Ferr 
N = 62 
ANB50 
N = 115 
Strain Sugar fed Blood fed 
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Fig. 3 Antiplasmodial vector pCG18.glr1. BMI promoters were added at the multiple cloning site to drive 
the antiplasmodial effector scorpine in the promoterless pCG18.glr1. This plasmid was generated from 
the fusion of the promoter region of pGLR1 into the constitutive antiplasmodial plasmid pCG18 that 
contains a secreted protein fusion of scorpine and alkaline phosphatase. T1 transcriptional terminator from 
E. coli rrnB, Rep pBBR1 origin of replication, 
KanR kanamycin resistance, mcs multiple cloning site, TonB SS Asaia TonB dependent signal sequence 
for secretion, phoA E. coli alkaline phosphatase 
 
Fig. 4 Scorpine is conditionally expressed in all BMI isolates when blood is present. Expression of 
scorpine was evaluated from colonies collected from minimal media agar plates (M) and chocolate agar 
plates that contain lysed blood (B) in a western analysis using an anti-alkaline phosphatase antibody to 
detect the fusion constructs. Two bands were detected by the antibody. The larger band (ca. 61.1 kD) 
correlates with the size of the secreted protein that contains the secretion signal while the smaller band 
(ca. 55.4 kD) correlates to the size of the protein construct lacking the secretion signal. All conditional 
constructs show protein production only when blood is supplemented in the media, whereas the 
constitutive strain (ACG18) produces the fusion protein on both media. SF2.1 = wild type Asaia; ACG18 
= constitutive expression of scorpine by Asaia; all others are strains where scorpine is driven by a BMI 
Sf2.1     
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Before testing for Plasmodium inhibition, the fitness of each of the strains was assessed to 
evaluate whether they differed from the Asaia strain that constitutively expresses scorpine. These 
data were measured in three ways: comparisons of maximum growth rate, competition between 
wild-type Asaia and transgenic strains in co-culture, and the relative ability of the strains to 
colonize mosquito midguts. The results of these analyses are shown in Fig. 5. 
Firstly, the maximum growth rate (µmax) of each strain was measured (Fig. 5a). While none of 
the paratransgenic strains grew as well as the wild-type Asaia control, the ACG18.Hem and 
ACG18.HlyA strains showed a significant increase in µmax over the constitutive positive control 
strain ACG18. 
Secondly, a competition experiment was performed in which each antiplasmodial strain was 
grown in the same culture at an equal initial density with wild-type Asaia. First, a plasmid retention 
experiment was conducted for all strains. Over a period of 6 h no significant loss of plasmid 
occurred while the strains were grown without antibiotic (Supplementary Fig. 1). For the 
competition, the scorpine secreting strains were grown in a 50/50 co-culture with wild-type Asaia 
inoculated at a 0.5 OD600, which is the beginning of log phase for the bacteria. These cultures were 
allowed to grow for 6 h and then plated on minimal media with or without antibiotic. The ratio of 
surviving transgenic Asaia was calculated by comparing the number of colony forming units 
(CFUs) on the kanamycin supplemented plates, which only contained strains harboring the 
antiplasmodial plasmid, to the non-selective plates, containing all of the bacteria present in the 
culture (Fig. 5b). The constitutively expressing strain showed the greatest reduction in the ratio of 
paratransgenic to wild-type CFUs while the BMI strains all retained significantly higher ratios of 
transgenic bacteria compared to the constitutive control strain. This is especially true for the 
ACG18.Hem construct which represented half of the bacterial population when grown with the 
wild-type Asaia strain, the same proportion as at the beginning of the experiment. 
Finally, the relative ability of these strains to colonize mosquito midguts was measured. The 
transgenic bacteria were fed to the mosquitoes as was done in the fluorescence experiments 
described above. After 2 days, ten midguts carrying each strain were dissected, homogenized in 
PBS, and paratransgenic CFUs were enumerated (Fig. 5c). ACG18.HlyA had the highest rate of 
colonization in the midgut followed by ACG18.Hem. A significant increase in colonization was 
also seen for ACG18.HF compared to ACG18. ACG18.HlyC did not show a significant increase 
in colonization over the constitutive control. 
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BMI promoters used for Plasmodium inhibition. Each antiplasmodial Asaia strain and wild-type 
Asaia were fed to A. stephensi mosquitoes as was done with the GFP strains. The mosquitoes were 
then fed on mice infected with Plasmodium berghei, a rodent model system for malaria. The 
parasites were left to develop in the mosquitoes for 12 days before the mosquitoes were dissected 
  
 
 
Fig. 5 BMI strains demonstrate increased fitness compared to a constitutively-expressing strain. a Growth 
curves and maximum growth rates were calculated from 10 individual isolates of each strain grown over 
log phase of the bacteria using RStudio; b Each strain was competed in minimal media with wild-type Asaia 
SF2.1 in an initial 50/50 co-culture during log phase of the bacteria. Ratios of transgenic vs. whole culture 
CFUs are displayed. A 50:50 ratio indicates no loss of the paratransgenic strain during the course of the 
experiment; c Antiplasmodial Asaia strains were fed to mosquitoes and 10 midguts from each sample were 
pooled and plated on selective media. Transgenic CFUs were counted for each isolate and taken as a ratio 
of the total across all strains. For each panel, box bars are medians. The top and bottom of the boxes 
represent the first and third quartile of the data spread. The lower and upper bounds of the whiskers are the 
lowest datum still within 1.5X interquartile range (IQR) of the lower quartile, and the highest datum still 
within 1.5X IQR of the upper quartile, respectively. Data lying beyond the upper or lower 1.5X IQR ranges 
are shown as single points. Statistical significance for each experiment was determined using one way 
ANOVA with Dunnett’s correction where significance is represented by *P < 0.05, **P < 0.01, and ***P 
< 0.001 with experimental replicates (n = 10, a; n ≥ 10, b; n = 3, c). Only significant comparisons are shown 
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and oocyst numbers counted for each midgut (Fig. 6). A significant decrease in median oocyst 
numbers occurred for all strains secreting the antiplasmodial construct when compared to 
mosquitoes fed on the wild-type Asaia sp. SF2.1. All scorpine secreting strains reduced the oocyst 
median number to almost one tenth of the wild-type control, indicating a strong antiplasmodial 
effect in these paratransgenic mosquitoes. Most importantly, the prevalence (the number of 
midguts showing any oocysts at all) of P. berghei infection was reduced significantly (26.3% – 
41.4%) for all BMI strains compared to wild-type Asaia (χ2, P < 0.01), whereas the constitutive 
strain did not (χ2, P = 0.081). Three of the four BMI strains reduced prevalence to a significant 
degree when compared to the constitutive strain. The strain that performed best against P. berghei 
(ACG18. Hem) also scored highest in two of the three fitness measurements (µmax and 
competition with wild-type Asaia), and second highest in its relative ability to colonize the 
mosquito midgut (Fig. 5). 
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Discussion 
Mosquito-borne diseases remain a persistent threat to over half of the world’s population, and their 
range has been spreading due to globalization, urbanization, and climate change32–34. Current 
preventative strategies center around controlling the vectors of these diseases; most often, this 
involves the use of bed nets and insecticides3,35,36. However, many mosquito species have evolved 
resistances to commonly used insecticides37 and some have even altered their biting behavior to 
gain access to humans at times of the day when bed nets are not being used38. Other vector control 
strategies involve transgenically modifying the mosquito vector genome; however, mutations in 
transgenes, reproductively isolated populations, as well as the large number of species that vector 
particular pathogens may make implementing this technology challenging in the field6,39,40. 
Paratransgenesis offers the possibility to bypass these roadblocks by utilizing bacteria to alter the 
disease transmission phenotype of mosquito vectors. Several bacterial species have been developed 
for use in antiplasmodial paratransgenesis, including ones that are naturally antiplasmodial (e.g., 
Enterobacter sp Esp_Z. and Chromobacterium sp. Csp_P.)23,24 or that have been genetically 
modified (e.g., Pantoea agglomerans, Serratia marcescens AS1, and Asaia sp. SF2.1)29,41,42. An 
ideal paratransgenic candidate is one that can be genetically modified, colonizes vector mosquitoes 
in the same body compartments where pathogens develop, spreads through mosquito populations, 
and is not a human pathogen. Asaia sp. SF2.1 meets all of these criteria. It colonizes Anopheles 
midguts, testes, ovaries, and 
promoter 
salivary glands25 and spreads in mosquito populations vertically and horizontally43. Importantly, 
there are very few reported human infections caused by members of the genus Asaia44–48. Asaia is 
not naturally antiplasmodial, so to make it a useful paratransgenic platform it must be genetically 
modified to express antiplasmodial factors. Genetic modifications of bacteria, however, can lead 
to a severe loss of bacterial fitness. In laboratory strains of E. coli, for example, numerous strategies 
have been developed over the years to control heterologous gene expression to allow for the 
production of foreign proteins because experience has shown that this often leads to a severe loss 
of fitness49,50. Strategies include varying the gene dosage of the heterologous gene by utilizing 
plasmids that vary in copy number and, more commonly, using conditional promoters to tightly 
control gene expression to the time preferred by the experimenter. For antiplasmodial 
paratransgenic strains to be most effective, they should be as fit as possible in order to compete 
with the microbiota already present in the midgut, and this will be especially true in the field where 
we can expect the microbiota of Anopheles to be more complex than that of lab colonies. We 
hypothesized that placing antiplasmodial genes under the control of a conditional promoter would 
increase Asaia fitness, allow the transgenic strains to colonize the midgut more efficiently, and 
lead to improved paratransgenesis. 
The most obvious change of condition in the mosquito related to Plasmodium sp. infection is the 
ingestion of an infected blood meal by female Anopheles mosquitoes. The introduction of blood 
into a mosquito midgut causes a striking environmental shift for the symbiotic bacteria in the 
midgut as well as a substantial increase in microbial flora51. This change in environment can induce 
a variety of conditionally expressed genes in the native microbiome. We isolated four Asaia 
promoters based on homology to genes in other bacterial species that showed conditional 
expression when exposed to blood. These promoters 
allowed induction of GFP in the midguts of blood fed female An. stephensi (Fig. 2) and retained 
conditional expression of the antiplasmodial peptide scorpine when the bacteria were grown on 
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agar plates that contained lysed red blood cells (Fig. 4). Importantly, the BMI strains showed 
significant increases in maximum growth rate, ability to compete when co-cultured with wild-type 
Asaia, and in their ability to colonize mosquito midguts when compared to Asaia strains where 
scorpine was constitutively expressed (Fig. 5), all measurements commonly associated with 
bacterial fitness. Finally, three of the BMI strains led to superior performance when the strains 
were employed paratransgenically to block P. berghei development in An. stephensi (Fig. 6). In 
particular, the BMI paratransgenic strains produced a significant reduction in parasite prevalence 
when compared to the strain that constitutively expressed scorpine. Since even a single oocyst can 
make a mosquito infectious, prevalence is the statistic of importance. Indeed, it is likely that Asaia 
would perform even better under more natural conditions, considering that, in nature, mosquitoes 
are rarely infected with more than 1–5 oocysts per midgut6,21, while our control mosquitoes had a 
median number of 19 oocysts per midgut. 
Although the BMI strains reported here improve paratransgenesis, these specific strains are not 
appropriate for use in the field for at least two reasons. Firstly, the effector gene is carried on a 
broad host range plasmid that needs drug selection in order to be retained by the bacteria. Field 
strains would necessarily require effector genes to be inserted into the Asaia chromosome where 
they can be inherited stably without drug selection. In addition, chromosomal insertion is a strategy 
that is far less prone to horizontal gene transfer than are plasmids. Secondly, the strains developed 
here used a single effector gene to kill parasites in mosquitoes. Field strains would need to express 
more than one antiplasmodial effector gene simultaneously to suppress the evolution of resistance 
by Plasmodium to the antiplasmodial products, as situation that is virtually guaranteed if a single 
effector is used. Nevertheless, the conditional expression of antiplasmodial genes by 
paratransgenic Asaia represents a first step toward improving this species for eventual use in the 
field, and is a strategy that could be employed in paratransgenic bacterial strains targeted against 
any blood feeding arthropod disease vector. 
 
Methods 
Bacterial strains and plasmids. All plasmid construction was performed in E. coli Top10 F′ (Invitrogen). Bacterial 
cultures were grown at 30 °C for both liquid and solid media. Plasmids were maintained in E. coli using 30 mg L−1 
kanamycin and 120 mg L−1 kanamycin in Asaia. A list of all plasmids created in this study and the genotypes of the 
bacterial strains that were used are listed in Supplementary Table 1. 
A PCR cloning strategy was used for all GFP-containing pGLR1-derived plasmids. In order to isolate blood-induced 
promoters in Asaia, the genomes of other better-characterized bacterial species were searched for genes shown to be 
induced when the bacteria encountered blood meal-like conditions. These BMI genes were aligned to the Asaia 
sp.SF2.1 genome using BLAST to find homologs (Table 1). The promoter regions of these genes were estimated to 
be contained within 500 base pairs upstream of the translational start site or up to the next open reading frame if that 
was encountered first. If the homologous gene was contained in an operon, the promoter region of the entire operon 
was used. For strains 
AGLR1.Hem and AGLR1.HF different sizes of the same promoter region was used due to the presence of a gene 
transcribed on the reverse DNA strand. The promoter region of the operon that contained the HlyA gene was analyzed 
using Bprom52 due to its complicated annotation in NCBI. Primers used to amplify promoter regions are listed in 
Supplementary Table 2. 
Each putative BMI Asaia promoter was amplified from Asaia SF2.1 genomic DNA using a primer pair 
(Supplementary table 2) specific for the promoter and designed to amplify a region 500 bp upstream of the first ORF 
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in the operon of the homologous genes listed in Table 1.These reactions (and all subsequent PCR reactions used for 
cloning) used Phusion DNA polymerase (NEB) and the reaction 
conditions specified by the manufacturer in a final volume of 25 µl. The reactions followed a 95 °C (1 min), 52 °C (30 
s), 72 °C (1 min) cycling profile for a total of 30 cycles. The reactions were cleaned and concentrated using the DNA 
Clean & Concentrator-5 kit (Zymo Research). Purified PCR products were then cut with AvrII and SphI restrictions 
enzymes and ligated into the same sites of the pGLR1 vector except for the Hem and ferr promoter fragments which 
were cut by EcoR1 and BamH1 and ligated into those same sites in the vector. All ligations followed an optimized 
temperature-cycle ligation reaction53. 
PCR cloning and Gibson assembly54 were used to construct the antiplasmodial plasmids. A plasmid that 
constitutively expressed scorpine under the control of the nptII promoter from Tn5 was constructed in two steps. 
Firstly, pNB9229 and a GBlock (IDT) synthetic dsDNA fragment (Supplementary Table 2) that contains the first 150 
nt of the Asaia TonB receptor protein 1 gene were each digested with NdeI and PacI, the DNAs purified, and the two 
ligated together to create pCG6 [https://www.ncbi.nlm.nih.gov/nuccore/?term = MH734181]. Next, pCG6 [https:// 
www.ncbi.nlm.nih.gov/nuccore/?term = MH734181] and pNB9729 were each cut with PacI and SbfI. The vector 
backbone-TonB-phoA fragment from pCG6 [https://www.ncbi.nlm.nih.gov/nuccore/?term = MH734181] and the 
scorpine gene fragment from pNB97 were purified and then ligated together to create pCG18 
[https://www.ncbi.nlm.nih.gov/nuccore/?term = MG702576]. 
Plasmids expressing scorpine under the control of BMI promoters were constructed in two steps. Firstly, the primers 
FpGLR1term/mcsNsiI and RpGLR1term/mcsNdeI (Supplementary Table 2) were used to amplify an upstream 
transcriptional terminator and multiple cloning site from pGLR1 in a PCR reaction identical to that described above 
except pGLR1 was used as the template DNA. The PCR product was cleaned and concentrated as described above 
and the PCR product cut with NsiI and NdeI restriction enzymes and ligated into the same sites in pCG18 
[https://www.ncbi.nlm.nih.gov/nuccore/?term = MG702576]. This replaced the constitutive promoter with the 
terminator and multiple cloning sites leading to the creation of pCG18.glr1 [https://www.ncbi.nlm.nih.gov/nuccore/? 
term = MG702577] (Fig. 3). Next, a two-fragment Gibson assembly procedure was used to introduce specific BMI 
promoters into pCG18.glr1 [https://www.ncbi.nlm. nih.gov/nuccore/?term = MG702577]. The plasmid backbone was 
amplified using pCG18.glr1 [https://www.ncbi.nlm.nih.gov/nuccore/?term = MG702577] as a template and the 
primers F18promGibs and R18promGibs. BMI promoter regions were amplified from their cognate pGLR1-based 
clones using the BMI promoter specific primer pair listed in Supplementary table 2. Both PCRs were run and the 
products purified as described above. A two-part Gibson assembly reaction was conducted exactly as described by 
Gibson et al54. the products transformed into E. coli Top10F’ cells (Invitrogen), and selected using kanamycin. 
In all cases, after sequence confirmation, plasmids were transformed by electroporation55 into Asaia sp.SF2.125. 
Plasmid sequences were deposited in Genbank under accession codes MG702576 though MG702589, and 
MH734181 for pCG6. 
Mosquito and parasite growth and maintenance. Anopheles stephensi mosquitoes were a gift from the Johns Hopkins 
Malaria Research Institute. The identity of the mosquitoes was confirmed by using morphological stock identification 
characters recommended by the Malaria Research and Reference Reagent Resource Center56. Mosquitoes were reared 
at 29˚C with a 12 h light:12 h dark photoperiod and maintained as adults on a 10% sucrose solution supplied on cotton 
wicks. Mated females were fed on anesthetized mice for a blood meal and allowed to lay eggs on wet filter paper for 
2 days. All experiments involving mice were approved by the Duquesne University Institutional Animal Care and Use 
Committee and followed approved ethical practices. Eggs were washed from the filter paper into larval water in 
photographic trays until the eggs hatched. Larvae were reared at 29 ° C and fed on crushed Tetramin Tropical Tablets 
for Bottom Feeders. Pupae were collected by hand and allowed to emerge as adults in 0.03 m3 screened cages. 
Plasmodium berghei ANKA parasites were a gift from the Johns Hopkins Malaria Research Institute and were 
maintained by infecting outbred Swiss Webster female mice (Charles River Laboratories). Frozen P. berghei infected 
mouse blood of ca. 25–40% parasitemia was diluted 1:1 with RPMI 164 media and 200 µl was injected 
interperitoneally into 2 mice. After 2 days, the level of parasitemia was measured by pricking the tail with a 26 G 
needle, smearing the blood onto a glass slide, fixing with 100% methanol for 10 s, and then staining with 10% Giemsa 
stain for 30 min. Slides were washed in deionized water and the smear measured to count the fraction of red blood 
cells that were infected with parasites ( = % parasitemia). When the blood in the infected mouse reached between 4 
and 10% parasitemia, the mouse was killed and infected blood was immediately removed by heart puncture. The blood 
was diluted to 2% parasitemia with RPMI containing 6 I.U. heparin per ml. Two hundred µl of this solution was 
 165 
injected into a new mouse as described above. Thirty-six hours later, mosquitoes were allowed to feed on this mouse 
for 6 min. 
Parasites were passed through mosquitoes to recover P0 blood (a parasite infection caused by the bite of an infected 
mosquito, rather than mouse-mouse transmission). In these cases, mosquitoes were fed for 30 min on the infected 
mouse and were allowed to rest at 19 °C for 25 days. On day 25 post infection, the P. berghei infected mosquitoes 
were allowed to feed on an uninfected mouse for 30–45 min. Seven days later, the P. berghei infection level in the 
mouse was measured and the mouse was killed and blood removed by heart puncture when the infection level reached 
25–40%. Infected blood was mixed 1:1 with 30% (vol/ vol) glycerol in PBS and 6 I.U heparin per ml. This mixture 
was then flash frozen in liquid nitrogen and stored in liquid nitrogen. 
Fluorescence analysis of Asaia strains. Constitutive and BMI-driven GFP strains of Asaia were assessed for 
conditional fluorescence using both solid and liquid media. All media used in the remainder of the study was Davis 
Minimal media57 supplemented with 5% (wt/vol) nectar solution made with a 1:2:1 ratio of sucrose: fructose:glucose 
in DI water. First, the putative BMI strains were streaked to single colonies on blood-supplemented (chocolate agar) 
and replete minimal agar to assess qualitative fluorescence. All human blood used in this study was obtained from a 
healthy, unpaid volunteer after informed consent was obtained by a licensed and certified physician assistant. The 
venipuncture was performed using sterile technique and universal precautions. Any strains that showed an increase in 
fluorescence on the chocolate agar plates were analyzed in liquid culture. Strains were grown to log phase and 
separated into minimal broth with or without the addition of 2.5% (vol/vol) human blood. They were allowed to grow 
in these conditions for one h and optical density and fluorescence were measured using a SPECTRAMAX i3x from 
Molecular Devices with SoftMax Pro 7 software. The data were normalized to the fluorescence of a premeasured 
culture of the constitutively fluorescent Asaia strain ANB50 that had been separated into the varying media directly 
before analysis, to account for any signal quenching that may have resulted from the addition of the blood. Data was 
visualized in RStudio using barplot2 and dotplot58 
In vivo activity of the promoters was assessed by observing the difference in fluorescence between blood and sugar-
fed mosquitoes. The BMI strains, AGLR1 negative control, and ANB50 constitutive positive control were fed to 
mosquitoes at 0.1 OD600 in a sugar meal. Bacteria were allowed to colonize the mosquito for 24 h; then half were fed 
blood and half fed sugar. The mosquitoes that fed on blood did so for 10 min on an anesthetized mouse. All mosquitoes 
were kept for 2 days at 29 °C and fed on sugar to allow time for the blood bolus to partially digest, after which the 
midguts of all mosquitos were dissected, washed once in PBS, and analyzed with fluorescent microscopy without 
other special preparations. Fluorescence in midguts was evaluated by eye. 
Assessing the conditionality of BMI scorpine strains. To ensure that the effector scorpine was conditionally expressed 
from the antiplasmodial plasmids, the secretion of scorpine was evaluated from Asaia colonies grown on minimal 
media and chocolate agar through western blotting analysis. Each construct was grown to log phase in minimal media 
and verified through PCR before being streaked on both minimal media and chocolate agar plates. Control plates 
without bacteria were used to evaluate the amount of protein collected from the media itself. These plates were allowed 
to grow for 2 days at 30 °C before colonies were collected by flooding the plates with 1.5 ml of minimal media and 
gently scraping the cells from the plates. One ml of each cell suspension was collected and spun down at 13,800×g for 
5 min. The supernatant from these cultures was collected and placed on ice while the pellet was resuspended in 20% 
(vol/vol) B-per (Thermo-Fisher) in TBS. The total protein for each of the pelleted samples was analyzed through a 
Bradford assay after accounting for the excess protein collected from the medium containing blood. Each supernatant 
sample was then diluted to the same total protein concentration based on the protein content of the pellets and 75 µl 
of each was added to 25 µl of 3x Laemmli buffer and boiled for 10 min. Fifteen µl of these samples were loaded into 
a 10% Mini-PROTEAN® TGX™ precast gel (BioRad) with a Precision Plus Protein™ Kaleidoscope™ size standard 
(BioRad). These were run at 200 V for 30 min after which they were transferred to a PVDF membrane in a BioRad 
transfer apparatus using Tris-Glycine transfer buffer (25 mM Tris, 150 mM glycine, 10% methanol) at 100 V for 60 
min. The membrane was blocked using 4% BSA TBST solution (50 mM Tris-Cl, 150 mM NaCl, 0.1% Tween20, 4% 
(wt/vol) fraction V BSA, pH 7.5) overnight at 4 °C. The following day the blot was incubated with the bacterial 
alkaline phosphatase antibody (HRP) (GeneTex, cat. #GTX27319) at a 1:5,000 dilution suspended in blocking buffer 
and again incubated overnight at 4 °C. The membrane was then washed in cold TBS-T for 15 min four times. 
WesternBright Sirius chemiluminescent HRP substrate (Advansta, cat. # GTX27319) was applied to the membrane 
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for 2 min in the dark before being visualized on an Odyssey Fc dual mode imaging system from LI-COR The 
uncropped western blot is shown in Supplementary Fig. 2. 
Fitness assessments of antiplasmodial Asaia strains. Fitness of the antiplasmodial Asaia strains was tested in three 
ways. The first was by measuring the maximum growth rate of each strain. To do this, each Asaia strain was inoculated 
at 0.1 OD600 in 200 µl of a 96 well plate. The OD600 was analyzed over 24 h at 15 min intervals using a SPECTRAMAX 
i3x (Molecular Devices). The SoftMax Pro 7 software was used to create growth curves of collated replicates of each 
strain until they reached stationary phase. Growth curves were further analyzed using the package growthrates59 in 
RStudio to find the maximum growth rate of each strain of Asaia. Data was visualized in RStudio using boxplot58 
The ability of the transgenic strains to survive when competed in a culture with wild-type Asaia was tested in a 
competition experiment. At least ten replicates of each transgenic strain were grown to log phase (ACG18, n = 10; 
ACG18.Hem, n = 11; ACG18.HF, n = 12; ACG18.HlyA, n = 10; ACG18.HlyC, n = 12) and mixed with wild-type 
Asaia in a 50/50 ratio of a 0.5 OD600 culture. These mixed cultures were allowed to grow for 6 h, then diluted to 1.0 × 
10−5 OD600 of which 100 µl was plated on minimal media with or without 120 µg ml−1 kanamycin. The ratio of 
transgenic bacteria to wild-type was calculated by comparing the CFUs on the selective media to the CFUs on the 
nonselective media. Data was visualized in 
RStudio using boxplot58 
The final fitness assessment performed was a mosquito colonization experiment that was repeated in triplicate. Each 
strain was fed to female An. stephensi mosquitoes at a 0.1 OD600 dilution in the sugar meal. After 48 h, mosquito 
midguts were dissected and homogenized using a tissue grinder. Ten midguts for each strain were pooled and diluted 
to 100 µl PBS per midgut. These samples were again diluted 100-fold in PBS and 100 µl of each dilution was plated 
on kanamycin supplemented minimal media. CFUs for each strain were counted and compared to the total number of 
CFUs collected across test groups. Data was visualized in RStudio using boxplot58 
Plasmodium berghei inhibition analysis. To evaluate the inhibitory effect of the Asaia strains containing the 
antiplasmodial plasmid constructs, adult female ND4 Swiss Webster mice were infected with Plasmodium berghei 
ANKA60. Parasites were allowed to develop in the mice until parasitemia level reached 4–10%. At this point the mice 
were killed and blood was collected via cardiac puncture. The infected blood was diluted with RPMI media to 2% 
parasitemia, then 200 µl (5 × 107 parasites) was injected intraperitoneally into an uninfected mouse. At the time of this 
transfer, each Asaia strain to be tested was fed to An. stephensi mosquitoes at a 0.1 OD600 dilution in the sugar meal. 
Thirty-six hours post-infection each test group of mosquitoes was blood-fed on the infected mouse for 6 min each. 
The order of the test groups was rotated randomly and blindly for each of the 3 trials. The ability of the parasite to 
undergo exflagellation was also tested at this time using 6 µl ookinete media (1 L RPMI media supplemented with 2 
g sodium bicarbonate, 50 mg hypoxanthine, 20.5 mg xanthurenic acid) mixed with 10% fetal bovine serum, 2 µl of 1 
mg ml−1 of heparin in PBS, and 2 µl of blood collected from a tail prick of the mouse. At least 2 exflagellation events 
occurred for each malarial trial. Exflaggellation occurs when microgametes exit red blood cells after a female mosquito 
takes a Plasmodium-infected blood meal and can be monitored by microscopy. The number of these events in the 
blood meal is a measure of how infectious it is to the mosquito. 
Parasites were allowed to develop in the mosquitoes for 12 days at 19 °C in order to form oocysts. After 12 days, 
the mosquito midguts were dissected and stained with a 100-fold dilution of mercurochrome stain for 2 min. They 
were then left to destain for 5 min in PBS. The midguts were analyzed at 100x magnification and the number of oocysts 
per midgut were counted for each test group. All steps in this process were performed blindly and ordered randomly. 
Data was visualized in RStudio using Bee Swarm.61 
Statistics and reproducibility. Significance was set to P < 0.05. Variance was estimated using standard error of the 
mean and is appropriately similar between test groups of each experiment. Significance of the mean was calculated 
using Welch’s two-tailed t-test (Fig. 1 and Supplementary Fig. 1) or one-way ANOVA with Dunnett’s correction (Fig. 
5) in RStudio appropriate for multiple comparisons to a single control with normal distribution unless otherwise noted. 
The qualitative evaluation of fluorescent midguts represented in Fig. 2 was repeated at least 3 times per strain, and 
over 5 times for the control groups as well as AGLR1.Hem. Each trial consisted of at least 20 midguts per strain, 
therefore, 10 midguts per test group. 
In Fig. 6, the data are pooled from 3 individual experiments. The median value of oocycts per midgut was calculated 
by and compared between treatments using quantile regression62 in RStudio. Quantile regression is a non-parametric 
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test that compares subsets of a data set individually and is useful for data showing unequal variation62. The significance 
of the difference in P. berghei oocyst prevalence was evaluated using binomial χ2 tests with 1° of freedom. All colony 
and oocyst counts were done blindly regarding which strain and condition was evaluated, and the strains were ordered 
randomly. 
Code availability. All data generated in R Studio (version 1.0.136) was obtained using standard coding for the 
programs listed for each experiment. This code is available upon request and no custom code was created. The actual 
code used in this study was deposited at Dryad Digital Repository doi:10.5061/dryad.s85j284. 
Data availability 
All experimentally generated data are readily available upon request of the corresponding author. In addition, 
quantitative data and R-based code used in Figs. 1, 5a-c, and 6 were deposited at Dryad Digital Repository 
doi:10.5061/dryad.s85j284. The original, uncropped western blot from Fig. 4 is provided in Supplementary Fig. 2. 
Sequences of plasmids generated in this study have been deposited in GenBank under the accession codes MG702576 
though MG702589, and MH734181 for pCG6. 
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